Cancer,Trial_ID,Title,Sponsor,Status,URL
Lung Cancer,NCT05817110,Validating Artificial Intelligence Effectiveness Defined Lung Nodule Malignancy Score in Patients With Pulmonary Nodule.,Information provided by AstraZeneca (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05817110?cond=Lung%20Cancer&viewType=Card&page=1&rank=1
Lung Cancer,NCT00188656,Computed Tomography (CT) in Head and Neck Patients,"Information provided by University Health Network, Toronto",Terminated,https://clinicaltrials.gov/study/NCT00188656?cond=Lung%20Cancer&viewType=Card&page=1&rank=2
Lung Cancer,NCT07117539,Impact of Different Lung Isolation Devices on Pharyngolaryngeal Injuries After Pulmonary Resection,"Information provided by Tingting Li, Shanghai Chest Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT07117539?cond=Lung%20Cancer&viewType=Card&page=1&rank=3
Lung Cancer,NCT06479798,Accuracy of Convex Probe EBUS-TBNA Versus FDG,"Information provided by Fatma Alzahraa, Ain Shams University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT06479798?cond=Lung%20Cancer&viewType=Card&page=1&rank=4
Lung Cancer,NCT02345798,Video,Information provided by City of Hope Medical Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02345798?cond=Lung%20Cancer&viewType=Card&page=1&rank=5
Lung Cancer,NCT00232128,Protocol for Radiofrequency Ablation of Pulmonary Neoplasms,"Information provided by Oncology Specialties, Alabama",Terminated,https://clinicaltrials.gov/study/NCT00232128?cond=Lung%20Cancer&viewType=Card&page=1&rank=6
Lung Cancer,NCT01621698,Study of Use of Paravertebral Blocks for Pain Relief in Video Assisted Lung Surgery,Information provided by University Hospitals Bristol and Weston NHS Foundation Trust (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01621698?cond=Lung%20Cancer&viewType=Card&page=1&rank=7
Lung Cancer,NCT02013063,Single Pulmonary Nodule Investigation,Information provided by University Hospital Southampton NHS Foundation Trust (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT02013063?cond=Lung%20Cancer&viewType=Card&page=1&rank=8
Lung Cancer,NCT01451359,Endobronchial Valves in Persistent Air Leak,Information provided by Universitaire Ziekenhuizen KU Leuven (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01451359?cond=Lung%20Cancer&viewType=Card&page=1&rank=9
Lung Cancer,NCT03010033,Effect of Pulmonary Rehabilitation on Perioperative Outcomes in Smoker Patients With Lung Cancer,"Information provided by Hecheng Li M.D., Ph.D, Ruijin Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03010033?cond=Lung%20Cancer&viewType=Card&page=1&rank=10
Lung Cancer,NCT03134534,Robot,"Information provided by Hecheng Li M.D., Ph.D, Ruijin Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03134534?cond=Lung%20Cancer&viewType=Card&page=2&rank=11
Lung Cancer,NCT04889989,Microwave Ablation in Chinese Patients With Lung Tumors,"Information provided by Ethicon, Inc. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04889989?cond=Lung%20Cancer&viewType=Card&page=2&rank=12&tab=results
Lung Cancer,NCT05118347,"Effects of Buteyko Breathing Technique Versus Incentive Spirometer on Breath Holding Time, Cardiopulmonary Endurance and Quality of Life in Patients With Post Lung Tumor Resection","Information provided by Shahbaz Ahmad, University of Lahore (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05118347?cond=Lung%20Cancer&viewType=Card&page=2&rank=13
Lung Cancer,NCT03881410,The Efficacy of Shear-wave Elastography,Information provided by National Taiwan University Hospital (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03881410?cond=Lung%20Cancer&viewType=Card&page=2&rank=14
Lung Cancer,NCT00128037,Trial of Pre,Information provided by Japan Clinical Oncology Group,Completed,https://clinicaltrials.gov/study/NCT00128037?cond=Lung%20Cancer&viewType=Card&page=2&rank=15
Lung Cancer,NCT02430597,Irreversible Electroporation(IRE) For Unresectable Hilus Pulmonis Neoplasms,"Information provided by Fuda Cancer Hospital, Guangzhou (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02430597?cond=Lung%20Cancer&viewType=Card&page=2&rank=16
Lung Cancer,NCT02853188,Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung,Information provided by Hopital Foch (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02853188?cond=Lung%20Cancer&viewType=Card&page=2&rank=17
Lung Cancer,NCT06934499,Tunisian Lung Cancer Study,Information provided by Dacima Consulting (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06934499?cond=Lung%20Cancer&viewType=Card&page=2&rank=18
Lung Cancer,NCT06531850,Prospective Study of Serum Marker LncRNA RP5,Information provided by Affiliated Cancer Hospital & Institute of Guangzhou Medical University (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06531850?cond=Lung%20Cancer&viewType=Card&page=2&rank=19
Lung Cancer,NCT06322329,RealMove (Lung): Assessing Tumour Motion With Dynamic MRI,Information provided by Region Stockholm (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06322329?cond=Lung%20Cancer&viewType=Card&page=2&rank=20
Lung Cancer,NCT01734980,Endobronchial Ultrasound Transbronchial Needle Aspiration Using Needle Suction Versus No Suction,"Information provided by Michel Chalhoub, Northwell Health (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01734980?cond=Lung%20Cancer&viewType=Card&page=3&rank=21
Lung Cancer,NCT00132639,Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non,"Information provided by Haruhiko Fukuda, Japan Clinical Oncology Group (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00132639?cond=Lung%20Cancer&viewType=Card&page=3&rank=22
Lung Cancer,NCT01679470,Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors,"Information provided by Nanospectra Biosciences, Inc. (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT01679470?cond=Lung%20Cancer&viewType=Card&page=3&rank=23
Lung Cancer,NCT04717804,4D CBCT and Intrafractional Imaging for the Determination of the Most Representative 4D Simulation Planning Technique for Lung SBRT Technique Patients,Information provided by The University of Texas Health Science Center at San Antonio (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04717804?cond=Lung%20Cancer&viewType=Card&page=3&rank=24
Lung Cancer,NCT00241267,Bronchial Ultrasonography Via a Fibrescope: Pilot Study in Tumoral Disease,"Information provided by University Hospital, Tours",Terminated,https://clinicaltrials.gov/study/NCT00241267?cond=Lung%20Cancer&viewType=Card&page=3&rank=25
Lung Cancer,NCT05918783,Padeliporfin VTP Using Robotic Assisted Bronchoscopy in Peripheral Lung Cancer,Information provided by Impact Biotech Ltd (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05918783?cond=Lung%20Cancer&viewType=Card&page=3&rank=26
Lung Cancer,NCT03645915,GLUT1: A Novel Tool re fl Ecting Proliferative Activity of Lung Neuroendocrine Tumors,"Information provided by Centre Hospitalier Universitaire, Amiens (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03645915?cond=Lung%20Cancer&viewType=Card&page=3&rank=27
Lung Cancer,NCT05545085,Thoracoscopic Laser Speckle Contrast Imaging for Segment Resections,"Information provided by E.C. Boerma, Frisius Medisch Centrum (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05545085?cond=Lung%20Cancer&viewType=Card&page=3&rank=28
Lung Cancer,NCT05890872,Aliya™ Pulsed Electric Fields (PEF) for Advanced Cancer,"Information provided by Galvanize Therapeutics, Inc. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05890872?cond=Lung%20Cancer&viewType=Card&page=3&rank=29
Lung Cancer,NCT02559349,Gut Microbiota And Radiotherapy,Information provided by Abramson Cancer Center at Penn Medicine (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02559349?cond=Lung%20Cancer&viewType=Card&page=3&rank=30
Lung Cancer,NCT06440616,Benefit of Spectral Information in Patients Suspected for Lung Cancer,"Information provided by Michael Brun Andersen, Copenhagen University Hospital at Herlev (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06440616?cond=Lung%20Cancer&viewType=Card&page=4&rank=31
Lung Cancer,NCT06788912,Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER,Information provided by Merck Sharp & Dohme LLC (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06788912?cond=Lung%20Cancer&viewType=Card&page=4&rank=32
Lung Cancer,NCT05826483,Almonertinib in the First,"Information provided by Zhou Chengzhi, Guangzhou Institute of Respiratory Disease (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05826483?cond=Lung%20Cancer&viewType=Card&page=4&rank=33
Lung Cancer,NCT05974475,MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non,Information provided by European Institute of Oncology (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05974475?cond=Lung%20Cancer&viewType=Card&page=4&rank=34
Lung Cancer,NCT01783236,Analgesic Efficacy of Intravenous Acetaminophen After Video,Information provided by Weill Medical College of Cornell University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01783236?cond=Lung%20Cancer&viewType=Card&page=4&rank=35&tab=results
Lung Cancer,NCT05414188,Beneficial Effect of Pulmonary Rehabilitation in Lung Cancer Patients Receiving Radiation Therapy,"Information provided by Sei Won Lee, Asan Medical Center (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05414188?cond=Lung%20Cancer&viewType=Card&page=4&rank=36
Lung Cancer,NCT03293433,Quantification of microRNAs in Diagnosis of Pulmonary Nodules,"Information provided by University Hospital, Toulouse (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03293433?cond=Lung%20Cancer&viewType=Card&page=4&rank=37
Lung Cancer,NCT04778826,Immune Response Following Lobectomy Along With or Without Bilateral Transcervical Mediastinal Lymphadenectomy,"Information provided by Mohamed Salama, Otto Wagner Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04778826?cond=Lung%20Cancer&viewType=Card&page=4&rank=38
Lung Cancer,NCT01048762,Multidisciplinary Rehabilitation After Cancer Pulmonis Operation,"Information provided by Barbara C. Brocki, Aalborg University Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01048762?cond=Lung%20Cancer&viewType=Card&page=4&rank=39
Lung Cancer,NCT04973293,Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non,"Information provided by Hecheng Li M.D., Ph.D, Ruijin Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04973293?cond=Lung%20Cancer&viewType=Card&page=4&rank=40
Lung Cancer,NCT03834116,Resistance Inspiratory Muscle Training for Patients With Thoracic Malignancies,"Information provided by Professor Alex MOLASIOTIS, The Hong Kong Polytechnic University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03834116?cond=Lung%20Cancer&viewType=Card&page=5&rank=41
Lung Cancer,NCT05840094,Multimodalitic Imaging in the N,Information provided by Peking University First Hospital (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT05840094?cond=Lung%20Cancer&viewType=Card&page=5&rank=42
Lung Cancer,NCT04059887,Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY],"Information provided by In-Jae, Oh, MD, Chonnam National University Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04059887?cond=Lung%20Cancer&viewType=Card&page=5&rank=43
Lung Cancer,NCT03352245,Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer,Information provided by Yale University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03352245?cond=Lung%20Cancer&viewType=Card&page=5&rank=44&tab=results
Lung Cancer,NCT07064395,Bright Light Therapy on Sleep Health in Lung Cancer Patients,"Information provided by Menghua Tao, Henry Ford Health System (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT07064395?cond=Lung%20Cancer&viewType=Card&page=5&rank=45
Lung Cancer,NCT07023068,⁶⁸Ga,Information provided by Peking Union Medical College Hospital (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07023068?cond=Lung%20Cancer&viewType=Card&page=5&rank=46
Lung Cancer,NCT02985203,Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non,Information provided by Guangdong Association of Clinical Trials (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT02985203?cond=Lung%20Cancer&viewType=Card&page=5&rank=47
Lung Cancer,NCT06926140,Acupuncture Combined With PD-1/PD,"Information provided by Liu Zhishun, Guang'anmen Hospital of China Academy of Chinese Medical Sciences (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06926140?cond=Lung%20Cancer&viewType=Card&page=5&rank=48
Lung Cancer,NCT06794125,An Evaluation of Dose,"Information provided by Chris Goodman, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06794125?cond=Lung%20Cancer&viewType=Card&page=5&rank=49
Lung Cancer,NCT06816121,Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High,"Information provided by Everest Detection, Inc. (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06816121?cond=Lung%20Cancer&viewType=Card&page=5&rank=50
Lung Cancer,NCT06713564,"A Single Dose, Open-Label, Dose-escalation Study of the Safety and Imaging Characteristics of LS301",Information provided by Integro Theranostics (Responsible Party),Active,https://clinicaltrials.gov/study/NCT06713564?cond=Lung%20Cancer&viewType=Card&page=6&rank=51
Lung Cancer,NCT06772363,SERS,Information provided by Fuzhou General Hospital (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06772363?cond=Lung%20Cancer&viewType=Card&page=6&rank=52
Lung Cancer,NCT06674252,A Study on the Improvement of Postoperative Symptoms and Survival Benefits of Modified Bufei Decoction in Elderly Patients With Lung Cancer Undergoing Radical Surgery,Information provided by Peking University Cancer Hospital & Institute (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06674252?cond=Lung%20Cancer&viewType=Card&page=6&rank=53
Lung Cancer,NCT06810375,Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery,"Information provided by Akhil Patel, George Washington University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06810375?cond=Lung%20Cancer&viewType=Card&page=6&rank=54
Lung Cancer,NCT07045532,Assessment the Effectiveness of BTVA in COPD and Ablation in Pulmonary Nodules by Pulmonary MRI,"Information provided by Jiayuan Sun, Shanghai Chest Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT07045532?cond=Lung%20Cancer&viewType=Card&page=6&rank=55
Lung Cancer,NCT00344773,First,Information provided by AstraZeneca,Completed,https://clinicaltrials.gov/study/NCT00344773?cond=Lung%20Cancer&viewType=Card&page=6&rank=56&tab=results
Lung Cancer,NCT03749512,NLCR in Prediction of the Grade of Lung Tumor.,"Information provided by Piotr Palaczyński, Medical University of Silesia (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03749512?cond=Lung%20Cancer&viewType=Card&page=6&rank=57
Lung Cancer,NCT04447482,ENB Vs. Conventional Bronchoscopy With Fluoroscopy for Safe and Effective Biopsy of Pulmonary Lesions,"Information provided by Shanghai Youhe Medical Technology Co., Ltd. (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04447482?cond=Lung%20Cancer&viewType=Card&page=6&rank=58
Lung Cancer,NCT04263467,High Intensity Aerobic Exercise Training and Immune Cell Mobilization in Patients With Lung Cancer (HI AIM),"Information provided by Per thor Straten, Herlev Hospital (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT04263467?cond=Lung%20Cancer&viewType=Card&page=6&rank=59
Lung Cancer,NCT07102589,SWEEP: Shuttle Walking Test for Exercise Evaluation in Pulmonary Resection,Information provided by Seoul National University Bundang Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT07102589?cond=Lung%20Cancer&viewType=Card&page=6&rank=60
Lung Cancer,NCT06546007,Rarecells Molecular Biomarkers for Early Detection of Lung Cancer,Information provided by Rarecells Diagnostics SAS (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06546007?cond=Lung%20Cancer&viewType=Card&page=7&rank=61
Lung Cancer,NCT05915221,Effect of SMS Use on Postoperative Respiratory and Cough Exercise Compliance,"Information provided by Zeynep Kızılcık Ozkan, Trakya University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05915221?cond=Lung%20Cancer&viewType=Card&page=7&rank=62
Lung Cancer,NCT04974632,Mobile 3D C,Information provided by Chang Gung Memorial Hospital (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04974632?cond=Lung%20Cancer&viewType=Card&page=7&rank=63
Lung Cancer,NCT02696863,Plan for Systematic Identification of Lung Cancers of Occupational Origin: Implementation Study,Information provided by Institut de Cancérologie de la Loire (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT02696863?cond=Lung%20Cancer&viewType=Card&page=7&rank=64
Lung Cancer,NCT05745506,Effect of Sleep Disorder on the Development of Lung Tumors,Information provided by RenJi Hospital (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT05745506?cond=Lung%20Cancer&viewType=Card&page=7&rank=65
Lung Cancer,NCT03861091,Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT,Information provided by Wake Forest University Health Sciences (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03861091?cond=Lung%20Cancer&viewType=Card&page=7&rank=66&tab=results
Lung Cancer,NCT06542055,Compare the Effects of Preoperative Pulmonary Rehabilitation Exercises on Postoperative Anxiety and Muscle Strength,Information provided by National Taiwan University Hospital (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06542055?cond=Lung%20Cancer&viewType=Card&page=7&rank=67
Lung Cancer,NCT06236516,One Fraction Simulation-Free Treatment With CT,Information provided by Washington University School of Medicine (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06236516?cond=Lung%20Cancer&viewType=Card&page=7&rank=68
Lung Cancer,NCT01388803,The Depth of Right Bronchial Blocker Placement in Taiwanese in Video,Information provided by National Taiwan University Hospital,Completed,https://clinicaltrials.gov/study/NCT01388803?cond=Lung%20Cancer&viewType=Card&page=7&rank=69
Lung Cancer,NCT04888429,Camrelizumab Plus Famitinib as Treatment in Patient With Advanced or Metastatic Pulmonary Sarcomatoid Carcinoma,"Information provided by Qian Chu, Tongji Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04888429?cond=Lung%20Cancer&viewType=Card&page=7&rank=70
Lung Cancer,NCT02483052,RejuvenAir Lobectomy for Safety and Histology,"Information provided by CSA Medical, Inc. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02483052?cond=Lung%20Cancer&viewType=Card&page=8&rank=71
Lung Cancer,NCT00638625,Correlation of X,"Information provided by Ernest Scalzetti, State University of New York - Upstate Medical University (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT00638625?cond=Lung%20Cancer&viewType=Card&page=8&rank=72
Lung Cancer,NCT02575898,"Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort Study","Information provided by Maxwell. T. Vergo, Dartmouth-Hitchcock Medical Center (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02575898?cond=Lung%20Cancer&viewType=Card&page=8&rank=73
Lung Cancer,NCT07100444,Spinal Metastasis as the First Presentation of Lung Malignancy: Clinical Characteristics and Postoperative Survival,"Information provided by Yu Zhang, PhD, Guangdong Provincial People's Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT07100444?cond=Lung%20Cancer&viewType=Card&page=8&rank=74
Lung Cancer,NCT07146568,Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital,Information provided by Washington University School of Medicine (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07146568?cond=Lung%20Cancer&viewType=Card&page=8&rank=75
Lung Cancer,NCT06898333,Implementation and Effectiveness of the BJC,Information provided by Washington University School of Medicine (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06898333?cond=Lung%20Cancer&viewType=Card&page=8&rank=76
Lung Cancer,NCT02331056,Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy?,"Information provided by Hyun Joo Ahn, Samsung Medical Center (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02331056?cond=Lung%20Cancer&viewType=Card&page=8&rank=77
Lung Cancer,NCT06157957,Cancer Screening Smoking Cessation AND Respiratory Assessment,Information provided by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06157957?cond=Lung%20Cancer&viewType=Card&page=8&rank=78
Lung Cancer,NCT06780098,Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER,Information provided by Merck Sharp & Dohme LLC (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06780098?cond=Lung%20Cancer&viewType=Card&page=8&rank=79
Lung Cancer,NCT06638398,Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules,"Information provided by Fabien Maldonado, Vanderbilt-Ingram Cancer Center (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06638398?cond=Lung%20Cancer&viewType=Card&page=8&rank=80
Lung Cancer,NCT04529603,The Efficacy of Intraoperative Pulmonary Nodules Localization Guided by Virtual Reality Technology,"Information provided by Hecheng Li M.D., Ph.D, Ruijin Hospital (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT04529603?cond=Lung%20Cancer&viewType=Card&page=9&rank=81
Lung Cancer,NCT06419114,Exploration of Optical Coherence Tomography,"Information provided by Guanghong Zhou, Sichuan Provincial People's Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06419114?cond=Lung%20Cancer&viewType=Card&page=9&rank=82
Lung Cancer,NCT06158971,Feasibility Study of the Microwave Ablation System for Lung Tissue Ablation,"Information provided by phenoMapper, LLC (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06158971?cond=Lung%20Cancer&viewType=Card&page=9&rank=83
Lung Cancer,NCT05081674,Brazilian Lung Immunotherapy Study,Information provided by Hospital Israelita Albert Einstein (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05081674?cond=Lung%20Cancer&viewType=Card&page=9&rank=84
Lung Cancer,NCT02906280,RCT Comparing 19Ga vs 22Ga EBUS,"Information provided by Christophe Dooms, MD, PhD, KU Leuven (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02906280?cond=Lung%20Cancer&viewType=Card&page=9&rank=85
Lung Cancer,NCT06159660,Ventilation Using Radiographic Examination: Functional Lung Imaging Techniques for the Reduction of Toxicity in Functional Avoidance Radiation Therapy,Information provided by University of Sydney (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06159660?cond=Lung%20Cancer&viewType=Card&page=9&rank=86
Lung Cancer,NCT05473052,Home,"Information provided by Pedro Machado, Instituto Politécnico de Leiria (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05473052?cond=Lung%20Cancer&viewType=Card&page=9&rank=87
Lung Cancer,NCT05469425,Home,"Information provided by Pedro Machado, Instituto Politécnico de Leiria (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05469425?cond=Lung%20Cancer&viewType=Card&page=9&rank=88
Lung Cancer,NCT03368820,Cardiovascular Morbidities and Lung Cancer Treatment: a Prospective Registry,Information provided by European Lung Cancer Working Party (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03368820?cond=Lung%20Cancer&viewType=Card&page=9&rank=89
Lung Cancer,NCT04995172,Feasibility of Mobile-CT,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04995172?cond=Lung%20Cancer&viewType=Card&page=9&rank=90
Lung Cancer,NCT05046067,Feasibility Study of Anatomical Modeling for Image Guided Thoracic Surgery,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05046067?cond=Lung%20Cancer&viewType=Card&page=10&rank=91
Lung Cancer,NCT05059132,Inspiratory Muscle Training and Behavioral Support to Alleviate Dyspnea and Promote Walking in Lung Cancer Survivors: A Pilot Study,Information provided by Kaiser Permanente (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05059132?cond=Lung%20Cancer&viewType=Card&page=10&rank=92
Lung Cancer,NCT02713828,Study of Glembatumumab Vedotin in gpNMB,"Information provided by PrECOG, LLC. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02713828?cond=Lung%20Cancer&viewType=Card&page=10&rank=93&tab=results
Lung Cancer,NCT06258954,Effect of 3D,"Information provided by Yihao Zhu, Sichuan Cancer Hospital and Research Institute (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06258954?cond=Lung%20Cancer&viewType=Card&page=10&rank=94
Lung Cancer,NCT00899782,Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer,Information provided by Alliance for Clinical Trials in Oncology (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00899782?cond=Lung%20Cancer&viewType=Card&page=10&rank=95
Lung Cancer,NCT05764928,Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy,Information provided by Rgene Corporation (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT05764928?cond=Lung%20Cancer&viewType=Card&page=10&rank=96
Lung Cancer,NCT06830694,"Clinical Trial for Safety and Effectiveness Evaluation of Tarlatamab (AMG757) with Etoposide, Carboplatin and Atezolizumab in Transformed Small Cell Lung Cancer Patients from Adenocarcinoma After EGFR TKI Treatment","Information provided by Myung-Ju Ahn, Samsung Medical Center (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06830694?cond=Lung%20Cancer&viewType=Card&page=10&rank=97
Lung Cancer,NCT03655015,Patient,Information provided by The University of Texas Health Science Center at San Antonio (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03655015?cond=Lung%20Cancer&viewType=Card&page=10&rank=98
Lung Cancer,NCT03741868,Symptom Burden and Unmet Supportive Care Needs in Lung Cancer Patients Undergoing First or Second Line Immunotherapy,Information provided by Wake Forest University Health Sciences (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03741868?cond=Lung%20Cancer&viewType=Card&page=10&rank=99
Lung Cancer,NCT02259582,"A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non","Information provided by Mereo BioPharma (OncoMed Pharmaceuticals, Inc.) (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02259582?cond=Lung%20Cancer&viewType=Card&page=10&rank=100&tab=results
Lung Cancer,NCT04917224,Study of LUNG Stereotactic Adaptive Ablative Radiotherapy,Information provided by Baptist Health South Florida (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT04917224?cond=Lung%20Cancer&viewType=Card&page=11&rank=101
Lung Cancer,NCT01261507,Reader Study of DeltaView™ Chest Radiograph Software,"Information provided by Matthew T. Freedman, MD, Georgetown University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01261507?cond=Lung%20Cancer&viewType=Card&page=11&rank=102&tab=results
Lung Cancer,NCT03070626,Preoperative Loading With Carbohydrates in Lung Cancer Surgery,"Information provided by Per Reidar Woldbæk, Oslo University Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03070626?cond=Lung%20Cancer&viewType=Card&page=11&rank=103
Lung Cancer,NCT02992353,"Single-port, Two-port Versus Three-port VATS on Non","Information provided by Ju-Wei Mu, Cancer Institute and Hospital, Chinese Academy of Medical Sciences (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02992353?cond=Lung%20Cancer&viewType=Card&page=11&rank=104
Lung Cancer,NCT05555342,A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single,"Information provided by Jeremy Harris, University of California, Irvine (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05555342?cond=Lung%20Cancer&viewType=Card&page=11&rank=105
Lung Cancer,NCT03469323,Effects of Succinylcholine on Nonintubated Thoracoscopic Surgery,Information provided by National Taiwan University Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03469323?cond=Lung%20Cancer&viewType=Card&page=11&rank=106
Lung Cancer,NCT02984761,Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy,Information provided by VA Office of Research and Development (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT02984761?cond=Lung%20Cancer&viewType=Card&page=11&rank=107
Lung Cancer,NCT03972228,Microdevice for Evaluating Drug Response in Site in Lung Lesions,"Information provided by Oliver Jonas, Brigham and Women's Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03972228?cond=Lung%20Cancer&viewType=Card&page=11&rank=108
Lung Cancer,NCT04773275,A Clinical Evaluation of the Aliya™ System in Late Stage Cancer,"Information provided by Galvanize Therapeutics, Inc. (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT04773275?cond=Lung%20Cancer&viewType=Card&page=11&rank=109
Lung Cancer,NCT06102369,The Role of Narrow Band Imaging (NBI) Bronchoscopy in Detecting Bronchial Squamous Dysplasia in Lung Cancer,"Information provided by Mia Elhidsi, MD, Fakultas Kedokteran Universitas Indonesia (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06102369?cond=Lung%20Cancer&viewType=Card&page=11&rank=110
Lung Cancer,NCT01814163,Observational Post,Information provided by Spanish Lung Cancer Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01814163?cond=Lung%20Cancer&viewType=Card&page=12&rank=111
Lung Cancer,NCT04056273,Assess the Use of rEBUS With a Guide Sheath to Increase Transbronchial Lung Biopsy Yield Rate,Information provided by National Taiwan University Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04056273?cond=Lung%20Cancer&viewType=Card&page=12&rank=112
Lung Cancer,NCT02852798,"Apatinib Combined With Docetaxel Monotherapy as Second-line Therapy of Advanced EGFR WT, Non","Information provided by Jiangsu ShengDiYa Medicine Co., Ltd. (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT02852798?cond=Lung%20Cancer&viewType=Card&page=12&rank=113
Lung Cancer,NCT01635400,Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer,Information provided by Zhejiang Cancer Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT01635400?cond=Lung%20Cancer&viewType=Card&page=12&rank=114
Lung Cancer,NCT05404022,Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 Years,Information provided by University of Hull (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05404022?cond=Lung%20Cancer&viewType=Card&page=12&rank=115
Lung Cancer,NCT00780611,Investigating the Improvement in 4D CT Images Using AV Biofeedback,"Information provided by Department of Radiation Oncology, University of Maryland, Baltimore (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00780611?cond=Lung%20Cancer&viewType=Card&page=12&rank=116
Lung Cancer,NCT01067755,Evaluation of the LungPoint Virtual Bronchoscopic Navigation (VBN) System,Information provided by Broncus Technologies,Recruiting,https://clinicaltrials.gov/study/NCT01067755?cond=Lung%20Cancer&viewType=Card&page=12&rank=117
Lung Cancer,NCT00638352,False/Negative Rate of Lung Percutaneous Needle Biopsy,"Information provided by Ernest Scalzetti, State University of New York - Upstate Medical University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00638352?cond=Lung%20Cancer&viewType=Card&page=12&rank=118
Lung Cancer,NCT01218529,Lapatinib and WBRT for Patients With Brain Metastases From Lung or Breast Tumors,Information provided by Hellenic Cooperative Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01218529?cond=Lung%20Cancer&viewType=Card&page=12&rank=119
Lung Cancer,NCT06412172,The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP),"Information provided by Sara Pai, MD, PhD, Massachusetts General Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06412172?cond=Lung%20Cancer&viewType=Card&page=12&rank=120
Lung Cancer,NCT00295672,Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy in Locally Advanced NSCLC.,"Information provided by University Hospital, Brest",Completed,https://clinicaltrials.gov/study/NCT00295672?cond=Lung%20Cancer&viewType=Card&page=13&rank=121
Lung Cancer,NCT01161173,An Observational Study of Tarceva (Erlotinib) in Routine Daily Clinical Practice as Second Line Treatment in Patients With Non,Information provided by Hoffmann-La Roche (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01161173?cond=Lung%20Cancer&viewType=Card&page=13&rank=122&tab=results
Lung Cancer,NCT01394978,NeoMend ProGEL™ Pleural Air Leak Sealant Post,Information provided by C. R. Bard (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01394978?cond=Lung%20Cancer&viewType=Card&page=13&rank=123&tab=results
Lung Cancer,NCT05470595,A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large,Information provided by Technische Universität Dresden (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05470595?cond=Lung%20Cancer&viewType=Card&page=13&rank=124
Lung Cancer,NCT03537378,Hybrid APC Therapy in Early Central Lung Neoplasms,"Information provided by Jiayuan Sun, Shanghai Chest Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03537378?cond=Lung%20Cancer&viewType=Card&page=13&rank=125
Lung Cancer,NCT02333474,Safety and Efficacy of Mix Vaccine in Lung Carcinoma Patient,"Information provided by Fuda Cancer Hospital, Guangzhou (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02333474?cond=Lung%20Cancer&viewType=Card&page=13&rank=126
Lung Cancer,NCT01969955,Nab-paclitaxel as Second,"Information provided by LI Junling, Chinese Academy of Medical Sciences (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT01969955?cond=Lung%20Cancer&viewType=Card&page=13&rank=127
Lung Cancer,NCT06955468,Evaluating a Bidirectional Priming Intervention for Goals-of,Information provided by Abramson Cancer Center at Penn Medicine (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06955468?cond=Lung%20Cancer&viewType=Card&page=13&rank=128
Lung Cancer,NCT06964698,Optimizing Post,"Information provided by Ozal Adiyeke, Başakşehir Çam & Sakura City Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT06964698?cond=Lung%20Cancer&viewType=Card&page=13&rank=129
Lung Cancer,NCT06950515,General Anesthesia vs Conscious Sedation for Radial Endobronchial Ultrasound,"Information provided by Marc Fortin, Institut universitaire de cardiologie et de pneumologie de Québec, University Laval (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06950515?cond=Lung%20Cancer&viewType=Card&page=13&rank=130
Lung Cancer,NCT05853575,Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21),Information provided by Mirati Therapeutics Inc. (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05853575?cond=Lung%20Cancer&viewType=Card&page=14&rank=131
Lung Cancer,NCT02009605,Icotinib in Previously Treated Non/Light,"Information provided by Qiong Zhao, Zhejiang University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT02009605?cond=Lung%20Cancer&viewType=Card&page=14&rank=132
Lung Cancer,NCT06942143,"An Open-label, Phase I Clinical Trial of Super1 TCR-T in NY-ESO-1","Information provided by Guangzhou FineImmune Biotechnology Co., LTD. (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06942143?cond=Lung%20Cancer&viewType=Card&page=14&rank=133
Lung Cancer,NCT03395964,Comparison of Preoperative CT Scan Guided and Intraoperative Hybrid DynaCT Scan,Information provided by Chang Gung Memorial Hospital (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03395964?cond=Lung%20Cancer&viewType=Card&page=14&rank=134
Lung Cancer,NCT06397807,Postoperative Pain Management on Patients Undergoing Lung Tumor Resection,"Information provided by Hsin-Yuan Fang, China Medical University Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06397807?cond=Lung%20Cancer&viewType=Card&page=14&rank=135
Lung Cancer,NCT06254196,Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted Therapies,Information provided by Regina Elena Cancer Institute (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06254196?cond=Lung%20Cancer&viewType=Card&page=14&rank=136
Lung Cancer,NCT06530667,Broadband Collaborative Pulse Ablation Instrument Treating Malignant Pulmonary Nodules,Information provided by Shanghai Zhongshan Hospital (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06530667?cond=Lung%20Cancer&viewType=Card&page=14&rank=137
Lung Cancer,NCT04230408,Intensified Chemo-immuno-radiotherapy With Durvalumab for Stage III Non,Information provided by Latin American Cooperative Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04230408?cond=Lung%20Cancer&viewType=Card&page=14&rank=138
Lung Cancer,NCT05912465,Predicting Lung Cancer,"Information provided by Univ.-Prof. Dr. Marcus Hacker, Medical University of Vienna (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05912465?cond=Lung%20Cancer&viewType=Card&page=14&rank=139
Lung Cancer,NCT06393816,FIRST-NEC (GFPC 01-2022),Information provided by Centre Leon Berard (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06393816?cond=Lung%20Cancer&viewType=Card&page=14&rank=140
Lung Cancer,NCT00922155,Diagnosis of Lung Lesions by Endobronchial Ultrasound With an Alternative Guide Sheath,Information provided by Chang Gung Memorial Hospital,Completed,https://clinicaltrials.gov/study/NCT00922155?cond=Lung%20Cancer&viewType=Card&page=15&rank=141
Lung Cancer,NCT04982900,Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground,"Information provided by Hecheng Li M.D., Ph.D, Ruijin Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04982900?cond=Lung%20Cancer&viewType=Card&page=15&rank=142
Lung Cancer,NCT06049966,Atezolizumab in Large Cell Neuroendocrine Carcinoma,Information provided by Oncology Center of Biochemical Education And Research (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06049966?cond=Lung%20Cancer&viewType=Card&page=15&rank=143
Lung Cancer,NCT02013297,Study of SBRT Efficacy on Intra and Extra,Information provided by Centre Leon Berard (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02013297?cond=Lung%20Cancer&viewType=Card&page=15&rank=144
Lung Cancer,NCT04026841,The Efficacy of PD-1 Antibody Sintilimab on Early,"Information provided by Jianxing He, The First Affiliated Hospital of Guangzhou Medical University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04026841?cond=Lung%20Cancer&viewType=Card&page=15&rank=145
Lung Cancer,NCT07143110,LUNG,Information provided by AstraZeneca (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07143110?cond=Lung%20Cancer&viewType=Card&page=15&rank=146
Lung Cancer,NCT04431921,"Assessment of Functional Capacity, Pain, Cognitive and Respiratory Functions in Lung Cancer Survivors","Information provided by Kübra Kılıç, Hacettepe University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04431921?cond=Lung%20Cancer&viewType=Card&page=15&rank=147
Lung Cancer,NCT03795155,Prospective Genomics Initiative on Multiple Synchronous Lung Cancer (PGI,Information provided by RenJi Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03795155?cond=Lung%20Cancer&viewType=Card&page=15&rank=148
Lung Cancer,NCT00639067,Breath Test for Early Detection of Lung Cancer,"Information provided by Menssana Research, Inc. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00639067?cond=Lung%20Cancer&viewType=Card&page=15&rank=149
Lung Cancer,NCT03528733,Feasibility of Multi,Information provided by KA Imaging Inc. (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03528733?cond=Lung%20Cancer&viewType=Card&page=15&rank=150
Lung Cancer,NCT05879354,Active Cycle of Breathing Techniques on Respiratory Distress Symptom Cluster,"Information provided by Doğa Ulcay, Maltepe University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05879354?cond=Lung%20Cancer&viewType=Card&page=16&rank=151
Lung Cancer,NCT05977803,Contribution of the CEST Sequence in the Characterization of Radionecrosis of Brain Metastases of Pulmonary Origin,Information provided by Assistance Publique - Hôpitaux de Paris (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05977803?cond=Lung%20Cancer&viewType=Card&page=16&rank=152
Lung Cancer,NCT07165691,TELEhealth Shared Decision,"Information provided by Evelyn Arana, DrPH, Rutgers, The State University of New Jersey (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT07165691?cond=Lung%20Cancer&viewType=Card&page=16&rank=153
Lung Cancer,NCT04036721,Coorticosteroid Regimen in Patients With Anti-PD-1/PD,"Information provided by Mateusz Polaczek, National Institute for Tuberculosis and Lung Diseases, Poland (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT04036721?cond=Lung%20Cancer&viewType=Card&page=16&rank=154
Lung Cancer,NCT07109154,DeniLA: Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Guideline-Concordant Care in First,Information provided by AstraZeneca (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07109154?cond=Lung%20Cancer&viewType=Card&page=16&rank=155
Lung Cancer,NCT02498860,Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung,"Information provided by Young-Chul Kim, Chonnam National University Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02498860?cond=Lung%20Cancer&viewType=Card&page=16&rank=156
Lung Cancer,NCT01563354,3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET,Information provided by Novartis (Novartis Pharmaceuticals) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01563354?cond=Lung%20Cancer&viewType=Card&page=16&rank=157&tab=results
Lung Cancer,NCT04211051,Safety and Feasibility of Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules,"Information provided by Hecheng Li M.D., Ph.D, Ruijin Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04211051?cond=Lung%20Cancer&viewType=Card&page=16&rank=158
Lung Cancer,NCT00351598,Lung Tumour Volume Database,Information provided by Trans Tasman Radiation Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00351598?cond=Lung%20Cancer&viewType=Card&page=16&rank=159
Lung Cancer,NCT06259461,Machine Learning to Construct an Association Model for Lung Cancer and Environmental Hormone,"Information provided by Pei-Hung Liao, National Taipei University of Nursing and Health Sciences (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT06259461?cond=Lung%20Cancer&viewType=Card&page=16&rank=160
Lung Cancer,NCT06195657,,Non spécifié,Inconnu,https://clinicaltrials.gov/study/NCT06195657?cond=Lung%20Cancer&viewType=Card&page=17&rank=161
Lung Cancer,NCT02757092,The Impacts of Pulmonary Rehabilitation Therapy on Patients After Thoracic Surgery,"Information provided by Liu Jui Fang, Chang Gung Memorial Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02757092?cond=Lung%20Cancer&viewType=Card&page=17&rank=162&tab=results
Lung Cancer,NCT07207278,Multi Omics Molecular Characteristics and Immunophenotyping of Lung Signet Ring Cell Carcinoma,Information provided by First People's Hospital of Hangzhou (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT07207278?cond=Lung%20Cancer&viewType=Card&page=17&rank=163
Lung Cancer,NCT05904015,The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS,"Information provided by LVHUA WANG, Cancer Institute and Hospital, Chinese Academy of Medical Sciences (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05904015?cond=Lung%20Cancer&viewType=Card&page=17&rank=164
Lung Cancer,NCT05850702,Attenuation of the Hemodynamic Response to Double,"Information provided by zhuhao, RenJi Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05850702?cond=Lung%20Cancer&viewType=Card&page=17&rank=165
Lung Cancer,NCT05543954,68Ga-FAPI,Information provided by Peking Union Medical College Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05543954?cond=Lung%20Cancer&viewType=Card&page=17&rank=166
Lung Cancer,NCT01303926,Quality of Life Comparison in Advanced Non,"Information provided by Giuseppe Colucci MD, Gruppo Oncologico Italia Meridionale (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT01303926?cond=Lung%20Cancer&viewType=Card&page=17&rank=167
Lung Cancer,NCT05491213,TELESCOPE- TELEhealth Shared Decision,"Information provided by Anita Y. Kinney, PhD, RN, Rutgers, The State University of New Jersey (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05491213?cond=Lung%20Cancer&viewType=Card&page=17&rank=168
Lung Cancer,NCT05426213,A Study of Robot,"Information provided by Auris Health, Inc. (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT05426213?cond=Lung%20Cancer&viewType=Card&page=17&rank=169
Lung Cancer,NCT01058785,Phase II Study of Lucanix™ in Patients With Stages II-IV Non,Information provided by NovaRx Corporation,Completed,https://clinicaltrials.gov/study/NCT01058785?cond=Lung%20Cancer&viewType=Card&page=17&rank=170
Lung Cancer,NCT05299606,POWER Study (Prospective Transbronchial Microwave + Robotic,"Information provided by Ethicon, Inc. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05299606?cond=Lung%20Cancer&viewType=Card&page=18&rank=171&tab=results
Lung Cancer,NCT05231278,Confocal Laser Endomicroscopy Nodule Localization by Robotic Bronchoscopy,Information provided by Johnson & Johnson Enterprise Innovation Inc. (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05231278?cond=Lung%20Cancer&viewType=Card&page=18&rank=172
Lung Cancer,NCT05203276,Envafolimab Combined With Endostar in the First,Information provided by The First People's Hospital of Lianyungang (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05203276?cond=Lung%20Cancer&viewType=Card&page=18&rank=173
Lung Cancer,NCT02744664,Cryotherapy Combine Icotinib for Advanced NSCLC Treatment,"Information provided by Fuda Cancer Hospital, Guangzhou (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02744664?cond=Lung%20Cancer&viewType=Card&page=18&rank=174
Lung Cancer,NCT02666755,Novel Detection System for Lung Cancer Curative Effect Monitoring,"Information provided by Jian Zhang, Air Force Military Medical University, China (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT02666755?cond=Lung%20Cancer&viewType=Card&page=18&rank=175
Lung Cancer,NCT05326425,Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI.,"Information provided by Jin Hyoung Kang, Seoul St. Mary's Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05326425?cond=Lung%20Cancer&viewType=Card&page=18&rank=176
Lung Cancer,NCT04726358,ProCaLung: Project on Cancer of the Lung,Information provided by Jules Bordet Institute (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04726358?cond=Lung%20Cancer&viewType=Card&page=18&rank=177
Lung Cancer,NCT04775901,Application of Three,"Information provided by Chang Chen, Shanghai Pulmonary Hospital, Shanghai, China (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04775901?cond=Lung%20Cancer&viewType=Card&page=18&rank=178
Lung Cancer,NCT04922073,Practical Usability of EGFR Mutation Detection in ctDNA From Resectable NSCLC,"Information provided by Jhingook Kim, MD, Samsung Medical Center (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04922073?cond=Lung%20Cancer&viewType=Card&page=18&rank=179
Lung Cancer,NCT02117440,Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer,"Information provided by Tim Lautenschlaeger, Indiana University (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT02117440?cond=Lung%20Cancer&viewType=Card&page=18&rank=180
Lung Cancer,NCT04721106,Korea Post Marketing Surveillance (PMS) Study of Vizimpro,Information provided by Pfizer (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04721106?cond=Lung%20Cancer&viewType=Card&page=19&rank=181
Lung Cancer,NCT02277366,Role of Bronchoscopy in Early Lung Cancer Screening of High Risk Population,Information provided by Tang-Du Hospital (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT02277366?cond=Lung%20Cancer&viewType=Card&page=19&rank=182
Lung Cancer,NCT02320617,Application of Diffusion Weighted MRI Versus CT in Evaluation of the Effect of Treating Lung Cancer,"Information provided by Jian Zhang, Air Force Military Medical University, China (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02320617?cond=Lung%20Cancer&viewType=Card&page=19&rank=183
Lung Cancer,NCT04513301,"Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum","Information provided by Shanghai Cancer Hospital, China (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04513301?cond=Lung%20Cancer&viewType=Card&page=19&rank=184
Lung Cancer,NCT04425135,Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy (Pemetrixed + Carboplatin) in Patients With Tyrosine Kinase Inhibitor Failure in ALK,Information provided by The First Affiliated Hospital of Xiamen University (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT04425135?cond=Lung%20Cancer&viewType=Card&page=19&rank=185
Lung Cancer,NCT04486287,Sintilimab After Stereotactic Ablation Brachytherapy for Refractory Oligometastatic Non,Information provided by Tianjin Medical University Second Hospital (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT04486287?cond=Lung%20Cancer&viewType=Card&page=19&rank=186
Lung Cancer,NCT04159337,NGS-based Large,"Information provided by Lu Shun, Shanghai Chest Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04159337?cond=Lung%20Cancer&viewType=Card&page=19&rank=187
Lung Cancer,NCT01313429,"Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or Mediastinum",Information provided by National Institutes of Health Clinical Center (CC),Terminated,https://clinicaltrials.gov/study/NCT01313429?cond=Lung%20Cancer&viewType=Card&page=19&rank=188
Lung Cancer,NCT03975504,China Lung Cancer Screening (CLUS) Study Version 2.0,"Information provided by Baohui Han, Shanghai Chest Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03975504?cond=Lung%20Cancer&viewType=Card&page=19&rank=189
Lung Cancer,NCT03940404,Anlotinib Therapy in Patients With Advanced Lung Cancer.,Information provided by First People's Hospital of Hangzhou (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03940404?cond=Lung%20Cancer&viewType=Card&page=19&rank=190
Lung Cancer,NCT04185467,Lung Cancer Rehabilitation After Medical Treatment,"Information provided by Jun Ni, Nantong University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT04185467?cond=Lung%20Cancer&viewType=Card&page=20&rank=191
Lung Cancer,NCT00415337,"Endobronchial Ultrasound Guided Transbronchial Lung Biopsy With or Without Guide Sheath in Lung Tumors and the Analysis of Echoic Patterns of Lung Tumors and Mediastinal Lymph Nodes, and the Association Between Diagnostic Yield of Transbronchial Lung Biopsy and EBUS Echoic Features.","Information provided by CHIH-HSI KUO, Chang Gung Memorial Hospital (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT00415337?cond=Lung%20Cancer&viewType=Card&page=20&rank=192
Lung Cancer,NCT03705546,"The Impact of Physical Activity on the Postoperative Symptoms, Complications, and Quality of Life Among Lung Cancer",Information provided by Samsung Medical Center (Responsible Party),Active,https://clinicaltrials.gov/study/NCT03705546?cond=Lung%20Cancer&viewType=Card&page=20&rank=193
Lung Cancer,NCT06746948,Dyadic Psychological Stress Among Lung Cancer Patient,"Information provided by Juan LI, Central South University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT06746948?cond=Lung%20Cancer&viewType=Card&page=20&rank=194
Lung Cancer,NCT01928836,Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China,"Information provided by Bai Chunxue, Chinese Alliance Against Lung Cancer (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01928836?cond=Lung%20Cancer&viewType=Card&page=20&rank=195
Lung Cancer,NCT03666728,A Study of SHR-1210 in Combination With BP102 in Subjects With Non,"Information provided by Jiangsu HengRui Medicine Co., Ltd. (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT03666728?cond=Lung%20Cancer&viewType=Card&page=20&rank=196
Lung Cancer,NCT03607539,Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non,Information provided by Innovent Biologics (Suzhou) Co. Ltd. (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03607539?cond=Lung%20Cancer&viewType=Card&page=20&rank=197&tab=results
Lung Cancer,NCT03357094,Pulmonary Ventilation/Perfusion Imaging for the Prediction of Postoperative Residual Pulmonary Function,Information provided by Beijing Tongren Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03357094?cond=Lung%20Cancer&viewType=Card&page=20&rank=198
Lung Cancer,NCT01527461,Identifying Unique Scent Signature of Lung Cancer Through Body Odor,"Information provided by Dr. Nir Peled MD, PhD, Sheba Medical Center (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT01527461?cond=Lung%20Cancer&viewType=Card&page=20&rank=199
Lung Cancer,NCT03521375,VIdeo Assisted Thoracoscopic Lobectomy Versus Conventional Open LobEcTomy for Lung Cancer,Information provided by University of Bristol (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03521375?cond=Lung%20Cancer&viewType=Card&page=20&rank=200
Lung Cancer,NCT00242723,"Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining",Information provided by National Institutes of Health Clinical Center (CC) (National Cancer Institute (NCI)) (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT00242723?cond=Lung%20Cancer&viewType=Card&page=21&rank=201
Lung Cancer,NCT03220230,Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.,Information provided by Pfizer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03220230?cond=Lung%20Cancer&viewType=Card&page=21&rank=202&tab=results
Lung Cancer,NCT03081741,Circulating Tumor DNA in Surgical Lung Cancer Patients,"Information provided by Shenzhen Gene Health Bio Tech Co., Ltd. (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03081741?cond=Lung%20Cancer&viewType=Card&page=21&rank=203
Lung Cancer,NCT01335893,Intraoperative Imaging of Thoracic Malignancies With Indocyanine Green,Information provided by University of Pennsylvania (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01335893?cond=Lung%20Cancer&viewType=Card&page=21&rank=204
Lung Cancer,NCT03325907,Transthoracic Needle Biopsy Using 3D Printed Navigational Template: A Phase I Feasibility Trial,"Information provided by Chang Chen, Shanghai Pulmonary Hospital, Shanghai, China (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03325907?cond=Lung%20Cancer&viewType=Card&page=21&rank=205
Lung Cancer,NCT03272087,Rational Approach to a Unilateral Pleural Effusion,"Information provided by Simon Reuter, Naestved Hospital (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT03272087?cond=Lung%20Cancer&viewType=Card&page=21&rank=206
Lung Cancer,NCT03137576,Erector Spinae Plane Block Versus Paravertebral Block During Non,Information provided by IRCCS Sacro Cuore Don Calabria di Negrar (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT03137576?cond=Lung%20Cancer&viewType=Card&page=21&rank=207
Lung Cancer,NCT02933294,Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer,"Information provided by Ju-Wei Mu, Cancer Institute and Hospital, Chinese Academy of Medical Sciences (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02933294?cond=Lung%20Cancer&viewType=Card&page=21&rank=208
Lung Cancer,NCT03017183,Detection of Heterogeneity in Central Lung Cancer - EBUS,Information provided by Wissenschaftliches Institut Bethanien e.V (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03017183?cond=Lung%20Cancer&viewType=Card&page=21&rank=209
Lung Cancer,NCT02962115,Development and Pilot Testing of a Clinical Informatics Lung Cancer Screening Intervention,Information provided by Wake Forest University Health Sciences (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02962115?cond=Lung%20Cancer&viewType=Card&page=21&rank=210
Lung Cancer,NCT03380468,Adjuvant Chemotherapy for High Risk Stage I Lung Adenocarcinoma,"Information provided by Haiquan Chen, Fudan University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03380468?cond=Lung%20Cancer&viewType=Card&page=22&rank=211
Lung Cancer,NCT01509612,Additive Homeopathy in Cancer Patients,"Information provided by Michael Frass, Medical University of Vienna (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01509612?cond=Lung%20Cancer&viewType=Card&page=22&rank=212&tab=results
Lung Cancer,NCT03046316,Local Therapy in Advanced NSCLC With Non,"Information provided by Yi-Long Wu, Guangdong Association of Clinical Trials (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03046316?cond=Lung%20Cancer&viewType=Card&page=22&rank=213
Lung Cancer,NCT02701231,Low-frequency Rotating Magnetic System Combined With Systemic Anti,"Information provided by Chen Liang_An, Chinese PLA General Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02701231?cond=Lung%20Cancer&viewType=Card&page=22&rank=214
Lung Cancer,NCT02855281,Sensitivity of PDL-1-analysis From Pleural Effusion in Non,Information provided by Wissenschaftliches Institut Bethanien e.V (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02855281?cond=Lung%20Cancer&viewType=Card&page=22&rank=215&tab=results
Lung Cancer,NCT02790866,Development and Feasibility Testing of a Lung Cancer Screening Decision Aid,"Information provided by Jamie Studts, University of Kentucky (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02790866?cond=Lung%20Cancer&viewType=Card&page=22&rank=216
Lung Cancer,NCT02790190,,Non spécifié,Inconnu,https://clinicaltrials.gov/study/NCT02790190?cond=Lung%20Cancer&viewType=Card&page=22&rank=217
Lung Cancer,NCT02834455,Rational Approach to a Unilateral Pleural Effusion2,"Information provided by Simon Reuter, Naestved Hospital (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT02834455?cond=Lung%20Cancer&viewType=Card&page=22&rank=218
Lung Cancer,NCT01947062,Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma,"Information provided by Swaroop Revannasiddaiah, Swami Rama Cancer Hospital and Research Institute (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT01947062?cond=Lung%20Cancer&viewType=Card&page=22&rank=219
Lung Cancer,NCT02540499,Deep Inspiration Breath Hold as Primary Strategy for Locally Advanced Lung Cancer Radiotherapy,"Information provided by Gitte Fredberg Persson, Rigshospitalet, Denmark (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02540499?cond=Lung%20Cancer&viewType=Card&page=22&rank=220
Lung Cancer,NCT02531737,Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With Lung Cancer,"Information provided by University Hospital, Limoges (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02531737?cond=Lung%20Cancer&viewType=Card&page=23&rank=221
Lung Cancer,NCT02740400,A Comparison Between EBUS-GS and CT,"Information provided by Jun Wang, Peking University People's Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02740400?cond=Lung%20Cancer&viewType=Card&page=23&rank=222
Lung Cancer,NCT02630615,Circulating Tumor Cells (CTC) in Lung Cancer,"Information provided by Shadia Jalal, Indiana University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02630615?cond=Lung%20Cancer&viewType=Card&page=23&rank=223
Lung Cancer,NCT02518802,Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma,Information provided by Tang-Du Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT02518802?cond=Lung%20Cancer&viewType=Card&page=23&rank=224
Lung Cancer,NCT02372448,Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non,Information provided by Centre Hospitalier Universitaire de Nice (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02372448?cond=Lung%20Cancer&viewType=Card&page=23&rank=225
Lung Cancer,NCT02839681,Anti,"Information provided by Raffit Hassan, M.D., National Institutes of Health Clinical Center (CC) (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02839681?cond=Lung%20Cancer&viewType=Card&page=23&rank=226&tab=results
Lung Cancer,NCT00657423,Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non,Information provided by Xijing Hospital,Recruiting,https://clinicaltrials.gov/study/NCT00657423?cond=Lung%20Cancer&viewType=Card&page=23&rank=227
Lung Cancer,NCT02284633,Blood Sample Monitoring of Patients With EGFR Mutated Lung Cancer,"Information provided by Eva Boysen Hansen, Aarhus University Hospital (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT02284633?cond=Lung%20Cancer&viewType=Card&page=23&rank=228
Lung Cancer,NCT02393664,Effects of Nonintubated Versus Intubated General Anesthesia on Recovery After Thoracoscopic Lung Resection,Information provided by National Taiwan University Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT02393664?cond=Lung%20Cancer&viewType=Card&page=23&rank=229
Lung Cancer,NCT02264236,Vaccination of Advanced,Information provided by University of Arkansas (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT02264236?cond=Lung%20Cancer&viewType=Card&page=23&rank=230
Lung Cancer,NCT02469493,The Effect and Mechanism of Electroacupuncture on Acute Chemotherapy,"Information provided by Wei Qin, Xidian University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02469493?cond=Lung%20Cancer&viewType=Card&page=24&rank=231
Lung Cancer,NCT02199886,Dose-escalation Study of BIBH 1 in Patients With Non,Information provided by Boehringer Ingelheim (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT02199886?cond=Lung%20Cancer&viewType=Card&page=24&rank=232
Lung Cancer,NCT00172575,Differentiation of Malig. & Ben. Solitary Pulm. Nodules & Prediction of Clin. Outcome Using Perfus. Analysis of DCEMRI,Information provided by National Taiwan University Hospital,Recruiting,https://clinicaltrials.gov/study/NCT00172575?cond=Lung%20Cancer&viewType=Card&page=24&rank=233
Lung Cancer,NCT02149576,Does Intense Regimented Surveillance Improve the Rates of Therapeutic Re,Information provided by McMaster University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02149576?cond=Lung%20Cancer&viewType=Card&page=24&rank=234
Lung Cancer,NCT02030444,,Non spécifié,Inconnu,https://clinicaltrials.gov/study/NCT02030444?cond=Lung%20Cancer&viewType=Card&page=24&rank=235
Lung Cancer,NCT02123173,Hemodynamic Changes During One Lung Ventilation in Non-intubated Vedio,Information provided by National Taiwan University Hospital (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02123173?cond=Lung%20Cancer&viewType=Card&page=24&rank=236
Lung Cancer,NCT02484872,Has Inflammation a Significant Implication in Lung Cancer Evolution?,Information provided by European Lung Cancer Working Party (Responsible Party),Active,https://clinicaltrials.gov/study/NCT02484872?cond=Lung%20Cancer&viewType=Card&page=24&rank=237
Lung Cancer,NCT06354959,Prehab for Lung and Esophageal Cancer,Information provided by Nova Scotia Health Authority (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06354959?cond=Lung%20Cancer&viewType=Card&page=24&rank=238
Lung Cancer,NCT02031809,Multicentric Study VATS Major Introperative Complications,"Information provided by Johnny Moons, University Hospital, Gasthuisberg (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02031809?cond=Lung%20Cancer&viewType=Card&page=24&rank=239
Lung Cancer,NCT01687647,Sputum Cytometry Analysis in Lung Cancer Screening After Professional Asbestos Exposure,"Information provided by University Hospital, Caen (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT01687647?cond=Lung%20Cancer&viewType=Card&page=24&rank=240
Lung Cancer,NCT01580982,Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer,"Information provided by University of Colorado, Denver (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT01580982?cond=Lung%20Cancer&viewType=Card&page=25&rank=241
Lung Cancer,NCT01585675,Specimen Banking From Patients With Lung Cancer,"Information provided by University of Colorado, Denver (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT01585675?cond=Lung%20Cancer&viewType=Card&page=25&rank=242
Lung Cancer,NCT01775943,Efficacy of EGFR TKIs in Patients With Rare EGFR,"Information provided by Young Joo Min, Ulsan University Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT01775943?cond=Lung%20Cancer&viewType=Card&page=25&rank=243
Lung Cancer,NCT01631565,Early Incorporation of Patient and Family to Attention and Care Program in Oncology Versus Standard of Care,"Information provided by Oscar Gerardo Arrieta Rodríguez MD, Instituto Nacional de Cancerologia de Mexico (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01631565?cond=Lung%20Cancer&viewType=Card&page=25&rank=244
Lung Cancer,NCT06809946,Feasibility of Fluorescence Imaging with Bevacizumab,Information provided by University Medical Center Groningen (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06809946?cond=Lung%20Cancer&viewType=Card&page=25&rank=245
Lung Cancer,NCT01622621,Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients Non,"Information provided by Dennis Wigle, Mayo Clinic (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT01622621?cond=Lung%20Cancer&viewType=Card&page=25&rank=246
Lung Cancer,NCT01413737,Postoperative Results of Surgical Treatment of Lung Cancer After 30 Days,Information provided by Norwegian University of Science and Technology (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01413737?cond=Lung%20Cancer&viewType=Card&page=25&rank=247
Lung Cancer,NCT01684696,Virtual Intervention for Lung Cancer,"Information provided by University of California, San Francisco (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT01684696?cond=Lung%20Cancer&viewType=Card&page=25&rank=248
Lung Cancer,NCT01466660,LUX,Information provided by Boehringer Ingelheim (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01466660?cond=Lung%20Cancer&viewType=Card&page=25&rank=249&tab=results
Lung Cancer,NCT02157857,One Step Nucleic Acid Amplification in Endobronchial Ultrasound,"Information provided by Filiz Oezkan, University Hospital, Essen (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02157857?cond=Lung%20Cancer&viewType=Card&page=25&rank=250
Lung Cancer,NCT00673283,Early Detection of Lung Cancer Via Bi,Information provided by Duke University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00673283?cond=Lung%20Cancer&viewType=Card&page=26&rank=251
Lung Cancer,NCT01266512,Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small,Information provided by Sanofi (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01266512?cond=Lung%20Cancer&viewType=Card&page=26&rank=252
Lung Cancer,NCT01307085,Effect of Remote Ischemic Preconditioning on Lung Injury After Pulmonary Resection,"Information provided by Cai Li, First Affiliated Hospital, Sun Yat-Sen University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01307085?cond=Lung%20Cancer&viewType=Card&page=26&rank=253
Lung Cancer,NCT01770418,A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non,Information provided by Proton Collaborative Group (Responsible Party),Active,https://clinicaltrials.gov/study/NCT01770418?cond=Lung%20Cancer&viewType=Card&page=26&rank=254
Lung Cancer,NCT01038661,Tax First,Information provided by Sanofi (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01038661?cond=Lung%20Cancer&viewType=Card&page=26&rank=255
Lung Cancer,NCT00826852,Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo,Information provided by Sanofi,Completed,https://clinicaltrials.gov/study/NCT00826852?cond=Lung%20Cancer&viewType=Card&page=26&rank=256
Lung Cancer,NCT05844761,Real,"Information provided by André Änghede Haraldsson, Region Skane (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05844761?cond=Lung%20Cancer&viewType=Card&page=26&rank=257
Lung Cancer,NCT00563420,Early Lung Cancer Detection in Patients With Sputum Cytology and Autofluorescence Bronchoscopy in People at High Risk of Lung Cancer,"Information provided by Hospital Authority, Hong Kong",Completed,https://clinicaltrials.gov/study/NCT00563420?cond=Lung%20Cancer&viewType=Card&page=26&rank=258
Lung Cancer,NCT00563160,Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small,"Information provided by Hospital Authority, Hong Kong",Recruiting,https://clinicaltrials.gov/study/NCT00563160?cond=Lung%20Cancer&viewType=Card&page=26&rank=259
Lung Cancer,NCT00998192,A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung,Information provided by Oncolytics Biotech (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00998192?cond=Lung%20Cancer&viewType=Card&page=26&rank=260
Lung Cancer,NCT00482118,"Smoky Coal Exposure, Genetic Susceptibility, and Lung Cancer in Non",Information provided by National Institutes of Health Clinical Center (CC) (National Cancer Institute (NCI)) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00482118?cond=Lung%20Cancer&viewType=Card&page=27&rank=261
Lung Cancer,NCT00497770,An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non,Information provided by Eli Lilly and Company (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00497770?cond=Lung%20Cancer&viewType=Card&page=27&rank=262&tab=results
Lung Cancer,NCT02054104,"Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum","Information provided by David Schrump, M.D., National Cancer Institute (NCI) (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02054104?cond=Lung%20Cancer&viewType=Card&page=27&rank=263&tab=results
Lung Cancer,NCT00339859,"DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer",Information provided by National Institutes of Health Clinical Center (CC) (National Cancer Institute (NCI)) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00339859?cond=Lung%20Cancer&viewType=Card&page=27&rank=264
Lung Cancer,NCT00356525,Chemotherapy Treatment in Re,Information provided by Eli Lilly and Company,Completed,https://clinicaltrials.gov/study/NCT00356525?cond=Lung%20Cancer&viewType=Card&page=27&rank=265&tab=results
Lung Cancer,NCT00805077,Pulmonary Surgery and Protective Mechanical Ventilation,Information provided by Assistance Publique - Hôpitaux de Paris (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00805077?cond=Lung%20Cancer&viewType=Card&page=27&rank=266
Lung Cancer,NCT04887545,Immune- and Microenvironment,"Information provided by Rune Matthiesen, Universidade Nova de Lisboa (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04887545?cond=Lung%20Cancer&viewType=Card&page=27&rank=267
Lung Cancer,NCT00174629,GILT Docetaxel - Non,Information provided by Sanofi,Completed,https://clinicaltrials.gov/study/NCT00174629?cond=Lung%20Cancer&viewType=Card&page=27&rank=268
Lung Cancer,NCT00178230,Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity,"Information provided by Yuhchyau Chen, University of Rochester (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00178230?cond=Lung%20Cancer&viewType=Card&page=27&rank=269
Lung Cancer,NCT00258739,Docetaxel in Non Small Cell Lung Cancer (NSCLC),Information provided by Sanofi,Completed,https://clinicaltrials.gov/study/NCT00258739?cond=Lung%20Cancer&viewType=Card&page=27&rank=270
Lung Cancer,NCT00558350,"Systemic, Intrapulmonary and Pleural Inflammatory Reaction in Patients Undergoing Thoracic Surgery","Information provided by University Hospital, Basel, Switzerland (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00558350?cond=Lung%20Cancer&viewType=Card&page=28&rank=271
Lung Cancer,NCT00174772,Pulmonart: Docetaxel - Non,Information provided by Sanofi,Completed,https://clinicaltrials.gov/study/NCT00174772?cond=Lung%20Cancer&viewType=Card&page=28&rank=272
Lung Cancer,NCT00090701,"A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non",Information provided by Pfizer,Withdrawn,https://clinicaltrials.gov/study/NCT00090701?cond=Lung%20Cancer&viewType=Card&page=28&rank=273
Lung Cancer,NCT00123747,Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non,Information provided by AHS Cancer Control Alberta (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00123747?cond=Lung%20Cancer&viewType=Card&page=28&rank=274
Lung Cancer,NCT00071136,Pemetrexed and Gemcitabine in Patients With Advanced Non,Information provided by Eli Lilly and Company,Completed,https://clinicaltrials.gov/study/NCT00071136?cond=Lung%20Cancer&viewType=Card&page=28&rank=275
Lung Cancer,NCT00050830,"A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non",Information provided by Pfizer,Completed,https://clinicaltrials.gov/study/NCT00050830?cond=Lung%20Cancer&viewType=Card&page=28&rank=276
Lung Cancer,NCT00074854,A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR,Information provided by Pfizer,Completed,https://clinicaltrials.gov/study/NCT00074854?cond=Lung%20Cancer&viewType=Card&page=28&rank=277
Lung Cancer,NCT00051506,ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.,Information provided by Eli Lilly and Company,Completed,https://clinicaltrials.gov/study/NCT00051506?cond=Lung%20Cancer&viewType=Card&page=28&rank=278
Lung Cancer,NCT01871454,Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non,"Information provided by Neal Edward Dunlap, University of Louisville (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT01871454?cond=Lung%20Cancer&viewType=Card&page=28&rank=279
Lung Cancer,NCT05078918,Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors,"Information provided by Dong Wook Shin, Samsung Medical Center (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05078918?cond=Lung%20Cancer&viewType=Card&page=28&rank=280
Lung Cancer,NCT03175861,Modeling of the Response to Hypofractionated Stereotactic Pulmonary Irradiation,"Information provided by University Hospital, Brest (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03175861?cond=Lung%20Cancer&viewType=Card&page=29&rank=281
Lung Cancer,NCT05676788,,Non spécifié,Inconnu,https://clinicaltrials.gov/study/NCT05676788?cond=Lung%20Cancer&viewType=Card&page=29&rank=282
Lung Cancer,NCT05875870,Effects of Bright,"Information provided by Taipei Veterans General Hospital, Taiwan (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05875870?cond=Lung%20Cancer&viewType=Card&page=29&rank=283
Lung Cancer,NCT02587455,Pembrolizumab and Palliative Radiotherapy in Lung,Information provided by Royal Marsden NHS Foundation Trust (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02587455?cond=Lung%20Cancer&viewType=Card&page=29&rank=284
Lung Cancer,NCT02862288,"Preliminary Study of Microwave Tumoral Ablation Performances for the Treatment of Pulmonary, Renal and Bone Neoplasia.",Information provided by Centre Hospitalier Universitaire de Besancon (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02862288?cond=Lung%20Cancer&viewType=Card&page=29&rank=285
Lung Cancer,NCT04945928,Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC,"Information provided by Hecheng Li M.D., Ph.D, Ruijin Hospital (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT04945928?cond=Lung%20Cancer&viewType=Card&page=29&rank=286
Lung Cancer,NCT05857995,Precision Lung Cancer Survivorship Care Intervention,"Information provided by Jerod L Stapleton, PhD, University of Kentucky (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05857995?cond=Lung%20Cancer&viewType=Card&page=29&rank=287
Lung Cancer,NCT03095274,Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung Origin,Information provided by Grupo Espanol de Tumores Neuroendocrinos (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03095274?cond=Lung%20Cancer&viewType=Card&page=29&rank=288&tab=results
Lung Cancer,NCT03849040,The Use of Artificial Intelligence to Predict Cancerous Lymph Nodes for Lung Cancer Staging During Ultrasound Imaging,"Information provided by Wael Hanna, St. Joseph's Healthcare Hamilton (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03849040?cond=Lung%20Cancer&viewType=Card&page=29&rank=289
Lung Cancer,NCT02965300,The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis,"Information provided by Chen Liang_An, Chinese PLA General Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02965300?cond=Lung%20Cancer&viewType=Card&page=29&rank=290
Lung Cancer,NCT03516500,Trial of Identifying the Lung Intersegmental Plane by Iron Sucrose Injection Staining,"Information provided by Hecheng Li M.D., Ph.D, Ruijin Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03516500?cond=Lung%20Cancer&viewType=Card&page=30&rank=291
Lung Cancer,NCT02050100,Biomarkers for Diagnosis of Lung Cancer,"Information provided by SK Medical (Beijing) Co., Ltd. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02050100?cond=Lung%20Cancer&viewType=Card&page=30&rank=292
Lung Cancer,NCT02793713,EBUS Score Validation for Malignancy,Information provided by McMaster University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02793713?cond=Lung%20Cancer&viewType=Card&page=30&rank=293
Lung Cancer,NCT03144622,18F,Information provided by National Taiwan University Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03144622?cond=Lung%20Cancer&viewType=Card&page=30&rank=294
Lung Cancer,NCT02931942,Changing Over Time of Ascorbic Acid After Chemotherapy,Information provided by Maastricht University Medical Center (Responsible Party),Active,https://clinicaltrials.gov/study/NCT02931942?cond=Lung%20Cancer&viewType=Card&page=30&rank=295
Lung Cancer,NCT06832592,Supportive Care Needs of Bronchial Cancer Patients in Active Treatment: A Descriptive Study in Outpatient Oncology,Information provided by L'hôpital Nord-Ouest - Villefranche Villefranche sur Saône (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06832592?cond=Lung%20Cancer&viewType=Card&page=30&rank=296
Lung Cancer,NCT03090880,Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE),Information provided by Assistance Publique - Hôpitaux de Paris (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT03090880?cond=Lung%20Cancer&viewType=Card&page=30&rank=297
Lung Cancer,NCT06775678,Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non,Information provided by Tianjin Medical University Cancer Institute and Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06775678?cond=Lung%20Cancer&viewType=Card&page=30&rank=298
Lung Cancer,NCT03134729,PATHOS Study Pain Assessment in Thoracic Oncologic Surgery,Information provided by IRCCS Sacro Cuore Don Calabria di Negrar (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03134729?cond=Lung%20Cancer&viewType=Card&page=30&rank=299
Lung Cancer,NCT05299125,"Amivantamab, Lazertinib, and Pemetrexed for First-line Treatment of Recurrent/Metastatic Non",Information provided by Latin American Cooperative Oncology Group (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05299125?cond=Lung%20Cancer&viewType=Card&page=30&rank=300
Breast Cancer,NCT01110954,Fluorescence,Information provided by photonamic GmbH & Co. KG (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT01110954?cond=Breast%20Cancer&viewType=Card&page=1&rank=1
Breast Cancer,NCT01522300,Etude Tomos- Apport de la Tomosynthèse Dans le Bilan d'Extension locorégional préthérapeutique d'Une Tumeur du Sein : Recherche de multicentricité Tomos Study,Information provided by Centre Jean Perrin (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT01522300?cond=Breast%20Cancer&viewType=Card&page=1&rank=2
Breast Cancer,NCT03777852,Emotional Evaluation and Reconstructed Breast Satisfaction,"Information provided by Helio Carrara, University of Sao Paulo (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT03777852?cond=Breast%20Cancer&viewType=Card&page=1&rank=3
Breast Cancer,NCT05781633,"The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.",Information provided by Tianjin Medical University Cancer Institute and Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05781633?cond=Breast%20Cancer&viewType=Card&page=1&rank=4
Breast Cancer,NCT01531036,3D Breast Ultrasound Elastography in Patients Under Neoadjuvant Chemotherapy,"Information provided by Institut National de la Santé Et de la Recherche Médicale, France (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01531036?cond=Breast%20Cancer&viewType=Card&page=1&rank=5
Breast Cancer,NCT05408676,Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer Surgery,"Information provided by Jun Zhang, Fudan University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05408676?cond=Breast%20Cancer&viewType=Card&page=1&rank=6
Breast Cancer,NCT04301375,Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2,"Information provided by David Garcia Cinca, Hospital Clinic of Barcelona (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT04301375?cond=Breast%20Cancer&viewType=Card&page=1&rank=7
Breast Cancer,NCT02229149,"Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre",Information provided by US Oncology Research (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT02229149?cond=Breast%20Cancer&viewType=Card&page=1&rank=8
Breast Cancer,NCT04678544,Cooling Cap Trial to Prevent Permanent Chemotherapy,"Information provided by Jin Seok Ahn, MD, Samsung Medical Center (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04678544?cond=Breast%20Cancer&viewType=Card&page=1&rank=9
Breast Cancer,NCT03204708,Open Technique Interpectoral Catheter for Postoperative Analgesia in Modified Radical Mastectomy,"Information provided by Guniz M.Koksal, Istanbul University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03204708?cond=Breast%20Cancer&viewType=Card&page=1&rank=10
Breast Cancer,NCT05976620,Clinical Study of 18F-FAPI,"Information provided by Hao Wang, Sichuan Provincial People's Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05976620?cond=Breast%20Cancer&viewType=Card&page=2&rank=11
Breast Cancer,NCT05665920,Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy,"Information provided by Eduardo Barbieri, Instituto Brasileiro de Controle do Cancer (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05665920?cond=Breast%20Cancer&viewType=Card&page=2&rank=12
Breast Cancer,NCT06994416,A Novel Fluorescent Ductal Needle for Localization and Sampling of High,"Information provided by JIAN WEN, The Fourth Affiliated Hospital of China Medical University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06994416?cond=Breast%20Cancer&viewType=Card&page=2&rank=13
Breast Cancer,NCT05408260,A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer,Information provided by Thomas Jefferson University (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05408260?cond=Breast%20Cancer&viewType=Card&page=2&rank=14
Breast Cancer,NCT04174391,Lifestyles and Breast Cancer,"Information provided by Estefania Toledo, University of Navarra (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT04174391?cond=Breast%20Cancer&viewType=Card&page=2&rank=15
Breast Cancer,NCT07095023,Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2,"Information provided by Liu Qiang, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT07095023?cond=Breast%20Cancer&viewType=Card&page=2&rank=16
Breast Cancer,NCT06954623,Partial Breast Re,"Information provided by Juergen Debus, University Hospital Heidelberg (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06954623?cond=Breast%20Cancer&viewType=Card&page=2&rank=17
Breast Cancer,NCT00941408,Biomarker Study of Breast Tumors,"Information provided by National University Hospital, Singapore",Recruiting,https://clinicaltrials.gov/study/NCT00941408?cond=Breast%20Cancer&viewType=Card&page=2&rank=18
Breast Cancer,NCT06825949,A Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Hormone Receptor Positive Breast Cancer Patients,"Information provided by Kun Wang, Guangdong Provincial People's Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06825949?cond=Breast%20Cancer&viewType=Card&page=2&rank=19
Breast Cancer,NCT06825975,A Phase II Single-Arm Clinical Study to Explore the Efficacy and Safety of Hyperbaric Oxygen in the Neoadjuvant Treatment of Triple,"Information provided by Kun Wang, Guangdong Provincial People's Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06825975?cond=Breast%20Cancer&viewType=Card&page=2&rank=20
Breast Cancer,NCT06811870,A Phase II Single,"Information provided by Kun Wang, Guangdong Provincial People's Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06811870?cond=Breast%20Cancer&viewType=Card&page=3&rank=21
Breast Cancer,NCT06819501,Hyperbaric Oxygen Therapy for Peripheral Neuropathy Due to Paclitaxel Analogs,"Information provided by Kun Wang, Guangdong Provincial People's Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06819501?cond=Breast%20Cancer&viewType=Card&page=3&rank=22
Breast Cancer,NCT06172270,Sub,"Information provided by Second Affiliated Hospital, School of Medicine, Zhejiang University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT06172270?cond=Breast%20Cancer&viewType=Card&page=3&rank=23
Breast Cancer,NCT06662864,"Study on Sleep, Lifestyle and Quality of Life in Women With Breast Cancer",Information provided by Institut Rafael (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06662864?cond=Breast%20Cancer&viewType=Card&page=3&rank=24
Breast Cancer,NCT07034248,"Electrochemical Biosensor Based on Lectin-functionalized Nitrogen, Sulfur",Information provided by Chang Gung Memorial Hospital (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07034248?cond=Breast%20Cancer&viewType=Card&page=3&rank=25
Breast Cancer,NCT03347864,68Ga-NOTA,Information provided by Peking Union Medical College Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03347864?cond=Breast%20Cancer&viewType=Card&page=3&rank=26
Breast Cancer,NCT01827969,Feasibility Study of Ablathermy Focused Ultrasound (USF) of Breast Tumors Before Mastectomy,Information provided by Institut Bergonié (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT01827969?cond=Breast%20Cancer&viewType=Card&page=3&rank=27
Breast Cancer,NCT00639171,Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant,"Information provided by Andrzej Krol, State University of New York - Upstate Medical University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00639171?cond=Breast%20Cancer&viewType=Card&page=3&rank=28
Breast Cancer,NCT02340468,Breast Tumor Oxygenation During Exercise,"Information provided by Beckman Laser Institute and Medical Center, University of California, Irvine (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT02340468?cond=Breast%20Cancer&viewType=Card&page=3&rank=29
Breast Cancer,NCT00558545,A Phase 1,Information provided by Aegera Therapeutics,Terminated,https://clinicaltrials.gov/study/NCT00558545?cond=Breast%20Cancer&viewType=Card&page=3&rank=30
Breast Cancer,NCT04132960,Study of DS,Information provided by UNICANCER (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04132960?cond=Breast%20Cancer&viewType=Card&page=4&rank=31
Breast Cancer,NCT05858762,Artificial Intelligence for Automated Diagnosis of Breast Cancer,Information provided by Regina Elena Cancer Institute (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05858762?cond=Breast%20Cancer&viewType=Card&page=4&rank=32
Breast Cancer,NCT05076266,COVID,Information provided by Eastern Cooperative Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05076266?cond=Breast%20Cancer&viewType=Card&page=4&rank=33&tab=results
Breast Cancer,NCT00721903,Three Dimensional (3D) Ultrasound in Predicting Response to Breast Cancer Therapies,"Information provided by Paul L. Carson Ph.D, University of Michigan (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00721903?cond=Breast%20Cancer&viewType=Card&page=4&rank=34
Breast Cancer,NCT06857669,Clinical Explorative Optical Breast Investigations,Information provided by Region Skane (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06857669?cond=Breast%20Cancer&viewType=Card&page=4&rank=35
Breast Cancer,NCT02642094,Aging Mammary Stem Cells and Breast Cancer Prevention,"Information provided by LuZhe Sun, The University of Texas Health Science Center at San Antonio (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02642094?cond=Breast%20Cancer&viewType=Card&page=4&rank=36&tab=results
Breast Cancer,NCT04948983,The Effect of a Patient Decision Aids for Breast Cancer Screening,Information provided by Pontificia Universidad Catolica de Chile (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04948983?cond=Breast%20Cancer&viewType=Card&page=4&rank=37
Breast Cancer,NCT00243698,A Pilot Study Evaluation of the Efficacy of SonoVue to Detect and Characterise Breast Lesions,"Information provided by University Hospital, Tours",Completed,https://clinicaltrials.gov/study/NCT00243698?cond=Breast%20Cancer&viewType=Card&page=4&rank=38
Breast Cancer,NCT03494400,Aerobic Training in Treatment for Breast Cancer,"Information provided by Andréa Dias Reis, Universidade Estadual Paulista Júlio de Mesquita Filho (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03494400?cond=Breast%20Cancer&viewType=Card&page=4&rank=39
Breast Cancer,NCT02375048,Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: WBI Versus APBI,"Information provided by Michele Tedeschi, Istituto Clinico Humanitas (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT02375048?cond=Breast%20Cancer&viewType=Card&page=4&rank=40
Breast Cancer,NCT05989022,Comparison of Low,Information provided by AB-CT - Advanced Breast-CT GmbH (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05989022?cond=Breast%20Cancer&viewType=Card&page=5&rank=41
Breast Cancer,NCT00542451,Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2,"Information provided by Sara Tolaney, MD, Dana-Farber Cancer Institute (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00542451?cond=Breast%20Cancer&viewType=Card&page=5&rank=42&tab=results
Breast Cancer,NCT03863522,Automated Method for Breast Cancer Detection,Information provided by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03863522?cond=Breast%20Cancer&viewType=Card&page=5&rank=43&tab=results
Breast Cancer,NCT04692818,3D Ultrasound Breast Imaging,Information provided by Mayo Clinic (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04692818?cond=Breast%20Cancer&viewType=Card&page=5&rank=44
Breast Cancer,NCT01247467,Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Breast Tumor,"Information provided by National University Hospital, Singapore",Active,https://clinicaltrials.gov/study/NCT01247467?cond=Breast%20Cancer&viewType=Card&page=5&rank=45
Breast Cancer,NCT03684408,Radiofrequency Chip for Localization of Non,"Information provided by Megha Garg, University of Missouri-Columbia (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03684408?cond=Breast%20Cancer&viewType=Card&page=5&rank=46&tab=results
Breast Cancer,NCT02725658,Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using DOSI,"Information provided by Beckman Laser Institute and Medical Center, University of California, Irvine (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT02725658?cond=Breast%20Cancer&viewType=Card&page=5&rank=47
Breast Cancer,NCT02869607,Institut Paoli Calmettes Breast Cancer Database,Information provided by Institut Paoli-Calmettes (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT02869607?cond=Breast%20Cancer&viewType=Card&page=5&rank=48
Breast Cancer,NCT02608281,Evaluation of Diagnostic Accuracy of Contrast Enhanced Dual Energy Mammography Imaging in Comparison to CE,Information provided by Siemens Healthcare QT (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02608281?cond=Breast%20Cancer&viewType=Card&page=5&rank=49
Breast Cancer,NCT01247480,Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin,"Information provided by National University Hospital, Singapore",Active,https://clinicaltrials.gov/study/NCT01247480?cond=Breast%20Cancer&viewType=Card&page=5&rank=50
Breast Cancer,NCT01952717,PMA Required Pivotal Multi-reader Multi,Information provided by Koning Corporation (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01952717?cond=Breast%20Cancer&viewType=Card&page=6&rank=51
Breast Cancer,NCT02396433,"Combination of Carboplatin, Eribulin Mesylate, and E7449 in BRCA","Information provided by Virginia G. Kaklamani, The University of Texas Health Science Center at San Antonio (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT02396433?cond=Breast%20Cancer&viewType=Card&page=6&rank=52
Breast Cancer,NCT02595372,Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy,"Information provided by Kathy Miller, Indiana University School of Medicine (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02595372?cond=Breast%20Cancer&viewType=Card&page=6&rank=53&tab=results
Breast Cancer,NCT03463954,Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors,Information provided by Novian Health Inc. (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03463954?cond=Breast%20Cancer&viewType=Card&page=6&rank=54
Breast Cancer,NCT01372917,Evaluating AlloMax in Immediate Expander,"Information provided by Mark L. Venturi, MD FACS, National Center for Plastic Surgery, Virginia (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01372917?cond=Breast%20Cancer&viewType=Card&page=6&rank=55
Breast Cancer,NCT00571987,Pilot Study of Radiofrequency Ablation of Breast Cancer Lumpectomy Sites to Decrease Re,Information provided by University of Arkansas (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00571987?cond=Breast%20Cancer&viewType=Card&page=6&rank=56&tab=results
Breast Cancer,NCT04794075,"Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non",Information provided by Centre Hospitalier Emile Roux (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04794075?cond=Breast%20Cancer&viewType=Card&page=6&rank=57
Breast Cancer,NCT00572481,Axillary Reverse Mapping,Information provided by University of Arkansas (Responsible Party),Active,https://clinicaltrials.gov/study/NCT00572481?cond=Breast%20Cancer&viewType=Card&page=6&rank=58
Breast Cancer,NCT00193778,Assessing Impact of Loco,"Information provided by Dr Rajendra A. Badwe, Tata Memorial Centre (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00193778?cond=Breast%20Cancer&viewType=Card&page=6&rank=59
Breast Cancer,NCT00217815,Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer,Information provided by NeuTec Pharma,Completed,https://clinicaltrials.gov/study/NCT00217815?cond=Breast%20Cancer&viewType=Card&page=6&rank=60
Breast Cancer,NCT00128362,Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer,"Information provided by Dr Rajendra A. Badwe, Tata Memorial Centre (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT00128362?cond=Breast%20Cancer&viewType=Card&page=7&rank=61
Breast Cancer,NCT03429907,An Early Stress,Information provided by M.D. Anderson Cancer Center (Responsible Party),Active,https://clinicaltrials.gov/study/NCT03429907?cond=Breast%20Cancer&viewType=Card&page=7&rank=62
Breast Cancer,NCT01105468,Breath Gas Analysis for the Diagnosis of Breast Cancer,Breath Gas Analysis for the Diagnosis of Breast Cancer,Terminated,https://clinicaltrials.gov/study/NCT01105468?cond=Breast%20Cancer&viewType=Card&page=7&rank=63
Breast Cancer,NCT02860104,Ultrasound Guided Percutaneous Microwave Ablation for Breast Lesions,"Information provided by Ping Liang, Chinese PLA General Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02860104?cond=Breast%20Cancer&viewType=Card&page=7&rank=64
Breast Cancer,NCT06251544,TRAIL-R2 and HER2 Bi,"Information provided by Valentina Hoyos, Baylor College of Medicine (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06251544?cond=Breast%20Cancer&viewType=Card&page=7&rank=65
Breast Cancer,NCT01503905,Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients,"Information provided by Fengxi Su, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT01503905?cond=Breast%20Cancer&viewType=Card&page=7&rank=66
Breast Cancer,NCT06433804,Clinicopathological Parameters of HER2 Low Breast Cancers,"Information provided by SANA AHUJA, Vardhman Mahavir Medical College And Safdarjung Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT06433804?cond=Breast%20Cancer&viewType=Card&page=7&rank=67
Breast Cancer,NCT04067726,RANKL Inhibition and Mammographic Breast Density,Information provided by Washington University School of Medicine (Responsible Party),Active,https://clinicaltrials.gov/study/NCT04067726?cond=Breast%20Cancer&viewType=Card&page=7&rank=68
Breast Cancer,NCT05159778,Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2,"Information provided by HiberCell, Inc. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05159778?cond=Breast%20Cancer&viewType=Card&page=7&rank=69
Breast Cancer,NCT03022864,Accurate Diagnosis System for Postoperative Chronic Pain Based on fMRI,Information provided by RenJi Hospital (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT03022864?cond=Breast%20Cancer&viewType=Card&page=7&rank=70
Breast Cancer,NCT04669873,"Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation, in Early Breast Cancer, After Breast","Information provided by Eduardo Barbieri, Instituto Brasileiro de Controle do Cancer (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04669873?cond=Breast%20Cancer&viewType=Card&page=8&rank=71
Breast Cancer,NCT04654208,Swedish Ibrance Registries Insights (SIRI),Information provided by Pfizer (Responsible Party),Active,https://clinicaltrials.gov/study/NCT04654208?cond=Breast%20Cancer&viewType=Card&page=8&rank=72
Breast Cancer,NCT01395706,ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes,Information provided by Pulsion Medical Systems SE,Inconnu,https://clinicaltrials.gov/study/NCT01395706?cond=Breast%20Cancer&viewType=Card&page=8&rank=73
Breast Cancer,NCT04327063,MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery,Information provided by Institut Curie (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04327063?cond=Breast%20Cancer&viewType=Card&page=8&rank=74
Breast Cancer,NCT04825444,Clinical Study of Vascular Imaging Evaluation of Computed Tomography Photoacoustic Breast Imaging System,Information provided by Peking Union Medical College Hospital (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT04825444?cond=Breast%20Cancer&viewType=Card&page=8&rank=75
Breast Cancer,NCT03368196,DS,"Information provided by Daiichi Sankyo (Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company) (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03368196?cond=Breast%20Cancer&viewType=Card&page=8&rank=76&tab=results
Breast Cancer,NCT04340180,Evaluating the Performance of AI in Evaluating Breast MRI Performed With Dose Reduction,"Information provided by Stefanie A. Woodard, University of Alabama at Birmingham (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT04340180?cond=Breast%20Cancer&viewType=Card&page=8&rank=77
Breast Cancer,NCT03425656,Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancer,Information provided by AryoGen Pharmed Co. (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03425656?cond=Breast%20Cancer&viewType=Card&page=8&rank=78&tab=results
Breast Cancer,NCT03366428,Phase 1 Study to Evaluate the Effect of DS-8201a on the QT/QTc Interval and Pharmacokinetics in HER2,"Information provided by Daiichi Sankyo (Daiichi Sankyo Co., Ltd.) (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03366428?cond=Breast%20Cancer&viewType=Card&page=8&rank=79&tab=results
Breast Cancer,NCT03289819,Neoadjuvant Pembrolizumab(Pbr)/Nab,Information provided by Institut fuer Frauengesundheit (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03289819?cond=Breast%20Cancer&viewType=Card&page=8&rank=80
Breast Cancer,NCT03159195,Ibrance Real World Insights,Information provided by Pfizer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03159195?cond=Breast%20Cancer&viewType=Card&page=9&rank=81&tab=results
Breast Cancer,NCT00698477,Chemotherapy on Methylation Patterns in Breast Tumor Tissue Correlating With Clinical Response and Outcomes,"Information provided by National University Hospital, Singapore",Recruiting,https://clinicaltrials.gov/study/NCT00698477?cond=Breast%20Cancer&viewType=Card&page=9&rank=82
Breast Cancer,NCT02495363,Analgesic Effects of Ultrasound Guided PEC Blocks on Analgesic Opioid Consumption of Cancer Surgery Patients,Information provided by Rabin Medical Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02495363?cond=Breast%20Cancer&viewType=Card&page=9&rank=83
Breast Cancer,NCT02408393,MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgery,Information provided by Institut Curie (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02408393?cond=Breast%20Cancer&viewType=Card&page=9&rank=84
Breast Cancer,NCT01943032,Discordant Hormonal Status of Breast Cancer.,"Information provided by AKANIST PIYAPANT, MD.,FRCST., National Cancer Institute, Thailand (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01943032?cond=Breast%20Cancer&viewType=Card&page=9&rank=85
Breast Cancer,NCT01935739,Discordant HER2/Neu Status of Breast Cancer.,"Information provided by AKANIST PIYAPANT, MD.,FRCST., National Cancer Institute, Thailand (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01935739?cond=Breast%20Cancer&viewType=Card&page=9&rank=86
Breast Cancer,NCT01953003,Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer,Information provided by Pierre Fabre Medicament (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01953003?cond=Breast%20Cancer&viewType=Card&page=9&rank=87&tab=results
Breast Cancer,NCT02376413,Oncoplastic Breast-conserving Surgery in Non,"Information provided by Erwei Song, M.D., Ph.D., Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT02376413?cond=Breast%20Cancer&viewType=Card&page=9&rank=88
Breast Cancer,NCT02905916,The Efficacy and Safety of PEG-rhG,"Information provided by Jun Zhu, Peking University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02905916?cond=Breast%20Cancer&viewType=Card&page=9&rank=89
Breast Cancer,NCT03030677,Establishing Technique for PECS2 Catheter Insertion,"Information provided by Mohamed Ahmed Mansour, Kasr El Aini Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03030677?cond=Breast%20Cancer&viewType=Card&page=9&rank=90
Breast Cancer,NCT01668238,Detection of Benign and Malignant Thyroid and Breast Tumors by Fourier Transform Infrared Spectrometry,"Information provided by XU Zhi, Peking University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT01668238?cond=Breast%20Cancer&viewType=Card&page=10&rank=91
Breast Cancer,NCT03667417,Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation,Information provided by Institut Paoli-Calmettes (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03667417?cond=Breast%20Cancer&viewType=Card&page=10&rank=92
Breast Cancer,NCT05486520,Low,"Information provided by Matthew S. Rosen, Ph.D., Massachusetts General Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05486520?cond=Breast%20Cancer&viewType=Card&page=10&rank=93
Breast Cancer,NCT01588834,Histology of Functional Density in Premenopausal Breast,"Information provided by Carrie Hruska, Mayo Clinic (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01588834?cond=Breast%20Cancer&viewType=Card&page=10&rank=94
Breast Cancer,NCT06185855,A Simplified Approach to Predicting the Malignancy of Breast Lesions: Nomogram in Ultrasonography,"Information provided by Lixin Jiang, RenJi Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06185855?cond=Breast%20Cancer&viewType=Card&page=10&rank=95
Breast Cancer,NCT06597175,Evaluating Investigational Medical Device for Breast Tumor Diagnosis Using Diffusion Optical Spectroscopy,Information provided by Olive Healthcare (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06597175?cond=Breast%20Cancer&viewType=Card&page=10&rank=96
Breast Cancer,NCT01240278,Histology of Functional Density in Postmenopausal Breast,"Information provided by Carrie Hruska, Mayo Clinic (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01240278?cond=Breast%20Cancer&viewType=Card&page=10&rank=97
Breast Cancer,NCT01711502,Epidemiology and Management of Metastatic Breast Cancer,Information provided by AstraZeneca (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01711502?cond=Breast%20Cancer&viewType=Card&page=10&rank=98
Breast Cancer,NCT05512260,"Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs","Information provided by Kaisa Fritzell, Karolinska Institutet (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05512260?cond=Breast%20Cancer&viewType=Card&page=10&rank=99
Breast Cancer,NCT00001496,Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer,Information provided by National Institutes of Health Clinical Center (CC),Completed,https://clinicaltrials.gov/study/NCT00001496?cond=Breast%20Cancer&viewType=Card&page=10&rank=100
Breast Cancer,NCT01644890,A Phase III Study of NK105 in Patients With Breast Cancer,"Information provided by Nippon Kayaku Co., Ltd. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01644890?cond=Breast%20Cancer&viewType=Card&page=11&rank=101&tab=results
Breast Cancer,NCT01703754,Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.,Information provided by Alaunos Therapeutics (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01703754?cond=Breast%20Cancer&viewType=Card&page=11&rank=102&tab=results
Breast Cancer,NCT01983501,A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T,Information provided by Seagen Inc. (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01983501?cond=Breast%20Cancer&viewType=Card&page=11&rank=103
Breast Cancer,NCT03262831,Mindful Movement in Women Receiving Adjuvant or Neoadjuvant Therapy for Breast Cancer,Information provided by Washington University School of Medicine (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03262831?cond=Breast%20Cancer&viewType=Card&page=11&rank=104
Breast Cancer,NCT04400552,Perioperative Oral Nutrition Supplementation in Malnourished Surgical Cancer Patients,"Information provided by Winnie Chee, IMU University, Malaysia (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04400552?cond=Breast%20Cancer&viewType=Card&page=11&rank=105
Breast Cancer,NCT03285607,"MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2",Information provided by Washington University School of Medicine (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT03285607?cond=Breast%20Cancer&viewType=Card&page=11&rank=106
Breast Cancer,NCT02472353,Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer,Information provided by Avera McKennan Hospital & University Health Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02472353?cond=Breast%20Cancer&viewType=Card&page=11&rank=107&tab=results
Breast Cancer,NCT00248911,The Effect Of Meditation On Quality Of Life In Women With Breast Cancer And Other Gynecological Cancers,"Information provided by Mary E. Charlson, MD, Weill Medical College of Cornell University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00248911?cond=Breast%20Cancer&viewType=Card&page=11&rank=108
Breast Cancer,NCT01807754,Simulated Screening Study for Breast Imaging,"Information provided by Paul L. Carson Ph.D, University of Michigan (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01807754?cond=Breast%20Cancer&viewType=Card&page=11&rank=109
Breast Cancer,NCT07195344,Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T,Information provided by Institut Claudius Regaud (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT07195344?cond=Breast%20Cancer&viewType=Card&page=11&rank=110
Breast Cancer,NCT05693766,Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort,"Information provided by Sonya Reid, Vanderbilt-Ingram Cancer Center (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05693766?cond=Breast%20Cancer&viewType=Card&page=12&rank=111
Breast Cancer,NCT02004834,Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than Levobupivacaine,"Information provided by Miroslav Župčić, University Hospital Dubrava (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT02004834?cond=Breast%20Cancer&viewType=Card&page=12&rank=112
Breast Cancer,NCT02229136,Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus,Information provided by US Oncology Research (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02229136?cond=Breast%20Cancer&viewType=Card&page=12&rank=113
Breast Cancer,NCT06981208,ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction,Information provided by Washington University School of Medicine (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06981208?cond=Breast%20Cancer&viewType=Card&page=12&rank=114
Breast Cancer,NCT02755896,Trial to Compare Radiation Fibrosis With Five Versus Three Fractions,Information provided by Weill Medical College of Cornell University (Responsible Party),Active,https://clinicaltrials.gov/study/NCT02755896?cond=Breast%20Cancer&viewType=Card&page=12&rank=115
Breast Cancer,NCT05716542,Prehabilitation to Revolutionize Oncology: Telehealth Exercise for Cognitive Triumphs (The PROTECT Trial),Information provided by Washington University School of Medicine (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05716542?cond=Breast%20Cancer&viewType=Card&page=12&rank=116
Breast Cancer,NCT05972343,COOL-IT-PRO: Cryoablation of Breast Cancer in Non,Information provided by Washington University School of Medicine (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05972343?cond=Breast%20Cancer&viewType=Card&page=12&rank=117
Breast Cancer,NCT05837455,"NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2",Information provided by Washington University School of Medicine (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05837455?cond=Breast%20Cancer&viewType=Card&page=12&rank=118
Breast Cancer,NCT01596530,Evaluation of Drug Activity in Women With Breast Cancer and no Previous Herceptin Treatment,Information provided by AstraZeneca (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT01596530?cond=Breast%20Cancer&viewType=Card&page=12&rank=119
Breast Cancer,NCT04968964,"Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing",Information provided by Washington University School of Medicine (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04968964?cond=Breast%20Cancer&viewType=Card&page=12&rank=120
Breast Cancer,NCT01509625,Retrospective Study Assessment Treatment Response Faslodex®( 500 mg),"Information provided by Isabel Blancas, Hospital Clinico Universitario San Cecilio (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01509625?cond=Breast%20Cancer&viewType=Card&page=13&rank=121&tab=results
Breast Cancer,NCT07209020,HealiAid Collagen Wound Dressing in Patients Undergoing Breast Tumor Surgery,Information provided by Maxigen Biotech Inc. (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT07209020?cond=Breast%20Cancer&viewType=Card&page=13&rank=122
Breast Cancer,NCT02807597,Real,"Information provided by Samuel Achilefu, University of Texas Southwestern Medical Center (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02807597?cond=Breast%20Cancer&viewType=Card&page=13&rank=123&tab=results
Breast Cancer,NCT04861220,Surgical Pre,"Information provided by Instituto Nacional de Cancer, Brazil (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04861220?cond=Breast%20Cancer&viewType=Card&page=13&rank=124
Breast Cancer,NCT05949983,Health Economic Evaluation of an Adapted Physical Activity Program for Women With Breast Cancer,"Information provided by University Hospital, Toulouse (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05949983?cond=Breast%20Cancer&viewType=Card&page=13&rank=125
Breast Cancer,NCT03286413,Comparison of Microwave Ablation With Cryoablation for Breast Tumor,"Information provided by Ping Liang, Chinese PLA General Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03286413?cond=Breast%20Cancer&viewType=Card&page=13&rank=126
Breast Cancer,NCT00859261,Two Dimensional (2D) Silicon Transducer,"Information provided by Paul L. Carson Ph.D, University of Michigan (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00859261?cond=Breast%20Cancer&viewType=Card&page=13&rank=127
Breast Cancer,NCT04440995,The Effects of Perioperative PECS Block During Robotic Breast Surgery and Breast Reconstruction,Information provided by Yonsei University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04440995?cond=Breast%20Cancer&viewType=Card&page=13&rank=128
Breast Cancer,NCT06672302,A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients At High Risk for Breast Cancer,Information provided by EXoPERT (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06672302?cond=Breast%20Cancer&viewType=Card&page=13&rank=129
Breast Cancer,NCT03379428,Trial of Ibrutinib Plus Trastuzumab in HER2,Information provided by US Oncology Research (Responsible Party),Active,https://clinicaltrials.gov/study/NCT03379428?cond=Breast%20Cancer&viewType=Card&page=13&rank=130
Breast Cancer,NCT02302196,Autologous Fat Grafting of the Breast in Women With Post Lumpectomy Contour Defects,Information provided by Kaiser Permanente (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02302196?cond=Breast%20Cancer&viewType=Card&page=14&rank=131
Breast Cancer,NCT02611544,Investigation of Three Approaches to Address Fear of Recurrence Among Breast Cancer Survivors,"Information provided by Shelley Johns, Indiana University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02611544?cond=Breast%20Cancer&viewType=Card&page=14&rank=132
Breast Cancer,NCT06294574,Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction,"Information provided by Ceren Yalniz, University of Alabama at Birmingham (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06294574?cond=Breast%20Cancer&viewType=Card&page=14&rank=133
Breast Cancer,NCT04583124,Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO),"Information provided by Irene Cantarero Villanueva, Universidad de Granada (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04583124?cond=Breast%20Cancer&viewType=Card&page=14&rank=134
Breast Cancer,NCT05507034,Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment.,"Information provided by Prof. dr. Mira Meeús, Universiteit Antwerpen (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05507034?cond=Breast%20Cancer&viewType=Card&page=14&rank=135
Breast Cancer,NCT06058650,Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities,Information provided by Mayo Clinic (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06058650?cond=Breast%20Cancer&viewType=Card&page=14&rank=136
Breast Cancer,NCT04652609,Preventing Chemotherapy,"Information provided by Irene Cantarero Villanueva, Universidad de Granada (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04652609?cond=Breast%20Cancer&viewType=Card&page=14&rank=137
Breast Cancer,NCT06090747,"Improving Lifestyle Behavior by ""Joven, Fuerte y Saludable"" Multidisciplinary Program.","Information provided by Marlid Cruz Ramos, Instituto Nacional de Cancerologia de Mexico (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06090747?cond=Breast%20Cancer&viewType=Card&page=14&rank=138
Breast Cancer,NCT05364450,Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors,"Information provided by Shelley Johns, Indiana University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05364450?cond=Breast%20Cancer&viewType=Card&page=14&rank=139
Breast Cancer,NCT05862610,The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC,Information provided by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT05862610?cond=Breast%20Cancer&viewType=Card&page=14&rank=140
Breast Cancer,NCT05604677,Factor Influencing Breast Surgery Type Decision,"Information provided by Etienne El Helou, Dr Etienne El Helou (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05604677?cond=Breast%20Cancer&viewType=Card&page=15&rank=141
Breast Cancer,NCT04396665,Breast Cancer: Feasibility of an Educational Intervention,"Information provided by Rubén Martín Payo, University of Oviedo (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04396665?cond=Breast%20Cancer&viewType=Card&page=15&rank=142&tab=results
Breast Cancer,NCT06056414,Study of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation,Information provided by Centre Henri Becquerel (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06056414?cond=Breast%20Cancer&viewType=Card&page=15&rank=143
Breast Cancer,NCT01194908,Re,"Information provided by Ruth O'Regan, Emory University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01194908?cond=Breast%20Cancer&viewType=Card&page=15&rank=144&tab=results
Breast Cancer,NCT05868187,CanRestoreFunction Cancer,"Information provided by Anne Fleischer, University of Cincinnati (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05868187?cond=Breast%20Cancer&viewType=Card&page=15&rank=145
Breast Cancer,NCT03024463,The Multi,"Information provided by Yongsheng Wang, Shandong Cancer Hospital and Institute (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03024463?cond=Breast%20Cancer&viewType=Card&page=15&rank=146
Breast Cancer,NCT02162667,Efficacy and Safety Evaluating Study of CT,Information provided by Celltrion (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02162667?cond=Breast%20Cancer&viewType=Card&page=15&rank=147&tab=results
Breast Cancer,NCT06480513,Cancer Of the BReast Asanas Study (COBRA),"Information provided by Dr. Evelyn Moninkhof, UMC Utrecht (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06480513?cond=Breast%20Cancer&viewType=Card&page=15&rank=148
Breast Cancer,NCT05889988,A Study of Ado-trastuzumab Emtansine (T-DM1)-Induced Peripheral Neuropathy in HER2,Information provided by Mayo Clinic (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05889988?cond=Breast%20Cancer&viewType=Card&page=15&rank=149
Breast Cancer,NCT06928818,Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2,"Information provided by Kyung-Hun Lee, Seoul National University Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06928818?cond=Breast%20Cancer&viewType=Card&page=15&rank=150
Breast Cancer,NCT03874598,Effectiveness of Ear Acupuncture to Improve Insomnia in Women With Breast Cancer,"Information provided by Dr. med. Petra Voiss, Universität Duisburg-Essen (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03874598?cond=Breast%20Cancer&viewType=Card&page=16&rank=151
Breast Cancer,NCT05050890,Prognostic Value of Circulating Tumor DNA Dosing in Patients in Neoadjuvant Breast Neoplasia,"Information provided by Camila Giro, Instituto Brasileiro de Controle do Cancer (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT05050890?cond=Breast%20Cancer&viewType=Card&page=16&rank=152
Breast Cancer,NCT02364960,Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT),"Information provided by Angela N Fellner PhD CCRP, TriHealth Inc. (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT02364960?cond=Breast%20Cancer&viewType=Card&page=16&rank=153
Breast Cancer,NCT04893421,Magnetic Occult Lesion Localization Instrument (MOLLI) Guidance System for Breast Lesion Localization,"Information provided by Nicole Look Hong, Sunnybrook Health Sciences Centre (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04893421?cond=Breast%20Cancer&viewType=Card&page=16&rank=154
Breast Cancer,NCT03756064,Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer,Information provided by Zhejiang Cancer Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03756064?cond=Breast%20Cancer&viewType=Card&page=16&rank=155
Breast Cancer,NCT06495164,A Real,Information provided by Pfizer (Responsible Party),Active,https://clinicaltrials.gov/study/NCT06495164?cond=Breast%20Cancer&viewType=Card&page=16&rank=156
Breast Cancer,NCT06843083,Contrast Enhanced Mammography or Breast Magnetic Resonance: Which Choice for Optimal Diagnostic Performance?,"Information provided by Graziella di Grezia, Link Campus University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06843083?cond=Breast%20Cancer&viewType=Card&page=16&rank=157
Breast Cancer,NCT06843096,Contrast Enhanced Mammography in the Evaluation of Cancer of Unknown Primary Syndrome,"Information provided by Graziella di Grezia, Link Campus University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06843096?cond=Breast%20Cancer&viewType=Card&page=16&rank=158
Breast Cancer,NCT03013881,"A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB",Information provided by United BioPharma (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03013881?cond=Breast%20Cancer&viewType=Card&page=16&rank=159
Breast Cancer,NCT06090630,MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer,Information provided by Jonsson Comprehensive Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06090630?cond=Breast%20Cancer&viewType=Card&page=16&rank=160
Breast Cancer,NCT00771381,A Study to Determine the Value of 18F,Information provided by AHS Cancer Control Alberta (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT00771381?cond=Breast%20Cancer&viewType=Card&page=17&rank=161
Breast Cancer,NCT06846814,Second-Look Ultrasound Post Contrast,"Information provided by Graziella di Grezia, Link Campus University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06846814?cond=Breast%20Cancer&viewType=Card&page=17&rank=162
Breast Cancer,NCT06472700,Endoscopic Extirpation of Benign Breast Tumors Using a Lateral Chest Wall Incision,"Information provided by Jinghua Zhao, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT06472700?cond=Breast%20Cancer&viewType=Card&page=17&rank=163
Breast Cancer,NCT04644848,Ultrasonographic Axillary Localization,"Information provided by Osama Hussein, Mansoura University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04644848?cond=Breast%20Cancer&viewType=Card&page=17&rank=164
Breast Cancer,NCT04824599,Regional Anesthesia and Partial Mastectomy,"Information provided by Patryk Eisler, Karlstad Central Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04824599?cond=Breast%20Cancer&viewType=Card&page=17&rank=165
Breast Cancer,NCT04388384,Real-life Pan-HER,Information provided by Pierre Fabre Pharma GmbH (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04388384?cond=Breast%20Cancer&viewType=Card&page=17&rank=166
Breast Cancer,NCT06517212,Tirzepatide Weight Loss for MRD+ Early Breast Cancer,Information provided by Baylor Research Institute (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06517212?cond=Breast%20Cancer&viewType=Card&page=17&rank=167
Breast Cancer,NCT04444882,"Complications After Lumpectomy, Sentinel Node and Radiotherapy in Breast Cancer Patients and Physiotherapy Care","Information provided by University Hospital, Grenoble (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04444882?cond=Breast%20Cancer&viewType=Card&page=17&rank=168
Breast Cancer,NCT02025192,A Study of Tucatinib (ONT,Information provided by Seagen Inc. (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02025192?cond=Breast%20Cancer&viewType=Card&page=17&rank=169
Breast Cancer,NCT04083027,Non,"Information provided by Sara Mohamed Gamal Hassan, Assiut University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04083027?cond=Breast%20Cancer&viewType=Card&page=17&rank=170
Breast Cancer,NCT00062751,Study Evaluating Temsirolimus (CCI,Information provided by Wyeth is now a wholly owned subsidiary of Pfizer,Completed,https://clinicaltrials.gov/study/NCT00062751?cond=Breast%20Cancer&viewType=Card&page=18&rank=171&tab=results
Breast Cancer,NCT06134570,ALDH1A1 Expression in Invasive Mammary Carcinoma,"Information provided by Nagwa Abd El-Sadek Ahmed, Sohag University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06134570?cond=Breast%20Cancer&viewType=Card&page=18&rank=172
Breast Cancer,NCT03939598,Feasibility of Preoperative Tattooing of Percutaneously Biopsied Axillary Lymph Node: A Quasi Experimental Pilot Study,"Information provided by Abida K. Sattar, MD, FACS, Aga Khan University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03939598?cond=Breast%20Cancer&viewType=Card&page=18&rank=173
Breast Cancer,NCT02056080,Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib,Information provided by MedSIR (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02056080?cond=Breast%20Cancer&viewType=Card&page=18&rank=174
Breast Cancer,NCT06291896,A Clinical Investigation to Evaluate Microwave Imaging Via MammoWave® in a Population,Information provided by Umbria Bioengineering Technologies (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06291896?cond=Breast%20Cancer&viewType=Card&page=18&rank=175
Breast Cancer,NCT01432002,FDG,"Information provided by Vincent Vinh-Hung, University of Geneva, Switzerland (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT01432002?cond=Breast%20Cancer&viewType=Card&page=18&rank=176
Breast Cancer,NCT03761420,Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical Outcome,Information provided by St. Olavs Hospital (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03761420?cond=Breast%20Cancer&viewType=Card&page=18&rank=177
Breast Cancer,NCT05576545,Develop and Evaluate the Effectiveness of a Self-Care Smartphone Application on the Self,"Information provided by Hsin-Tien Hsu, Kaohsiung Medical University Chung-Ho Memorial Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05576545?cond=Breast%20Cancer&viewType=Card&page=18&rank=178
Breast Cancer,NCT03275727,A Guided Internet-delivered Individually-tailored ACT,"Information provided by Gerhard Andersson, Linkoeping University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT03275727?cond=Breast%20Cancer&viewType=Card&page=18&rank=179
Breast Cancer,NCT05033756,Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO,Information provided by Institut fuer Frauengesundheit (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05033756?cond=Breast%20Cancer&viewType=Card&page=18&rank=180
Breast Cancer,NCT03445637,Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®,Information provided by Pfizer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03445637?cond=Breast%20Cancer&viewType=Card&page=19&rank=181
Breast Cancer,NCT03269981,Randomized Study of Elective Regional Lymph Node Irradiation in N1 Breast Cancer,Information provided by Samsung Medical Center (Responsible Party),Active,https://clinicaltrials.gov/study/NCT03269981?cond=Breast%20Cancer&viewType=Card&page=19&rank=182
Breast Cancer,NCT03266562,Estrogen Receptor Expression in Breast Cancer,"Information provided by Michael O'Connor, Mayo Clinic (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT03266562?cond=Breast%20Cancer&viewType=Card&page=19&rank=183
Breast Cancer,NCT03273426,Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.,"Information provided by Wonshik Han, Seoul National University Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03273426?cond=Breast%20Cancer&viewType=Card&page=19&rank=184&tab=results
Breast Cancer,NCT03330717,Interventional Study on the Impact of the Hypnosis Used as Sedation or Relaxation in the Breast Oncologic Surgery,Information provided by Cliniques universitaires Saint-Luc- Université Catholique de Louvain (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03330717?cond=Breast%20Cancer&viewType=Card&page=19&rank=185
Breast Cancer,NCT05723237,The Effect of Breast Cancer Screening Training,"Information provided by DİLEK YILDIRIM, Istanbul Aydın University (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT05723237?cond=Breast%20Cancer&viewType=Card&page=19&rank=186
Breast Cancer,NCT00463788,"Cetuximab and Cisplatin in the Treatment of ""Triple Negative"" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer","Information provided by Merck KGaA, Darmstadt, Germany (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00463788?cond=Breast%20Cancer&viewType=Card&page=19&rank=187&tab=results
Breast Cancer,NCT03069742,Study of Web,"Information provided by Katherine D. Crew, Columbia University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03069742?cond=Breast%20Cancer&viewType=Card&page=19&rank=188
Breast Cancer,NCT03295552,Decitabine Plus Carboplatin in the Treatment of Metastatic TNBC,"Information provided by Kunwei Shen, Shanghai Jiao Tong University School of Medicine (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT03295552?cond=Breast%20Cancer&viewType=Card&page=19&rank=189
Breast Cancer,NCT03024580,A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer,"Information provided by Instituto Nacional de Cancer, Brazil (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03024580?cond=Breast%20Cancer&viewType=Card&page=19&rank=190
Breast Cancer,NCT03220178,Impact of eHealth,Information provided by Palleos Healthcare GmbH (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT03220178?cond=Breast%20Cancer&viewType=Card&page=20&rank=191
Breast Cancer,NCT02970682,SFX,Information provided by Evgen Pharma (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02970682?cond=Breast%20Cancer&viewType=Card&page=20&rank=192
Breast Cancer,NCT03066947,SV-BR-1,Information provided by BriaCell Therapeutics Corporation (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03066947?cond=Breast%20Cancer&viewType=Card&page=20&rank=193&tab=results
Breast Cancer,NCT03124095,Combined Training Intervention for Women Who Underwent Primary Treatment for Breast Cancer,"Information provided by Stephanie Santana Pinto, Federal University of Pelotas (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03124095?cond=Breast%20Cancer&viewType=Card&page=20&rank=194
Breast Cancer,NCT02913573,Effect of Pectoral Nerve Block on Post,"Information provided by Jeannie Shen, Huntington Memorial Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02913573?cond=Breast%20Cancer&viewType=Card&page=20&rank=195
Breast Cancer,NCT02914197,Giving Information on the Risks and Limitations of Mammography Screening (GIRLS),Information provided by McMaster University (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT02914197?cond=Breast%20Cancer&viewType=Card&page=20&rank=196
Breast Cancer,NCT02513472,Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Combination With Pembrolizumab in Participants With Metastatic Triple,Information provided by Eisai Inc. (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02513472?cond=Breast%20Cancer&viewType=Card&page=20&rank=197&tab=results
Breast Cancer,NCT02455141,Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple,"Information provided by Kunwei Shen, Shanghai Jiao Tong University School of Medicine (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT02455141?cond=Breast%20Cancer&viewType=Card&page=20&rank=198
Breast Cancer,NCT02432118,Radiofrequency,Information provided by Stanford University (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT02432118?cond=Breast%20Cancer&viewType=Card&page=20&rank=199
Breast Cancer,NCT02561468,The Preemptive Analgesic Efficacy of Nefopam,"Information provided by Hyo-Seok Na, Seoul National University Bundang Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02561468?cond=Breast%20Cancer&viewType=Card&page=20&rank=200
Breast Cancer,NCT02316561,Single Dose Ablative Radiation Treatment for Early,"Information provided by K.R. Charaghvandi, UMC Utrecht (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02316561?cond=Breast%20Cancer&viewType=Card&page=21&rank=201
Breast Cancer,NCT02372305,Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery,Information provided by University of Arkansas (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT02372305?cond=Breast%20Cancer&viewType=Card&page=21&rank=202
Breast Cancer,NCT04429269,A Comparative Study of Mammography and Ultrasound for Breast Cancer Screening and Early Diagnosis,Information provided by Peking Union Medical College Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04429269?cond=Breast%20Cancer&viewType=Card&page=21&rank=203
Breast Cancer,NCT00295529,GenetiKiT: Evaluation of an Educational Intervention on the Delivery of Genetics Services by Family Physicians,"Information provided by June Carroll, University of Toronto (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00295529?cond=Breast%20Cancer&viewType=Card&page=21&rank=204
Breast Cancer,NCT02370082,SAVI SCOUT Clinical Evaluation Study,"Information provided by Cianna Medical, Inc. (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT02370082?cond=Breast%20Cancer&viewType=Card&page=21&rank=205
Breast Cancer,NCT03988777,Magnetic Seed Localisation for Nonpalpable Breast Lesions,Information provided by Universitaire Ziekenhuizen KU Leuven (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03988777?cond=Breast%20Cancer&viewType=Card&page=21&rank=206
Breast Cancer,NCT02065960,Feasibility Study of Stereotactic Body Radiotherapy for Early Breast Cancer,"Information provided by Julie Arsenault, Juravinski Cancer Center (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02065960?cond=Breast%20Cancer&viewType=Card&page=21&rank=207
Breast Cancer,NCT00107016,Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post,Information provided by Novartis (Novartis Pharmaceuticals) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00107016?cond=Breast%20Cancer&viewType=Card&page=21&rank=208
Breast Cancer,NCT06428799,Evaluation of Carebot AI MMG Medical Device for Breast Lesion Detection and Density Assessment,Information provided by Carebot s.r.o. (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06428799?cond=Breast%20Cancer&viewType=Card&page=21&rank=209
Breast Cancer,NCT01859936,Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary Treatment,"Information provided by Brita Arver, Karolinska University Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01859936?cond=Breast%20Cancer&viewType=Card&page=21&rank=210
Breast Cancer,NCT03261323,Breast Reconstruction Following Breast Cancer in Very High Risk Patients,Information provided by Case Comprehensive Cancer Center (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT03261323?cond=Breast%20Cancer&viewType=Card&page=22&rank=211
Breast Cancer,NCT01221870,Tesetaxel as First,Information provided by Genta Incorporated (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT01221870?cond=Breast%20Cancer&viewType=Card&page=22&rank=213
Breast Cancer,NCT01233947,Study of AFP464 +/,Information provided by Tigris Pharmaceuticals,Terminated,https://clinicaltrials.gov/study/NCT01233947?cond=Breast%20Cancer&viewType=Card&page=22&rank=214
Breast Cancer,NCT01015521,Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer,Information provided by Tigris Pharmaceuticals,Withdrawn,https://clinicaltrials.gov/study/NCT01015521?cond=Breast%20Cancer&viewType=Card&page=22&rank=215
Breast Cancer,NCT01061359,Application Of Epirubicin Within A Neo,Information provided by Pfizer,Completed,https://clinicaltrials.gov/study/NCT01061359?cond=Breast%20Cancer&viewType=Card&page=22&rank=216&tab=results
Breast Cancer,NCT00821288,Post,"Information provided by Dawn L. Hershman, Columbia University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00821288?cond=Breast%20Cancer&viewType=Card&page=22&rank=217
Breast Cancer,NCT00779285,Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED),Information provided by Merck Sharp & Dohme LLC (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00779285?cond=Breast%20Cancer&viewType=Card&page=22&rank=218&tab=results
Breast Cancer,NCT00779129,A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948),Information provided by Merck Sharp & Dohme LLC (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00779129?cond=Breast%20Cancer&viewType=Card&page=22&rank=219
Breast Cancer,NCT00687440,A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679),Information provided by Merck Sharp & Dohme LLC (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00687440?cond=Breast%20Cancer&viewType=Card&page=22&rank=220&tab=results
Breast Cancer,NCT00736333,A Study to Evaluate Safety and Tolerability in Patients With Metastatic Breast Cancer Receiving Treatment With Caelyx (Study P04878)(COMPLETED),Information provided by Merck Sharp & Dohme LLC (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00736333?cond=Breast%20Cancer&viewType=Card&page=23&rank=221&tab=results
Breast Cancer,NCT02101385,Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer,"Information provided by Bryan Schneider, MD, Hoosier Cancer Research Network (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02101385?cond=Breast%20Cancer&viewType=Card&page=23&rank=222&tab=results
Breast Cancer,NCT00550771,Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2,Information provided by Merck Sharp & Dohme LLC (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00550771?cond=Breast%20Cancer&viewType=Card&page=23&rank=223&tab=results
Breast Cancer,NCT06143020,Effect of ESPB on Postoperative Pain in Patients With Breast Cancer Implant Reconstruction,"Information provided by Jun Zhang, Fudan University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT06143020?cond=Breast%20Cancer&viewType=Card&page=23&rank=224
Breast Cancer,NCT00313248,Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer,Information provided by Bayer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00313248?cond=Breast%20Cancer&viewType=Card&page=23&rank=225
Breast Cancer,NCT00270894,Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II,Information provided by Accelerated Community Oncology Research Network (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00270894?cond=Breast%20Cancer&viewType=Card&page=23&rank=226&tab=results
Breast Cancer,NCT02172989,Clinical Application of Near,"Information provided by So-Youn Jung, National Cancer Center, Korea (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02172989?cond=Breast%20Cancer&viewType=Card&page=23&rank=227
Breast Cancer,NCT00251095,Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer,Information provided by Achieve Life Sciences,Terminated,https://clinicaltrials.gov/study/NCT00251095?cond=Breast%20Cancer&viewType=Card&page=23&rank=228
Breast Cancer,NCT00194727,Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer,Information provided by University of Washington (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00194727?cond=Breast%20Cancer&viewType=Card&page=23&rank=229
Breast Cancer,NCT00194740,Taxotere Plus Weekly Navelbine and G,Information provided by University of Washington,Completed,https://clinicaltrials.gov/study/NCT00194740?cond=Breast%20Cancer&viewType=Card&page=23&rank=230
Breast Cancer,NCT00194753,Adjuvant Therapy for High-Risk Breast Cancer With Wkly Adriamycin & Oral Cytoxan With G,Information provided by University of Washington (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00194753?cond=Breast%20Cancer&viewType=Card&page=24&rank=231
Breast Cancer,NCT00583739,Yoga to Reduce Cancer Fatigue,Information provided by University of Iowa,Completed,https://clinicaltrials.gov/study/NCT00583739?cond=Breast%20Cancer&viewType=Card&page=24&rank=232
Breast Cancer,NCT00201435,Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC,Information provided by Norwegian Breast Cancer Group,Completed,https://clinicaltrials.gov/study/NCT00201435?cond=Breast%20Cancer&viewType=Card&page=24&rank=233
Breast Cancer,NCT05035745,Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START),"Information provided by National University Hospital, Singapore (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05035745?cond=Breast%20Cancer&viewType=Card&page=24&rank=234
Breast Cancer,NCT01980823,Pre,"Information provided by Katherine D. Crew, Columbia University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01980823?cond=Breast%20Cancer&viewType=Card&page=24&rank=235
Breast Cancer,NCT06335108,Postoperative Pain After Breast Surgery Under Tumescent Local Anaesthesia Versus General Anaesthesia ( TLA,Information provided by University Hospital Tuebingen (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06335108?cond=Breast%20Cancer&viewType=Card&page=24&rank=236
Breast Cancer,NCT06606730,Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer,Information provided by UNICANCER (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06606730?cond=Breast%20Cancer&viewType=Card&page=24&rank=237
Breast Cancer,NCT06749210,DAANCE FOR CHEMOTHERAPY,"Information provided by Lise Worthen-Chaudhari, Ohio State University Comprehensive Cancer Center (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06749210?cond=Breast%20Cancer&viewType=Card&page=24&rank=238
Breast Cancer,NCT04626986,Comparison of Microwave Ablation With Breast Conserving Surgery for Breast Tumor,"Information provided by Ping Liang, Chinese PLA General Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04626986?cond=Breast%20Cancer&viewType=Card&page=24&rank=239
Breast Cancer,NCT02462200,Shave Margins in Breast Conservation Therapy,Information provided by Washington University School of Medicine (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT02462200?cond=Breast%20Cancer&viewType=Card&page=24&rank=240
Breast Cancer,NCT04571307,Cryotherapy in Breast B3 Lesions,Information provided by KK Women's and Children's Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04571307?cond=Breast%20Cancer&viewType=Card&page=25&rank=241
Breast Cancer,NCT05185752,Comparative Analysis of Three Locoregional Anesthesia Methods in Breast Tumour Pathology Surgery,Information provided by University of Valencia (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05185752?cond=Breast%20Cancer&viewType=Card&page=25&rank=242
Breast Cancer,NCT02624973,PErsonalized TREatment of High-risk MAmmary Cancer,Information provided by Haukeland University Hospital (Responsible Party),Active,https://clinicaltrials.gov/study/NCT02624973?cond=Breast%20Cancer&viewType=Card&page=25&rank=243
Breast Cancer,NCT01478438,"A Multicenter ""Ablate and Resect"" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Breast Cancers",Information provided by Novian Health Inc. (Responsible Party),Active,https://clinicaltrials.gov/study/NCT01478438?cond=Breast%20Cancer&viewType=Card&page=25&rank=244
Breast Cancer,NCT00477100,Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer,Information provided by M.D. Anderson Cancer Center (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT00477100?cond=Breast%20Cancer&viewType=Card&page=25&rank=245
Breast Cancer,NCT02296801,A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen,Information provided by NSABP Foundation Inc (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02296801?cond=Breast%20Cancer&viewType=Card&page=25&rank=246&tab=results
Breast Cancer,NCT03007979,Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer,Information provided by Washington University School of Medicine (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03007979?cond=Breast%20Cancer&viewType=Card&page=25&rank=247&tab=results
Breast Cancer,NCT02907918,Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II,Information provided by Washington University School of Medicine (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02907918?cond=Breast%20Cancer&viewType=Card&page=25&rank=248&tab=results
Breast Cancer,NCT00832338,Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores,"Information provided by Elisavet Paplomata, Emory University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00832338?cond=Breast%20Cancer&viewType=Card&page=25&rank=249&tab=results
Breast Cancer,NCT06622967,KNUCH CadAI-B-1(KCB,"Information provided by JeeYeon Lee, Kyungpook National University Chilgok Hospital (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT06622967?cond=Breast%20Cancer&viewType=Card&page=25&rank=250
Breast Cancer,NCT02733601,Epidemiology of Breast Cancer in Women Based on Diagnosis Data From Oncologists and Breast Surgeons in Algeria,Information provided by AstraZeneca (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02733601?cond=Breast%20Cancer&viewType=Card&page=26&rank=251
Breast Cancer,NCT05392608,SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL,Information provided by Borstkanker Onderzoek Groep (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05392608?cond=Breast%20Cancer&viewType=Card&page=26&rank=252
Breast Cancer,NCT05544123,The Treatment Situation of Chinese County Population With Breast Cancer,Information provided by The First Affiliated Hospital of Xinxiang Medical College (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05544123?cond=Breast%20Cancer&viewType=Card&page=26&rank=253
Breast Cancer,NCT05851053,Breast Cancer Long,Information provided by University Medical Center Groningen (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05851053?cond=Breast%20Cancer&viewType=Card&page=26&rank=254
Breast Cancer,NCT03165487,Comparison of the Breast Tumor Microenvironment,"Information provided by Eileen Connolly, Columbia University (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT03165487?cond=Breast%20Cancer&viewType=Card&page=26&rank=255
Breast Cancer,NCT04109079,Axillary Management in Breast Cancer Patients with Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy,"Information provided by Dr Amit Goyal, University Hospitals of Derby and Burton NHS Foundation Trust (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04109079?cond=Breast%20Cancer&viewType=Card&page=26&rank=256
Breast Cancer,NCT06970561,Analysis of Recurrence of Intraductal Papilloma Treated With Vacuum,"Information provided by Gang Hu, Wuhan Children's Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT06970561?cond=Breast%20Cancer&viewType=Card&page=26&rank=257
Breast Cancer,NCT06085313,Cancer Pain Management Using a Web,Information provided by University of Texas at Austin (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06085313?cond=Breast%20Cancer&viewType=Card&page=26&rank=258
Breast Cancer,NCT03870620,Metastatic Breast Cancer in Austria,Information provided by Arbeitsgemeinschaft medikamentoese Tumortherapie (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03870620?cond=Breast%20Cancer&viewType=Card&page=26&rank=259
Breast Cancer,NCT07114679,Molecular Breast Imaging (MBI),Information provided by Smart Breast Corp. (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07114679?cond=Breast%20Cancer&viewType=Card&page=26&rank=260
Breast Cancer,NCT03596463,Influence of Multidisciplinary Breast Tumor Board on Physician Decision,"Information provided by Murat Ferhat Ferhatoglu, Okan University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT03596463?cond=Breast%20Cancer&viewType=Card&page=27&rank=261
Breast Cancer,NCT04812652,Digitally Distributed Yoga for Women Treated for Breast Cancer,Information provided by Region Örebro County (Responsible Party),Active,https://clinicaltrials.gov/study/NCT04812652?cond=Breast%20Cancer&viewType=Card&page=27&rank=262
Breast Cancer,NCT05729451,Change in Cardiorespiratory Fitness and Breast Cancer Incidence and Mortality,Information provided by The Swedish School of Sport and Health Sciences (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05729451?cond=Breast%20Cancer&viewType=Card&page=27&rank=263
Breast Cancer,NCT06336928,A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis,Information provided by University of Southern California (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06336928?cond=Breast%20Cancer&viewType=Card&page=27&rank=264
Breast Cancer,NCT05305937,Implantation of CEST and CESL MRI Methods for Detection of Breast Tumors,"Information provided by Rotem Sivan-Hoffmann, Meir Medical Center (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05305937?cond=Breast%20Cancer&viewType=Card&page=27&rank=265
Breast Cancer,NCT06960291,Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada,Information provided by University of Calgary (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06960291?cond=Breast%20Cancer&viewType=Card&page=27&rank=266
Breast Cancer,NCT04200768,FATLAS: Comprehensive Multi,Information provided by Universitaire Ziekenhuizen KU Leuven (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04200768?cond=Breast%20Cancer&viewType=Card&page=27&rank=267
Breast Cancer,NCT03162627,Selumetinib and Olaparib in Solid Tumors,Information provided by M.D. Anderson Cancer Center (Responsible Party),Active,https://clinicaltrials.gov/study/NCT03162627?cond=Breast%20Cancer&viewType=Card&page=27&rank=268
Breast Cancer,NCT07084519,Hypofractionated vs Conventional RT After Prosthetic Breast Reconstruction,"Information provided by Shulian Wang, Cancer Institute and Hospital, Chinese Academy of Medical Sciences (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT07084519?cond=Breast%20Cancer&viewType=Card&page=27&rank=269
Breast Cancer,NCT05900986,LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I,Information provided by Integro Theranostics (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05900986?cond=Breast%20Cancer&viewType=Card&page=27&rank=270
Breast Cancer,NCT06217874,Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer,Information provided by Mayo Clinic (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06217874?cond=Breast%20Cancer&viewType=Card&page=28&rank=271
Breast Cancer,NCT07180433,Piloting 18F,Information provided by St. Olavs Hospital (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07180433?cond=Breast%20Cancer&viewType=Card&page=28&rank=272
Breast Cancer,NCT03788187,Persistant Organics Pollutants in Breast Cancer.,"Information provided by Koual Meriem, European Georges Pompidou Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03788187?cond=Breast%20Cancer&viewType=Card&page=28&rank=273
Breast Cancer,NCT04778670,Artificial Intelligence in Large,"Information provided by Fredrik Strand, Karolinska University Hospital (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT04778670?cond=Breast%20Cancer&viewType=Card&page=28&rank=274
Breast Cancer,NCT05361018,Sensorimotor Training Using Whole Body Vibration Exercise to Reduce Chemotherapy,"Information provided by Yvonne Wengstrom, Karolinska Institutet (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05361018?cond=Breast%20Cancer&viewType=Card&page=28&rank=275
Breast Cancer,NCT05505643,Cryoablation vs Lumpectomy in T1 Breast Cancers,Information provided by Washington University School of Medicine (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05505643?cond=Breast%20Cancer&viewType=Card&page=28&rank=276
Breast Cancer,NCT06499077,Non,"Information provided by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT06499077?cond=Breast%20Cancer&viewType=Card&page=28&rank=277
Breast Cancer,NCT04602910,Developing a Web-based Shared Decision,"Information provided by Chin-Tsung Shen, Mackay Medical College (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04602910?cond=Breast%20Cancer&viewType=Card&page=28&rank=278
Breast Cancer,NCT02318615,Immediate Axillary Plasty With a Pedicled Muscle Flap for Breast Cancer Related Lymphedema Prevention,Information provided by Peking University People's Hospital (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT02318615?cond=Breast%20Cancer&viewType=Card&page=28&rank=279
Breast Cancer,NCT06293508,mHealth Behavioural Intervention to Increase Breast Cancer Screening Rates Among Members of the Public,"Information provided by Nicholas Hing Yee Liang, Clinical Research Centre, Malaysia (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT06293508?cond=Breast%20Cancer&viewType=Card&page=28&rank=280
Breast Cancer,NCT04436809,Sentinel Node Biopsy Alone or With Axillary Dissection After Primary Chemotherapy,"Information provided by Gabriele Martelli, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04436809?cond=Breast%20Cancer&viewType=Card&page=29&rank=281
Breast Cancer,NCT04479098,Effects of Training and Detraining on Postmenopausal Breast Cancer Survivors,"Information provided by Igor Moraes Mariano, Federal University of Uberlandia (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04479098?cond=Breast%20Cancer&viewType=Card&page=29&rank=282
Breast Cancer,NCT06234137,"A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2","Information provided by Wang Ouchen, First Affiliated Hospital of Wenzhou Medical University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06234137?cond=Breast%20Cancer&viewType=Card&page=29&rank=283
Breast Cancer,NCT06258863,Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision,"Information provided by Xinhong Wu, PhD, Hubei Cancer Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06258863?cond=Breast%20Cancer&viewType=Card&page=29&rank=284
Breast Cancer,NCT06102018,Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine,Information provided by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06102018?cond=Breast%20Cancer&viewType=Card&page=29&rank=285
Breast Cancer,NCT00530868,Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post,"Information provided by Lisle Nabell, University of Alabama at Birmingham (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00530868?cond=Breast%20Cancer&viewType=Card&page=29&rank=286&tab=results
Breast Cancer,NCT06843681,Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2,Information provided by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06843681?cond=Breast%20Cancer&viewType=Card&page=29&rank=287
Breast Cancer,NCT05969184,Palbociclib Combine With Anti,"Information provided by Li Huiping, Peking University Cancer Hospital & Institute (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05969184?cond=Breast%20Cancer&viewType=Card&page=29&rank=288
Breast Cancer,NCT00626106,QUILT,"Information provided by NantCell, Inc. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00626106?cond=Breast%20Cancer&viewType=Card&page=29&rank=289&tab=results
Breast Cancer,NCT01272141,"A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer","Information provided by William Read, Emory University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01272141?cond=Breast%20Cancer&viewType=Card&page=29&rank=290&tab=results
Breast Cancer,NCT05574816,Evaluation of the Diagnostic Performance of a Bra Prototype to Detect Breast Cancer,Information provided by Hospices Civils de Lyon (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05574816?cond=Breast%20Cancer&viewType=Card&page=30&rank=291
Breast Cancer,NCT03826979,PILATES METHOD ON THE UPPER LIMBS FUNCTIONALITY,"Information provided by Raphael do Nascimento Pereira, Universidade Metodista de Piracicaba (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03826979?cond=Breast%20Cancer&viewType=Card&page=30&rank=292
Breast Cancer,NCT03524430,RNA Disruption Assay (RDA),Information provided by Rna Diagnostics Inc. (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03524430?cond=Breast%20Cancer&viewType=Card&page=30&rank=293
Breast Cancer,NCT02061085,Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment,Information provided by MedSIR (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02061085?cond=Breast%20Cancer&viewType=Card&page=30&rank=294&tab=results
Breast Cancer,NCT05577442,"Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer","Information provided by Li Huiping, Peking University Cancer Hospital & Institute (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05577442?cond=Breast%20Cancer&viewType=Card&page=30&rank=295
Breast Cancer,NCT05299021,Serratus Anterior Plane Block for Modified Radical Mastectomy: Double-point VS Single,"Information provided by Jun Zhang, Fudan University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05299021?cond=Breast%20Cancer&viewType=Card&page=30&rank=296
Breast Cancer,NCT03447132,Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant,"Information provided by International Cancer Research Group, United Arab Emirates (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03447132?cond=Breast%20Cancer&viewType=Card&page=30&rank=297
Breast Cancer,NCT05480189,"Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real","Information provided by Wang Xiaojia, Zhejiang Cancer Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05480189?cond=Breast%20Cancer&viewType=Card&page=30&rank=298
Breast Cancer,NCT05244993,AK105 Plus Anlotinib Hydrochloride Combined With Albumin Paclitaxel as a First-line Therapy in Patients With Advanced Triple,"Information provided by Tao Sun, Liaoning Cancer Hospital & Institute (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05244993?cond=Breast%20Cancer&viewType=Card&page=30&rank=299
Breast Cancer,NCT05151224,Circulating microRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast Carcinoma,"Information provided by Ebtehal Mohamed Mahmoud Salah, Ain Shams University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05151224?cond=Breast%20Cancer&viewType=Card&page=30&rank=300
Pancreatic Cancer,NCT02074046,Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer,"Information provided by Fuda Cancer Hospital, Guangzhou (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02074046?cond=Pancreatic%20Cancer&viewType=Card&page=1&rank=1
Pancreatic Cancer,NCT06478225,Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer,Information provided by RenJi Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06478225?cond=Pancreatic%20Cancer&viewType=Card&page=1&rank=2
Pancreatic Cancer,NCT07183280,Multicentric Database for Solid Pseudopapillary Neoplasm of the Pancreas,"Information provided by Guopei Luo, Fudan University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT07183280?cond=Pancreatic%20Cancer&viewType=Card&page=1&rank=3
Pancreatic Cancer,NCT04896073,Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP),"Information provided by Anish Thomas, National Cancer Institute (NCI) (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04896073?cond=Pancreatic%20Cancer&viewType=Card&page=1&rank=4&tab=results
Pancreatic Cancer,NCT01455311,Evaluation of Image,Information provided by H. Lee Moffitt Cancer Center and Research Institute (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT01455311?cond=Pancreatic%20Cancer&viewType=Card&page=1&rank=5
Pancreatic Cancer,NCT04728750,Laparoscopic Enucleation of Frantz's Tumor of the Pancreas,"Information provided by Alejandro Ruiz Velasco Santacruz, Tecnologico de Monterrey (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04728750?cond=Pancreatic%20Cancer&viewType=Card&page=1&rank=6
Pancreatic Cancer,NCT02318095,Gemcitabine/Nab,Information provided by Duke University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02318095?cond=Pancreatic%20Cancer&viewType=Card&page=1&rank=7&tab=results
Pancreatic Cancer,NCT05528614,Evaluation of the Results of Simultaneous Pancreatic and Hepatic Resections for Metastatic Neuroendocrine Tumors.,"Information provided by University Hospital, Strasbourg, France (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05528614?cond=Pancreatic%20Cancer&viewType=Card&page=1&rank=8
Pancreatic Cancer,NCT01526590,Contrast Enhanced Endoscopic Ultrasound for Vascular Involvement in Pancreatic Lesions,"Information provided by James Hebert, University of Vermont (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT01526590?cond=Pancreatic%20Cancer&viewType=Card&page=1&rank=9
Pancreatic Cancer,NCT01501903,Standard Versus Fanning Techniques for Endoscopic Ultrasound-Fine Needle Aspiration (EUS,"Information provided by Shyam Varadarajulu, University of Alabama at Birmingham (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01501903?cond=Pancreatic%20Cancer&viewType=Card&page=1&rank=10
Pancreatic Cancer,NCT03558945,Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor,"Information provided by Anda Biopharmaceutical Development (Shenzhen) Co., Ltd. (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03558945?cond=Pancreatic%20Cancer&viewType=Card&page=2&rank=11
Pancreatic Cancer,NCT01692873,Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors,Information provided by Institut Paoli-Calmettes (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01692873?cond=Pancreatic%20Cancer&viewType=Card&page=2&rank=12
Pancreatic Cancer,NCT03788382,Failure to Adjuvant Therapy After Pancreatic Resection for Pancreatic Cancer,"Information provided by Salvatore Paiella, MD, Universita di Verona (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03788382?cond=Pancreatic%20Cancer&viewType=Card&page=2&rank=13
Pancreatic Cancer,NCT01838317,A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas,"Information provided by Muhammad Beg, University of Texas Southwestern Medical Center (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01838317?cond=Pancreatic%20Cancer&viewType=Card&page=2&rank=14&tab=results
Pancreatic Cancer,NCT01673334,Evaluation of EUS-Guided 22 Gauge Core Biopsy Versus Fine,Information provided by University of Virginia (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01673334?cond=Pancreatic%20Cancer&viewType=Card&page=2&rank=15
Pancreatic Cancer,NCT06770439,IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer,"Information provided by TingBo Liang, Zhejiang University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06770439?cond=Pancreatic%20Cancer&viewType=Card&page=2&rank=16
Pancreatic Cancer,NCT06760364,A Clinical Study of CHT102 in MSLN,Information provided by Tianjin Medical University Cancer Institute and Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06760364?cond=Pancreatic%20Cancer&viewType=Card&page=2&rank=17
Pancreatic Cancer,NCT06519097,Study of IPMN Progression Prevention With Tocotrienol (SIPP,Information provided by H. Lee Moffitt Cancer Center and Research Institute (Responsible Party),Active,https://clinicaltrials.gov/study/NCT06519097?cond=Pancreatic%20Cancer&viewType=Card&page=2&rank=18
Pancreatic Cancer,NCT06641947,Differentiation Benign and Malignant Pancreatic Lesions,"Information provided by Liao Hongfan, First Affiliated Hospital of Chongqing Medical University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT06641947?cond=Pancreatic%20Cancer&viewType=Card&page=2&rank=19
Pancreatic Cancer,NCT04637256,Evaluation of Outcomes from Treatment of Benign or Malignant Gastroesophageal Diseases,Information provided by Methodist Health System (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04637256?cond=Pancreatic%20Cancer&viewType=Card&page=2&rank=20
Pancreatic Cancer,NCT03610100,Acelarin First Line Randomised Pancreatic Study,Information provided by The Clatterbridge Cancer Centre NHS Foundation Trust (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT03610100?cond=Pancreatic%20Cancer&viewType=Card&page=3&rank=21
Pancreatic Cancer,NCT05871164,"Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency",Information provided by GCS Ramsay Santé pour l'Enseignement et la Recherche (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05871164?cond=Pancreatic%20Cancer&viewType=Card&page=3&rank=22
Pancreatic Cancer,NCT04037241,Study of Anti-CEA CAR,Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases,Withdrawn,https://clinicaltrials.gov/study/NCT04037241?cond=Pancreatic%20Cancer&viewType=Card&page=3&rank=23
Pancreatic Cancer,NCT04357483,Effect of Thrombin-containing Collagen,"Information provided by Song Cheol Kim, Asan Medical Center (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04357483?cond=Pancreatic%20Cancer&viewType=Card&page=3&rank=24
Pancreatic Cancer,NCT05794048,METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors,Information provided by Assistance Publique - Hôpitaux de Paris (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05794048?cond=Pancreatic%20Cancer&viewType=Card&page=3&rank=25
Pancreatic Cancer,NCT05604716,Cross-sectional Follow,"Information provided by Qiaofei Liu, Peking Union Medical College Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05604716?cond=Pancreatic%20Cancer&viewType=Card&page=3&rank=26
Pancreatic Cancer,NCT06573398,Radiotherapy With Sequential Chemotherapy Combined With PD,"Information provided by JIABIN JIN, Ruijin Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06573398?cond=Pancreatic%20Cancer&viewType=Card&page=3&rank=27
Pancreatic Cancer,NCT02716207,Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife,"Information provided by Zhang Huo Jun, Changhai Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02716207?cond=Pancreatic%20Cancer&viewType=Card&page=3&rank=28
Pancreatic Cancer,NCT02534246,Head to Head Comparison of Two Needles EUS Guided FNB,"Information provided by John M. Levenick, Milton S. Hershey Medical Center (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT02534246?cond=Pancreatic%20Cancer&viewType=Card&page=3&rank=29
Pancreatic Cancer,NCT02269683,Robotic vs. Laparoscopic Distal Pancreatectomy for Pancreatic Cancer,Information provided by Technische Universität Dresden (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT02269683?cond=Pancreatic%20Cancer&viewType=Card&page=3&rank=30
Pancreatic Cancer,NCT06211933,Evaluation of the High Intensity Focused Ultrasound (HIFU) Technique for Patients With Unresectable Pancreatic Tumor Treatment (PULS),Information provided by Centre Leon Berard (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06211933?cond=Pancreatic%20Cancer&viewType=Card&page=4&rank=31
Pancreatic Cancer,NCT05723978,Selective Extended Dissection in Different Types of Pancreatic Head Cancer: A Retrospective Cohort Study.,Information provided by Tianjin Medical University Cancer Institute and Hospital (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05723978?cond=Pancreatic%20Cancer&viewType=Card&page=4&rank=32
Pancreatic Cancer,NCT01978808,Efficiency Study of the EUS,Information provided by National Taiwan University Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT01978808?cond=Pancreatic%20Cancer&viewType=Card&page=4&rank=33
Pancreatic Cancer,NCT05621824,A Cohort Study on Screening and Follow-up of High,"Information provided by Wu Xi, Peking Union Medical College Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05621824?cond=Pancreatic%20Cancer&viewType=Card&page=4&rank=34
Pancreatic Cancer,NCT05489458,Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy,"Information provided by BUSQUETS, JULI, Hospital Universitari de Bellvitge (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05489458?cond=Pancreatic%20Cancer&viewType=Card&page=4&rank=35
Pancreatic Cancer,NCT01434550,Phase II Study of First-line SBRT in Patients With Non,Information provided by H. Lee Moffitt Cancer Center and Research Institute (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT01434550?cond=Pancreatic%20Cancer&viewType=Card&page=4&rank=36
Pancreatic Cancer,NCT05523154,"""Answers in Hours"" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures",Information provided by Mayo Clinic (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05523154?cond=Pancreatic%20Cancer&viewType=Card&page=4&rank=37&tab=results
Pancreatic Cancer,NCT04146441,Ultrasound,Information provided by St. Olavs Hospital (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04146441?cond=Pancreatic%20Cancer&viewType=Card&page=4&rank=38
Pancreatic Cancer,NCT00428597,A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors,Information provided by Pfizer,Completed,https://clinicaltrials.gov/study/NCT00428597?cond=Pancreatic%20Cancer&viewType=Card&page=4&rank=39&tab=results
Pancreatic Cancer,NCT03432624,Detection of MicroRNA,"Information provided by Xian-Jun Yu, Fudan University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT03432624?cond=Pancreatic%20Cancer&viewType=Card&page=4&rank=40
Pancreatic Cancer,NCT03403101,The Combination Chemotherapy of SIRIOX as First- or Second,"Information provided by Xian-Jun Yu, Fudan University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03403101?cond=Pancreatic%20Cancer&viewType=Card&page=5&rank=41
Pancreatic Cancer,NCT03500068,"Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT","Information provided by J.W. Wilmink, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03500068?cond=Pancreatic%20Cancer&viewType=Card&page=5&rank=42
Pancreatic Cancer,NCT03513705,Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP,"Information provided by M.G. Besselink, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03513705?cond=Pancreatic%20Cancer&viewType=Card&page=5&rank=43
Pancreatic Cancer,NCT02653313,Parvovirus H,Information provided by Oryx GmbH & Co. KG (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02653313?cond=Pancreatic%20Cancer&viewType=Card&page=5&rank=44
Pancreatic Cancer,NCT02750657,Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection,"Information provided by University Health Network, Toronto (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02750657?cond=Pancreatic%20Cancer&viewType=Card&page=5&rank=45
Pancreatic Cancer,NCT01394120,Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer,"Information provided by Sofia Perea, Director Clinical Trials Unit., Grupo Hospital de Madrid (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT01394120?cond=Pancreatic%20Cancer&viewType=Card&page=5&rank=46
Pancreatic Cancer,NCT03623984,Molecular,"Information provided by Sushanth Reddy, University of Alabama at Birmingham (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT03623984?cond=Pancreatic%20Cancer&viewType=Card&page=5&rank=47
Pancreatic Cancer,NCT02928081,Standard Versus Extended Lymphadenectomy in Pancreatoduodenectomy for Patients With Pancreatic Head Adenocarcinoma,"Information provided by Chen Hongyu, West China Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02928081?cond=Pancreatic%20Cancer&viewType=Card&page=5&rank=48
Pancreatic Cancer,NCT02817308,Correlation of Serum CA19,Information provided by Rambam Health Care Campus (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT02817308?cond=Pancreatic%20Cancer&viewType=Card&page=5&rank=49
Pancreatic Cancer,NCT02529579,Safety and Efficacy Evaluation of iAPA,"Information provided by Zhaoshen Li, Changhai Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02529579?cond=Pancreatic%20Cancer&viewType=Card&page=5&rank=50
Pancreatic Cancer,NCT06164769,Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery,"Information provided by Sheng Yan, Zhejiang University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06164769?cond=Pancreatic%20Cancer&viewType=Card&page=6&rank=51
Pancreatic Cancer,NCT07030348,Early Diagnosis of Pancreatic Cancer Duodenal Fluid,"Information provided by Do Hyun Park, Asan Medical Center (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT07030348?cond=Pancreatic%20Cancer&viewType=Card&page=6&rank=52
Pancreatic Cancer,NCT02150408,Evaluation of PET,Information provided by Assistance Publique Hopitaux De Marseille (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02150408?cond=Pancreatic%20Cancer&viewType=Card&page=6&rank=53
Pancreatic Cancer,NCT01808638,Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I,Information provided by Silence Therapeutics GmbH (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01808638?cond=Pancreatic%20Cancer&viewType=Card&page=6&rank=54
Pancreatic Cancer,NCT02150746,Circulating Tumor Cells in Operative Blood,Information provided by University of Florida (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02150746?cond=Pancreatic%20Cancer&viewType=Card&page=6&rank=55
Pancreatic Cancer,NCT02682394,Evaluation of Pancreatic Steatosis in Patients With Cancer of Pancreas,Information provided by Soroka University Medical Center (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT02682394?cond=Pancreatic%20Cancer&viewType=Card&page=6&rank=56
Pancreatic Cancer,NCT00226746,"Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer","Information provided by Hani Ashamalla, MD, New York Presbyterian Brooklyn Methodist Hospital (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT00226746?cond=Pancreatic%20Cancer&viewType=Card&page=6&rank=57
Pancreatic Cancer,NCT06545344,Palliative Care Consultation to Improve Communication for Patients Considering Surgery for a Pancreatic Neoplasm,Information provided by Fred Hutchinson Cancer Center (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT06545344?cond=Pancreatic%20Cancer&viewType=Card&page=6&rank=58
Pancreatic Cancer,NCT06013228,Trajectories of Fatigue and Quality of Life in People With Both Operable Pancreatic Tumor and Diabetes Mellitus,Information provided by National Taiwan University Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06013228?cond=Pancreatic%20Cancer&viewType=Card&page=6&rank=59
Pancreatic Cancer,NCT00471146,Study Of Gemcitabine Plus AG,Information provided by Pfizer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00471146?cond=Pancreatic%20Cancer&viewType=Card&page=6&rank=60&tab=results
Pancreatic Cancer,NCT02993731,A Study of Napabucasin Plus Nab,"Information provided by Sumitomo Pharma America, Inc. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02993731?cond=Pancreatic%20Cancer&viewType=Card&page=7&rank=61&tab=results
Pancreatic Cancer,NCT05961982,Evaluation of Endoscopic Ultrasound,"Information provided by Somashekar Krishna, Ohio State University Comprehensive Cancer Center (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05961982?cond=Pancreatic%20Cancer&viewType=Card&page=7&rank=62
Pancreatic Cancer,NCT02635971,Intra,"Information provided by Zhiqiang Meng, Fudan University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02635971?cond=Pancreatic%20Cancer&viewType=Card&page=7&rank=63
Pancreatic Cancer,NCT02634502,Radiofrequency Ablation Combined With S,"Information provided by Hao Chen, Fudan University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02634502?cond=Pancreatic%20Cancer&viewType=Card&page=7&rank=64
Pancreatic Cancer,NCT07235930,Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer,"Information provided by Ying Jieer, Zhejiang Cancer Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT07235930?cond=Pancreatic%20Cancer&viewType=Card&page=7&rank=65
Pancreatic Cancer,NCT00714701,Screening for Early Pancreatic Neoplasia (Cancer of the Pancreas Screening or CAPS4 Study),Information provided by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00714701?cond=Pancreatic%20Cancer&viewType=Card&page=7&rank=66
Pancreatic Cancer,NCT06162468,Feasibility Trial of EUS,"Information provided by Michael Jameson, University of Auckland, New Zealand (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06162468?cond=Pancreatic%20Cancer&viewType=Card&page=7&rank=67
Pancreatic Cancer,NCT05914077,Aspiration of Duodenopancreatic Juice After Secretin Stimulation vs Endoscopic Aspiration for Molecular Analysis of Intraductal Papillary Mucinous Intraductal Neoplasia.,Information provided by Fundacion Clinic per a la Recerca Biomédica (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05914077?cond=Pancreatic%20Cancer&viewType=Card&page=7&rank=68
Pancreatic Cancer,NCT05234450,Multi,"Information provided by University Hospital, Strasbourg, France (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05234450?cond=Pancreatic%20Cancer&viewType=Card&page=7&rank=69
Pancreatic Cancer,NCT06393166,Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced Pancreatic Cancer,"Information provided by Ying Jieer, Zhejiang Cancer Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06393166?cond=Pancreatic%20Cancer&viewType=Card&page=7&rank=70
Pancreatic Cancer,NCT03444051,Comparison of Two Endoscopic Biopsic Needles for Pancreatic Tumors,"Information provided by KARSENTI, Société Française d'Endoscopie Digestive (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03444051?cond=Pancreatic%20Cancer&viewType=Card&page=8&rank=71
Pancreatic Cancer,NCT00711191,A Study On An Immunostimulant Antibody In Combination With Chemotherapy For Advanced Cancer Of The Pancreas,Information provided by Hoffmann-La Roche (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00711191?cond=Pancreatic%20Cancer&viewType=Card&page=8&rank=72&tab=results
Pancreatic Cancer,NCT07257523,Carbon Ion Radiotherapy in Frail Patients With Pancreatic Cancer,Information provided by Yonsei University (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT07257523?cond=Pancreatic%20Cancer&viewType=Card&page=8&rank=73
Pancreatic Cancer,NCT01712971,Reduced Intra-operative Blood Loss in Pancreaticoduodenectomy for Pancreatic or Peri,"Information provided by Baki Topal, University Hospital, Gasthuisberg (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT01712971?cond=Pancreatic%20Cancer&viewType=Card&page=8&rank=74
Pancreatic Cancer,NCT06046794,Efficacy of First,Information provided by Institut Paoli-Calmettes (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06046794?cond=Pancreatic%20Cancer&viewType=Card&page=8&rank=75
Pancreatic Cancer,NCT06148298,Cell,Information provided by University of Central Florida (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06148298?cond=Pancreatic%20Cancer&viewType=Card&page=8&rank=76
Pancreatic Cancer,NCT03807999,Nab,"Information provided by Suayib Yalcin, Hacettepe University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03807999?cond=Pancreatic%20Cancer&viewType=Card&page=8&rank=77
Pancreatic Cancer,NCT05566743,A Study Evaluating Maintenance Therapy After First Line Chemotherapy in Metastatic Cancer Pancreas,"Information provided by Nahla Atef Shabaan, Menoufia University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05566743?cond=Pancreatic%20Cancer&viewType=Card&page=8&rank=78
Pancreatic Cancer,NCT02311439,"Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas","Information provided by Ahmed Allam Abdelhamed Mohamed, Assiut University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02311439?cond=Pancreatic%20Cancer&viewType=Card&page=8&rank=79
Pancreatic Cancer,NCT05163977,Pancreatico Enteric Anastomosis Post Pancreaticoduodenectomy,"Information provided by Ehab Abdulkarim Abdulmaksoud, Cairo University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05163977?cond=Pancreatic%20Cancer&viewType=Card&page=8&rank=80
Pancreatic Cancer,NCT06858631,IMPact of AerobiC Exercise in Addition to Nutritional Treatment on Quality of Life After Pancreatectomy,"Information provided by Mezza Teresa, Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT06858631?cond=Pancreatic%20Cancer&viewType=Card&page=9&rank=81
Pancreatic Cancer,NCT05745415,Cancer Stem Cell Specific Aptamer's Ability to Detect Blood Circulating Cancer Stem Cells and Its Role as a Predictor of Prognosis in Pancreatic Cancer,Information provided by Yonsei University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05745415?cond=Pancreatic%20Cancer&viewType=Card&page=9&rank=82
Pancreatic Cancer,NCT04677244,Echo,Information provided by Institut Paoli-Calmettes (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04677244?cond=Pancreatic%20Cancer&viewType=Card&page=9&rank=83
Pancreatic Cancer,NCT02791503,CROSSFIRE Trial: Comparing the Efficacy of Irreversible Electroporation With Radiotherapy,"Information provided by Dr. M.R. Meijerink, Amsterdam UMC, location VUmc (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02791503?cond=Pancreatic%20Cancer&viewType=Card&page=9&rank=84
Pancreatic Cancer,NCT05259384,Robotic Versus Laparoscopic Surgery for Patients With Pancreatic Cystic Neoplasms,Information provided by Peking Union Medical College Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05259384?cond=Pancreatic%20Cancer&viewType=Card&page=9&rank=85
Pancreatic Cancer,NCT05222204,DDP ip Combined With AG in PDAC With Peritoneal Metastasis,"Information provided by Xian-Jun Yu, Fudan University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05222204?cond=Pancreatic%20Cancer&viewType=Card&page=9&rank=86
Pancreatic Cancer,NCT03111368,EUS-FNA of Solid Pancreatic Mass: Comparison Between Negative Pressure and Slow,Information provided by University of Sao Paulo General Hospital (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03111368?cond=Pancreatic%20Cancer&viewType=Card&page=9&rank=87
Pancreatic Cancer,NCT04128332,Pre,"Information provided by CCTU- Cancer Theme, Cambridge University Hospitals NHS Foundation Trust (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT04128332?cond=Pancreatic%20Cancer&viewType=Card&page=9&rank=88
Pancreatic Cancer,NCT03961646,Evaluation of the FOCUS Diffusion's Added Clinical Value Compared to Conventional MRI,Information provided by Fondation Hôpital Saint-Joseph (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03961646?cond=Pancreatic%20Cancer&viewType=Card&page=9&rank=89
Pancreatic Cancer,NCT04843956,Comparison of EUS,"Information provided by Dr. med. Hector Eloy Tamez Perez, Hospital Universitario Dr. Jose E. Gonzalez (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04843956?cond=Pancreatic%20Cancer&viewType=Card&page=9&rank=90
Pancreatic Cancer,NCT03659292,Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal Pancreatectomy,"Information provided by Changhong Miao, Fudan University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT03659292?cond=Pancreatic%20Cancer&viewType=Card&page=10&rank=91
Pancreatic Cancer,NCT03649321,Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer,"Information provided by Syed Kazmi, University of Texas Southwestern Medical Center (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03649321?cond=Pancreatic%20Cancer&viewType=Card&page=10&rank=92&tab=results
Pancreatic Cancer,NCT04693754,"Endoscopic Ultrasound Radiofrequency Ablation, Database Repository","Information provided by John DeWitt, Indiana University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT04693754?cond=Pancreatic%20Cancer&viewType=Card&page=10&rank=93
Pancreatic Cancer,NCT04662346,Evaluation of Difficulty Score for Robotic Pancreatoduodenectomy,"Information provided by Concetta Cacace, University of Pisa (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT04662346?cond=Pancreatic%20Cancer&viewType=Card&page=10&rank=94
Pancreatic Cancer,NCT03278015,Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post,"Information provided by Dabin Xu, Chinese PLA General Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT03278015?cond=Pancreatic%20Cancer&viewType=Card&page=10&rank=95
Pancreatic Cancer,NCT03245346,Effects of Epidural Anesthesia and Analgesia on the Prognosis in Patients Undergoing Pancreatic Cancer Surgery,"Information provided by Changhong Miao, Fudan University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03245346?cond=Pancreatic%20Cancer&viewType=Card&page=10&rank=96
Pancreatic Cancer,NCT02296736,The Pre-operative Pathway in Pancreatic Head Malignancy,Information provided by University Hospital Plymouth NHS Trust (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02296736?cond=Pancreatic%20Cancer&viewType=Card&page=10&rank=97
Pancreatic Cancer,NCT02902484,Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer,"Information provided by Salwan Al Mutar MD MS, University of Texas Southwestern Medical Center (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02902484?cond=Pancreatic%20Cancer&viewType=Card&page=10&rank=98&tab=results
Pancreatic Cancer,NCT03541486,A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients,"Information provided by Joseph Caster, Ph.D., M.D., University of Iowa (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT03541486?cond=Pancreatic%20Cancer&viewType=Card&page=10&rank=99
Pancreatic Cancer,NCT02681601,Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer,Information provided by Jonsson Comprehensive Cancer Center (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT02681601?cond=Pancreatic%20Cancer&viewType=Card&page=10&rank=100
Pancreatic Cancer,NCT07259317,Relacorilant With Nab,Information provided by Corcept Therapeutics (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07259317?cond=Pancreatic%20Cancer&viewType=Card&page=11&rank=101
Pancreatic Cancer,NCT02442323,A Pilot Study of a Home,"Information provided by Carolyn Fang, PhD, Fox Chase Cancer Center (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02442323?cond=Pancreatic%20Cancer&viewType=Card&page=11&rank=102
Pancreatic Cancer,NCT03310632,Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer,Information provided by Golden Biotechnology Corporation (Responsible Party),Active,https://clinicaltrials.gov/study/NCT03310632?cond=Pancreatic%20Cancer&viewType=Card&page=11&rank=103
Pancreatic Cancer,NCT07178587,Evaluating the roLe of Multiplexed PET Imaging in the Detection and Staging of hepatocellulaR Carcinoma and gAstro-entero,Information provided by Nantes University Hospital (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07178587?cond=Pancreatic%20Cancer&viewType=Card&page=11&rank=104
Pancreatic Cancer,NCT02910960,Comparison of Two Fine Needle Biopsy Needles for Solid Pancreatic Masses,Information provided by AdventHealth (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02910960?cond=Pancreatic%20Cancer&viewType=Card&page=11&rank=105
Pancreatic Cancer,NCT02911974,Comparing Biopsy Needles for Endoscopic Ultrasound Guided Samples for Pancreatic Masses,Information provided by AdventHealth (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02911974?cond=Pancreatic%20Cancer&viewType=Card&page=11&rank=106
Pancreatic Cancer,NCT02181140,Core Biopsy Endo Sonography Study Evaluation of the Significance of the Pro,"Information provided by Prof. Dr. Thomas Rösch, Universitätsklinikum Hamburg-Eppendorf (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02181140?cond=Pancreatic%20Cancer&viewType=Card&page=11&rank=107&tab=results
Pancreatic Cancer,NCT02830620,Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy,Information provided by Centre Hospitalier Universitaire de Nice (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02830620?cond=Pancreatic%20Cancer&viewType=Card&page=11&rank=108
Pancreatic Cancer,NCT03435588,Endoscopic Ultrasound (EUS)-Guided Fine Needle Aspiration (FNA) With Rapid On-site Evaluation (ROSE) of Cytopathology vs. EUS,"Information provided by Yen-I Chen, McGill University Health Centre/Research Institute of the McGill University Health Centre (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03435588?cond=Pancreatic%20Cancer&viewType=Card&page=11&rank=109
Pancreatic Cancer,NCT01394159,22G FNA Needle vs. 22G ProCore Needle,Information provided by AdventHealth (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01394159?cond=Pancreatic%20Cancer&viewType=Card&page=11&rank=110&tab=results
Pancreatic Cancer,NCT01278381,Prognostic Score To Predict Major Complications After Pancreaticoduodenectomy,Information provided by Università Vita-Salute San Raffaele,Completed,https://clinicaltrials.gov/study/NCT01278381?cond=Pancreatic%20Cancer&viewType=Card&page=12&rank=111
Pancreatic Cancer,NCT05475366,Personalized First,Information provided by Institut Curie (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05475366?cond=Pancreatic%20Cancer&viewType=Card&page=12&rank=112
Pancreatic Cancer,NCT00574275,Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer,Information provided by Sanofi (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00574275?cond=Pancreatic%20Cancer&viewType=Card&page=12&rank=113&tab=results
Pancreatic Cancer,NCT00657995,Tight Glycemic Control by Artificial Pancreas,Information provided by Kochi University,Completed,https://clinicaltrials.gov/study/NCT00657995?cond=Pancreatic%20Cancer&viewType=Card&page=12&rank=114
Pancreatic Cancer,NCT00267020,Phase 2 Study of Gemcitabine or Gemcitabine + Enzastaurin in Participants With Advanced or Metastatic Pancreatic Cancer,Information provided by Eli Lilly and Company (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00267020?cond=Pancreatic%20Cancer&viewType=Card&page=12&rank=115&tab=results
Pancreatic Cancer,NCT07153289,CD318-targeted CAR,Information provided by University Hospital Tuebingen (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07153289?cond=Pancreatic%20Cancer&viewType=Card&page=12&rank=116
Pancreatic Cancer,NCT01703650,Role of Perfusion CT in Pancreatic Cancer,"Information provided by Jeong Min Lee, Seoul National University Hospital (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT01703650?cond=Pancreatic%20Cancer&viewType=Card&page=12&rank=117
Pancreatic Cancer,NCT03536793,Tumour Regulatory Molecules in Early Pancreatic Cancer Detection,Information provided by Hull University Teaching Hospitals NHS Trust (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03536793?cond=Pancreatic%20Cancer&viewType=Card&page=12&rank=118
Pancreatic Cancer,NCT06914674,Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas,"Information provided by Guopei Luo, Fudan University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06914674?cond=Pancreatic%20Cancer&viewType=Card&page=12&rank=119
Pancreatic Cancer,NCT04977596,Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic Cancer,"Information provided by Second Affiliated Hospital, School of Medicine, Zhejiang University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04977596?cond=Pancreatic%20Cancer&viewType=Card&page=12&rank=120
Pancreatic Cancer,NCT02651987,Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg,Information provided by Ipsen (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02651987?cond=Pancreatic%20Cancer&viewType=Card&page=13&rank=121&tab=results
Pancreatic Cancer,NCT07114939,FTT PET/CT in Pancreatic Neuroendocrine Tumors,Information provided by Abramson Cancer Center at Penn Medicine (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT07114939?cond=Pancreatic%20Cancer&viewType=Card&page=13&rank=122
Pancreatic Cancer,NCT06160323,Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer,"Information provided by CHAN SHANNON MELISSA, Chinese University of Hong Kong (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06160323?cond=Pancreatic%20Cancer&viewType=Card&page=13&rank=123
Pancreatic Cancer,NCT04783844,Usefulness of 3D Digital Reconstruction in the Imaging Diagnosis of Pancreatic Tumors,"Information provided by David Ferreras, Hospital Universitario Virgen de la Arrixaca (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04783844?cond=Pancreatic%20Cancer&viewType=Card&page=13&rank=124
Pancreatic Cancer,NCT05841420,Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients with Non,"Information provided by Morten Ladekarl, Aalborg University Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05841420?cond=Pancreatic%20Cancer&viewType=Card&page=13&rank=125
Pancreatic Cancer,NCT04049461,Heterotopic Ossification in Abdominal Incision and Pancreatic Cancer,"Information provided by Yi Miao, Prof., Nanjing Medical University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT04049461?cond=Pancreatic%20Cancer&viewType=Card&page=13&rank=126
Pancreatic Cancer,NCT05193604,A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma,"Information provided by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.) (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT05193604?cond=Pancreatic%20Cancer&viewType=Card&page=13&rank=127
Pancreatic Cancer,NCT02676349,Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS,Information provided by Institut de Cancérologie de Lorraine (Responsible Party),Active,https://clinicaltrials.gov/study/NCT02676349?cond=Pancreatic%20Cancer&viewType=Card&page=13&rank=128
Pancreatic Cancer,NCT06833658,Effects of Aromatherapy with Essential Oils on Anxiety and Depression in Perioperative Patients with Pancreatic Cancer,Information provided by Peking University First Hospital (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06833658?cond=Pancreatic%20Cancer&viewType=Card&page=13&rank=129
Pancreatic Cancer,NCT02333409,Acupuncture for Pain Control in Patients With Inoperable Pancreatic Cancer,"Information provided by Charing Chong, MD, Chinese University of Hong Kong (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT02333409?cond=Pancreatic%20Cancer&viewType=Card&page=13&rank=130
Pancreatic Cancer,NCT02310971,Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas,Information provided by Prima BioMed Ltd (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT02310971?cond=Pancreatic%20Cancer&viewType=Card&page=14&rank=131
Pancreatic Cancer,NCT06505395,"A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP","Information provided by CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06505395?cond=Pancreatic%20Cancer&viewType=Card&page=14&rank=132
Pancreatic Cancer,NCT04687410,Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS,"Information provided by Peter Vilmann MD, DSc, HC, FASGE, Herlev Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04687410?cond=Pancreatic%20Cancer&viewType=Card&page=14&rank=133
Pancreatic Cancer,NCT02869581,Institut Paoli,Information provided by Institut Paoli-Calmettes (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT02869581?cond=Pancreatic%20Cancer&viewType=Card&page=14&rank=134
Pancreatic Cancer,NCT05216120,Pemigatinib in Subjects With Adenosquamous Carcinoma of the Pancreas,Information provided by HonorHealth Research Institute (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT05216120?cond=Pancreatic%20Cancer&viewType=Card&page=14&rank=135
Pancreatic Cancer,NCT01771146,Neoadjuvant FOLFIRINOX Regimen in Patients With Non,Information provided by Baylor Research Institute (Responsible Party),Active,https://clinicaltrials.gov/study/NCT01771146?cond=Pancreatic%20Cancer&viewType=Card&page=14&rank=136
Pancreatic Cancer,NCT06538857,CEB,Information provided by CEBIOTEX (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06538857?cond=Pancreatic%20Cancer&viewType=Card&page=14&rank=137
Pancreatic Cancer,NCT03323944,CAR T Cell Immunotherapy for Pancreatic Cancer,Information provided by University of Pennsylvania (Responsible Party),Active,https://clinicaltrials.gov/study/NCT03323944?cond=Pancreatic%20Cancer&viewType=Card&page=14&rank=138
Pancreatic Cancer,NCT06744595,Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic Cancer,Information provided by Mayo Clinic (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06744595?cond=Pancreatic%20Cancer&viewType=Card&page=14&rank=139
Pancreatic Cancer,NCT06271291,Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts,Information provided by Mayo Clinic (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06271291?cond=Pancreatic%20Cancer&viewType=Card&page=14&rank=140
Pancreatic Cancer,NCT03218345,EUS,"Information provided by Anthony Teoh, Chinese University of Hong Kong (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03218345?cond=Pancreatic%20Cancer&viewType=Card&page=15&rank=141
Pancreatic Cancer,NCT06767813,Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First,"Information provided by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.) (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06767813?cond=Pancreatic%20Cancer&viewType=Card&page=15&rank=142
Pancreatic Cancer,NCT05155475,Endoscopic Ultrasound Evaluation of the Common Bile Duct in Patients With Obstructive Jaundice Due to Bilio,Information provided by Ramsay Générale de Santé (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05155475?cond=Pancreatic%20Cancer&viewType=Card&page=15&rank=143
Pancreatic Cancer,NCT05141656,Construction and Evaluation of China's Advanced Pancreatic Tumor Big Data Center,Information provided by RenJi Hospital (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05141656?cond=Pancreatic%20Cancer&viewType=Card&page=15&rank=144
Pancreatic Cancer,NCT06706700,"Endocrine, Metabolic, Inflammatory Biomarkers to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with IPMN of the Pancreas","Information provided by Stefano Crippa, IRCCS San Raffaele (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06706700?cond=Pancreatic%20Cancer&viewType=Card&page=15&rank=145
Pancreatic Cancer,NCT05711433,Risk Factors for Postoperative Pancreatic Fistula Following Non,"Information provided by Tamer.A.A.M.Habeeb, Zagazig University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05711433?cond=Pancreatic%20Cancer&viewType=Card&page=15&rank=146
Pancreatic Cancer,NCT01446458,Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer,"Information provided by Natalyn N. Hawk, Emory University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01446458?cond=Pancreatic%20Cancer&viewType=Card&page=15&rank=147
Pancreatic Cancer,NCT01598194,Comparison of a Novel 22,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01598194?cond=Pancreatic%20Cancer&viewType=Card&page=15&rank=148&tab=results
Pancreatic Cancer,NCT05830019,Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery,"Information provided by Guoliang Jiang, Shanghai Proton and Heavy Ion Center (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05830019?cond=Pancreatic%20Cancer&viewType=Card&page=15&rank=149
Pancreatic Cancer,NCT06080854,AG Combined With Immunotherapy and SBRT in Patients With Potentially Resectable Pancreatic Cancer,Information provided by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06080854?cond=Pancreatic%20Cancer&viewType=Card&page=15&rank=150
Pancreatic Cancer,NCT02822716,Irreversible Electroporation for Inoperable Hepatic and Pancreatic Malignancy,"Information provided by Simon Yu, Chinese University of Hong Kong (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT02822716?cond=Pancreatic%20Cancer&viewType=Card&page=16&rank=151
Pancreatic Cancer,NCT06084013,Use Of Indocyanine Green In Pancreas Surgery,"Information provided by Patrick J. Worth, M.D., F.A.C.S., F.S.S.O., OHSU Knight Cancer Institute (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06084013?cond=Pancreatic%20Cancer&viewType=Card&page=16&rank=152
Pancreatic Cancer,NCT02358356,Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium,Information provided by Australasian Gastro-Intestinal Trials Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02358356?cond=Pancreatic%20Cancer&viewType=Card&page=16&rank=153
Pancreatic Cancer,NCT05634564,Concurrent Chemoradiotherapy Combined With Immunotherapy in Patients With Potentially Resectable Pancreatic Cancer,"Information provided by Du Juan, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05634564?cond=Pancreatic%20Cancer&viewType=Card&page=16&rank=154
Pancreatic Cancer,NCT05058846,Pilot Study of Pancreatic Cancer Screening,"Information provided by University of California, San Francisco (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05058846?cond=Pancreatic%20Cancer&viewType=Card&page=16&rank=155
Pancreatic Cancer,NCT03791073,New Biomarkers in Pancreatic Cancer Using EXPEL Concept,"Information provided by University Hospital, Montpellier (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03791073?cond=Pancreatic%20Cancer&viewType=Card&page=16&rank=156
Pancreatic Cancer,NCT04592393,Pancreas Cancer Surveillance Using an Abbreviated MRI,"Information provided by Jeong Min Lee, Seoul National University Hospital (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT04592393?cond=Pancreatic%20Cancer&viewType=Card&page=16&rank=157
Pancreatic Cancer,NCT04841616,Multicentered Prospective Randomized Controlled Trial For Solid Pancreatic Lesions,"Information provided by Charing Chong, MD, Chinese University of Hong Kong (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04841616?cond=Pancreatic%20Cancer&viewType=Card&page=16&rank=158
Pancreatic Cancer,NCT04965311,Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy,"Information provided by Brett C. Sheppard, M.D., FACS, OHSU Knight Cancer Institute (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04965311?cond=Pancreatic%20Cancer&viewType=Card&page=16&rank=159&tab=results
Pancreatic Cancer,NCT04724551,The Neutrophil-to,Information provided by Institut Paoli-Calmettes (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04724551?cond=Pancreatic%20Cancer&viewType=Card&page=16&rank=160
Pancreatic Cancer,NCT04082455,Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer,"Information provided by Guoliang Jiang, Shanghai Proton and Heavy Ion Center (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT04082455?cond=Pancreatic%20Cancer&viewType=Card&page=17&rank=161
Pancreatic Cancer,NCT06807437,Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula,Information provided by SWOG Cancer Research Network (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06807437?cond=Pancreatic%20Cancer&viewType=Card&page=17&rank=162
Pancreatic Cancer,NCT04889404,LYNPARZA Pancreas Cancer Japan Post,Information provided by AstraZeneca (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04889404?cond=Pancreatic%20Cancer&viewType=Card&page=17&rank=163
Pancreatic Cancer,NCT02338752,Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient,"Information provided by Fuda Cancer Hospital, Guangzhou (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02338752?cond=Pancreatic%20Cancer&viewType=Card&page=17&rank=164
Pancreatic Cancer,NCT03949933,,Non spécifié,Inconnu,https://clinicaltrials.gov/study/NCT03949933?cond=Pancreatic%20Cancer&viewType=Card&page=17&rank=165
Pancreatic Cancer,NCT04239573,Comparing Two Methods to Follow Patients With Pancreatic Cysts,Information provided by Eastern Cooperative Oncology Group (ECOG-ACRIN Cancer Research Group) (Responsible Party),Active,https://clinicaltrials.gov/study/NCT04239573?cond=Pancreatic%20Cancer&viewType=Card&page=17&rank=166
Pancreatic Cancer,NCT07045571,MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer,"Information provided by Yingbin Liu, MD, PhD, FACS, Shanghai Jiao Tong University School of Medicine (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT07045571?cond=Pancreatic%20Cancer&viewType=Card&page=17&rank=167
Pancreatic Cancer,NCT04833959,Pilot Study of 89,Information provided by Stanford University (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT04833959?cond=Pancreatic%20Cancer&viewType=Card&page=17&rank=168
Pancreatic Cancer,NCT03745794,Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03745794?cond=Pancreatic%20Cancer&viewType=Card&page=17&rank=169&tab=results
Pancreatic Cancer,NCT06757244,"DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer",Information provided by Hopital Foch (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06757244?cond=Pancreatic%20Cancer&viewType=Card&page=17&rank=170
Pancreatic Cancer,NCT00041639,Safety Study of 90Y,Information provided by Gilead Sciences,Completed,https://clinicaltrials.gov/study/NCT00041639?cond=Pancreatic%20Cancer&viewType=Card&page=18&rank=171
Pancreatic Cancer,NCT01330823,L,Information provided by University Medicine Greifswald,Inconnu,https://clinicaltrials.gov/study/NCT01330823?cond=Pancreatic%20Cancer&viewType=Card&page=18&rank=172
Pancreatic Cancer,NCT06593431,Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial,Information provided by M.D. Anderson Cancer Center (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06593431?cond=Pancreatic%20Cancer&viewType=Card&page=18&rank=173
Pancreatic Cancer,NCT06651580,"Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study",Information provided by M.D. Anderson Cancer Center (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06651580?cond=Pancreatic%20Cancer&viewType=Card&page=18&rank=174
Pancreatic Cancer,NCT02517268,Accelerated Recovery Pathway for Discharge After Surgery in Patients With Pancreatic Cancer,Information provided by Thomas Jefferson University (Sidney Kimmel Cancer Center at Thomas Jefferson University) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02517268?cond=Pancreatic%20Cancer&viewType=Card&page=18&rank=175&tab=results
Pancreatic Cancer,NCT04768660,Effects of Chewing Gum Against Postoperative Ileus,"Information provided by Andrew Mokbel, Assiut University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT04768660?cond=Pancreatic%20Cancer&viewType=Card&page=18&rank=176
Pancreatic Cancer,NCT06157671,The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma,"Information provided by Adenocyte, LLC (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06157671?cond=Pancreatic%20Cancer&viewType=Card&page=18&rank=177
Pancreatic Cancer,NCT00732082,Lag,Information provided by Washington University School of Medicine (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT00732082?cond=Pancreatic%20Cancer&viewType=Card&page=18&rank=178
Pancreatic Cancer,NCT01774019,Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer,Information provided by Boston Scientific Corporation (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01774019?cond=Pancreatic%20Cancer&viewType=Card&page=18&rank=179&tab=results
Pancreatic Cancer,NCT03162510,"Biweekly SOLAR, as First","Information provided by National Health Research Institutes, Taiwan (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03162510?cond=Pancreatic%20Cancer&viewType=Card&page=18&rank=180
Pancreatic Cancer,NCT06360354,"A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)",Information provided by Amgen (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06360354?cond=Pancreatic%20Cancer&viewType=Card&page=19&rank=181
Pancreatic Cancer,NCT01411072,Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer,Information provided by AHS Cancer Control Alberta (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT01411072?cond=Pancreatic%20Cancer&viewType=Card&page=19&rank=182
Pancreatic Cancer,NCT05463328,Open Versus Laparoscopic Assisted Pancreaticoduodenectomy,"Information provided by Mohammed Aly, Assiut University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05463328?cond=Pancreatic%20Cancer&viewType=Card&page=19&rank=183
Pancreatic Cancer,NCT02905578,A Phase 2 Trial of High,"Information provided by Joseph J. Cullen, University of Iowa (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02905578?cond=Pancreatic%20Cancer&viewType=Card&page=19&rank=184
Pancreatic Cancer,NCT00689715,Long Term Outcomes After EUS,"Information provided by Dong Wan Seo, Asan Medical Center (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT00689715?cond=Pancreatic%20Cancer&viewType=Card&page=19&rank=185
Pancreatic Cancer,NCT01677312,Trial Comparing 19 and 25-gauge EUS,Information provided by AdventHealth (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01677312?cond=Pancreatic%20Cancer&viewType=Card&page=19&rank=186&tab=results
Pancreatic Cancer,NCT01996540,"The Role of Early Systematic Best Palliative Care Versus on Request Palliative Care Consultation During Standard Oncologic Treatment for Patients With Advanced Gastric or Pancreatic Cancers: a Randomized, Controlled, Multicenter Trial.",Information provided by Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01996540?cond=Pancreatic%20Cancer&viewType=Card&page=19&rank=187
Pancreatic Cancer,NCT06310902,Single,"Information provided by Yu Pan, Fujian Medical University Union Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06310902?cond=Pancreatic%20Cancer&viewType=Card&page=19&rank=188
Pancreatic Cancer,NCT03182270,Clinical Evaluation Of Needle,Information provided by Peking Union Medical College Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03182270?cond=Pancreatic%20Cancer&viewType=Card&page=19&rank=189
Pancreatic Cancer,NCT05714111,Radiology Registry on Pancreatic Malignancies,"Information provided by Francesco De Cobelli, IRCCS San Raffaele (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05714111?cond=Pancreatic%20Cancer&viewType=Card&page=19&rank=190
Pancreatic Cancer,NCT04275557,Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas,Information provided by H. Lee Moffitt Cancer Center and Research Institute (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04275557?cond=Pancreatic%20Cancer&viewType=Card&page=20&rank=191
Pancreatic Cancer,NCT06276764,The LINFU® U.S. Registry in Patients With IPMN (Intraductal Papillary Mucinous Neoplasm of the Pancreas),"Information provided by Adenocyte, LLC (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06276764?cond=Pancreatic%20Cancer&viewType=Card&page=20&rank=192
Pancreatic Cancer,NCT05840341,Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer,"Information provided by Hao Chen, Fudan University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05840341?cond=Pancreatic%20Cancer&viewType=Card&page=20&rank=193
Pancreatic Cancer,NCT02713763,Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib,Information provided by Grupo Espanol de Tumores Neuroendocrinos (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02713763?cond=Pancreatic%20Cancer&viewType=Card&page=20&rank=194
Pancreatic Cancer,NCT06630910,New Technique of Pancreaticojejunostomy During Whipple Operation,"Information provided by Mahmoud Rady, Theodor Bilharz Research Institute (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT06630910?cond=Pancreatic%20Cancer&viewType=Card&page=20&rank=195
Pancreatic Cancer,NCT03397342,MRI Only Radiation Therapy With CPAP,Information provided by Albert Einstein College of Medicine (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03397342?cond=Pancreatic%20Cancer&viewType=Card&page=20&rank=196&tab=results
Pancreatic Cancer,NCT05914987,Determining Individualized Cancer Therapy in Pancreatic Cancer,"Information provided by Mandana Kamgar, MD, Medical College of Wisconsin (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05914987?cond=Pancreatic%20Cancer&viewType=Card&page=20&rank=197
Pancreatic Cancer,NCT00279292,Randomized Trial of EUS Neurolysis in Pancreas Cancer,Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),Completed,https://clinicaltrials.gov/study/NCT00279292?cond=Pancreatic%20Cancer&viewType=Card&page=20&rank=198
Pancreatic Cancer,NCT01693419,S,Information provided by Hallym University Medical Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01693419?cond=Pancreatic%20Cancer&viewType=Card&page=20&rank=199
Pancreatic Cancer,NCT07144917,Immunoparalysis After Pancreaticoduodenectomy,Information provided by Hospices Civils de Lyon (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07144917?cond=Pancreatic%20Cancer&viewType=Card&page=20&rank=200
Pancreatic Cancer,NCT00690300,Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer,Information provided by University of Ulm,Recruiting,https://clinicaltrials.gov/study/NCT00690300?cond=Pancreatic%20Cancer&viewType=Card&page=21&rank=201
Pancreatic Cancer,NCT03818165,Phase 1b Study of CAR2Anti-CEA CAR,"Information provided by Sorrento Therapeutics, Inc. (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT03818165?cond=Pancreatic%20Cancer&viewType=Card&page=21&rank=202
Pancreatic Cancer,NCT00985777,Vitamin E δ,Information provided by H. Lee Moffitt Cancer Center and Research Institute (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00985777?cond=Pancreatic%20Cancer&viewType=Card&page=21&rank=203
Pancreatic Cancer,NCT05187416,Correlation Between Elastic Modulus of Ultrasonic Shear Wave and Tumor Stromal Component in Pancreatic Cancer,Information provided by Xijing Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05187416?cond=Pancreatic%20Cancer&viewType=Card&page=21&rank=204
Pancreatic Cancer,NCT06638866,AI-powered Early Detection for Pancreatic Cancer Via Non,Information provided by Changhai Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06638866?cond=Pancreatic%20Cancer&viewType=Card&page=21&rank=205
Pancreatic Cancer,NCT05546970,Efficacy of the Transversus Abdominis Plane Block on Analgesia After Cephalic Duodeno,"Information provided by University Hospital, Strasbourg, France (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05546970?cond=Pancreatic%20Cancer&viewType=Card&page=21&rank=206
Pancreatic Cancer,NCT01784081,Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer,Information provided by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT01784081?cond=Pancreatic%20Cancer&viewType=Card&page=21&rank=207
Pancreatic Cancer,NCT07057895,Diagnostic Consistency of GLIM and PG,"Information provided by Feifei Wang, The First Hospital of Hebei Medical University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT07057895?cond=Pancreatic%20Cancer&viewType=Card&page=21&rank=208
Pancreatic Cancer,NCT02305810,A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus,Information provided by European Institute of Oncology (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02305810?cond=Pancreatic%20Cancer&viewType=Card&page=21&rank=209
Pancreatic Cancer,NCT05722223,Trimodal Prehabilitation in Pancreatic Cancer Patients Urdergoing Neoadjuvant Treatment,"Information provided by Ana Ruiz-Casado, Puerta de Hierro University Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05722223?cond=Pancreatic%20Cancer&viewType=Card&page=21&rank=210
Pancreatic Cancer,NCT06685939,The Differences of Complications Between LPD(Laparoscopic Pancreaticoduodenectomy) and OPD(Open Pancreaticoduodenectomy),"Information provided by Zhijun Bao, Fudan University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06685939?cond=Pancreatic%20Cancer&viewType=Card&page=22&rank=211
Pancreatic Cancer,NCT06000553,Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the Pancreas,Information provided by Institut Paoli-Calmettes (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06000553?cond=Pancreatic%20Cancer&viewType=Card&page=22&rank=212
Pancreatic Cancer,NCT02703545,International CAPS Registry: Pancreas Cancer Cases in Surveillance Programs,Information provided by Johns Hopkins University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02703545?cond=Pancreatic%20Cancer&viewType=Card&page=22&rank=213
Pancreatic Cancer,NCT06532617,Cadonilimab Combined With S-1 or Capecitabine as Second,"Information provided by Jiang Long, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06532617?cond=Pancreatic%20Cancer&viewType=Card&page=22&rank=214
Pancreatic Cancer,NCT06336694,A Deep Learning Radiomics Model for Predicting Occult Peritoneal Metastases of Pancreatic Adenocarcinoma,"Information provided by Siya Shi, First Affiliated Hospital, Sun Yat-Sen University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT06336694?cond=Pancreatic%20Cancer&viewType=Card&page=22&rank=215
Pancreatic Cancer,NCT00100321,Surgery for Pancreatic Tumors and Collection of Tumor Tissue for Study,Information provided by National Institutes of Health Clinical Center (CC),Terminated,https://clinicaltrials.gov/study/NCT00100321?cond=Pancreatic%20Cancer&viewType=Card&page=22&rank=216
Pancreatic Cancer,NCT00936104,Side Population in Pancreatic Ductal Adenocarcinoma (PDAC),"Information provided by Baki Topal, University Hospital, Gasthuisberg (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00936104?cond=Pancreatic%20Cancer&viewType=Card&page=22&rank=217
Pancreatic Cancer,NCT07121478,Patients With High,"Information provided by Sang Myung Woo, National Cancer Center, Korea (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT07121478?cond=Pancreatic%20Cancer&viewType=Card&page=22&rank=218
Pancreatic Cancer,NCT03855800,Molecular Detection of Advanced Neoplasia in Pancreatic Cysts,Information provided by Mayo Clinic (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03855800?cond=Pancreatic%20Cancer&viewType=Card&page=22&rank=219
Pancreatic Cancer,NCT04422730,Evolution of Body Connection After Surgery,Information provided by Institut Paoli-Calmettes (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04422730?cond=Pancreatic%20Cancer&viewType=Card&page=22&rank=220
Pancreatic Cancer,NCT04747600,Outcomes of Surgical Resection of Pancreatic Cystic Neoplasms Based on the European Expert Consensus Statement: A Prospective Observational Study.,"Information provided by Tamer.A.A.M.Habeeb, Zagazig University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04747600?cond=Pancreatic%20Cancer&viewType=Card&page=23&rank=221
Pancreatic Cancer,NCT00259532,Three New Methods for Diagnosing Pancreas Cancer,Information provided by University of Copenhagen,Recruiting,https://clinicaltrials.gov/study/NCT00259532?cond=Pancreatic%20Cancer&viewType=Card&page=23&rank=222
Pancreatic Cancer,NCT05795920,Utidelone Injection Combined With Gemcitabine in First,"Information provided by Qi Li, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05795920?cond=Pancreatic%20Cancer&viewType=Card&page=23&rank=223
Pancreatic Cancer,NCT01371240,Secretin,Information provided by University Hospitals Cleveland Medical Center (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT01371240?cond=Pancreatic%20Cancer&viewType=Card&page=23&rank=224
Pancreatic Cancer,NCT05681390,Tislelizumab With Anlotinib and Chemotherapy for Second,Information provided by First Affiliated Hospital Xi'an Jiaotong University (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05681390?cond=Pancreatic%20Cancer&viewType=Card&page=23&rank=225
Pancreatic Cancer,NCT03435770,Evaluation of Safety and Feasibility of EUS,"Information provided by Chin Yung Ka, Singapore General Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT03435770?cond=Pancreatic%20Cancer&viewType=Card&page=23&rank=226
Pancreatic Cancer,NCT05587387,Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal,Information provided by Yonsei University (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05587387?cond=Pancreatic%20Cancer&viewType=Card&page=23&rank=227
Pancreatic Cancer,NCT06981273,Robotic vs Open Pancreatoduodenectomy,"Information provided by Benedetto Ielpo, Hospital del Mar (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06981273?cond=Pancreatic%20Cancer&viewType=Card&page=23&rank=228
Pancreatic Cancer,NCT05493995,A Study of Penpulimab and Anlotinib Plus Nab,"Information provided by Du Juan, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05493995?cond=Pancreatic%20Cancer&viewType=Card&page=23&rank=229
Pancreatic Cancer,NCT05549960,Pre-planning Mathematical Models in EUS,"Information provided by Francesco Maria Di Matteo, Campus Bio-Medico University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05549960?cond=Pancreatic%20Cancer&viewType=Card&page=23&rank=230
Pancreatic Cancer,NCT05481463,Surufatinib Combined With TAS-102 in Third-line and Later,"Information provided by Dong sheng Zhang, Sun Yat-sen University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05481463?cond=Pancreatic%20Cancer&viewType=Card&page=24&rank=231
Pancreatic Cancer,NCT05481476,Surufatinib Combined With Sintilimab and AG in First,"Information provided by Dong sheng Zhang, Sun Yat-sen University (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT05481476?cond=Pancreatic%20Cancer&viewType=Card&page=24&rank=232
Pancreatic Cancer,NCT00005926,"Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas",Information provided by National Institutes of Health Clinical Center (CC),Completed,https://clinicaltrials.gov/study/NCT00005926?cond=Pancreatic%20Cancer&viewType=Card&page=24&rank=233
Pancreatic Cancer,NCT05616403,Textbook Outcome as a Composite Outcome Measure in Laparoscopic Pancreaticoduodenectomy,"Information provided by Renyi Qin, Tongji Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05616403?cond=Pancreatic%20Cancer&viewType=Card&page=24&rank=234
Pancreatic Cancer,NCT03199144,Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer,"Information provided by Centre Francois Baclesse, Luxembourg (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT03199144?cond=Pancreatic%20Cancer&viewType=Card&page=24&rank=235
Pancreatic Cancer,NCT03679910,Evaluation of CEMIP in Pancreatic Cancer,"Information provided by Dina Safwat, Assiut University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03679910?cond=Pancreatic%20Cancer&viewType=Card&page=24&rank=236
Pancreatic Cancer,NCT00881621,Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer,Information provided by Georgetown University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00881621?cond=Pancreatic%20Cancer&viewType=Card&page=24&rank=237&tab=results
Pancreatic Cancer,NCT06411795,Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy,"Information provided by Masonic Cancer Center, University of Minnesota (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06411795?cond=Pancreatic%20Cancer&viewType=Card&page=24&rank=238
Pancreatic Cancer,NCT04947696,Circulating Epigenetics in Pancreatic Surgery,"Information provided by Martin Sillesen, Rigshospitalet, Denmark (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04947696?cond=Pancreatic%20Cancer&viewType=Card&page=24&rank=239
Pancreatic Cancer,NCT04877340,Comparation Between Needles for EUS,Information provided by Instituto do Cancer do Estado de São Paulo (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04877340?cond=Pancreatic%20Cancer&viewType=Card&page=24&rank=240
Pancreatic Cancer,NCT04808687,Neoadjuvant Nab-Paclitaxel and S,Information provided by Tianjin Medical University Cancer Institute and Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04808687?cond=Pancreatic%20Cancer&viewType=Card&page=25&rank=241
Pancreatic Cancer,NCT00680420,DNA Microarray Study of Pancreas Cancer,"Information provided by Sarah Rodriguez, Oregon Health and Science University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00680420?cond=Pancreatic%20Cancer&viewType=Card&page=25&rank=242
Pancreatic Cancer,NCT02599662,Intraoperative Radiation Therapy for Resectable Pancreas Cancer,"Information provided by Tarita Thomas, Loyola University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02599662?cond=Pancreatic%20Cancer&viewType=Card&page=25&rank=243
Pancreatic Cancer,NCT07139236,Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD,"Information provided by Saleh Khairy Saleh MD, Minia University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT07139236?cond=Pancreatic%20Cancer&viewType=Card&page=25&rank=244
Pancreatic Cancer,NCT06705335,Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma,Information provided by Institut Bergonié (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06705335?cond=Pancreatic%20Cancer&viewType=Card&page=25&rank=245
Pancreatic Cancer,NCT03798769,Supportive Oncology Care at Home for Patients With Pancreatic Cancer Receiving Preoperative FOLFIRINOX,"Information provided by Ryan Nipp, Massachusetts General Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03798769?cond=Pancreatic%20Cancer&viewType=Card&page=25&rank=246
Pancreatic Cancer,NCT05110573,Single-centre Propensity Score,"Information provided by Dr. M. D'hondt, General Hospital Groeninge (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05110573?cond=Pancreatic%20Cancer&viewType=Card&page=25&rank=247
Pancreatic Cancer,NCT04975620,Comparison of Two Types of Biopsy Needles for EUS,"Information provided by Mehdi Mohamadnejad, University of Tehran (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04975620?cond=Pancreatic%20Cancer&viewType=Card&page=25&rank=248
Pancreatic Cancer,NCT02173353,Feasibility of Using Ultrasound to Track Respiration Motion,"Information provided by An Tai, Medical College of Wisconsin (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02173353?cond=Pancreatic%20Cancer&viewType=Card&page=25&rank=249
Pancreatic Cancer,NCT04370574,Discovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All,"Information provided by University Hospital, Montpellier (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04370574?cond=Pancreatic%20Cancer&viewType=Card&page=25&rank=250
Pancreatic Cancer,NCT03250078,A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals,"Information provided by Richard Frank, Nuvance Health (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03250078?cond=Pancreatic%20Cancer&viewType=Card&page=26&rank=251
Pancreatic Cancer,NCT06572813,Bortezomib Combined with PD,"Information provided by TingBo Liang, Zhejiang University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06572813?cond=Pancreatic%20Cancer&viewType=Card&page=26&rank=252
Pancreatic Cancer,NCT06549751,MT,"Information provided by Marker Therapeutics, Inc. (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06549751?cond=Pancreatic%20Cancer&viewType=Card&page=26&rank=253
Pancreatic Cancer,NCT04289792,Split,"Information provided by Benhua Xu, Fujian Medical University Union Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04289792?cond=Pancreatic%20Cancer&viewType=Card&page=26&rank=254
Pancreatic Cancer,NCT00081549,Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard Therapies,Information provided by Aronex Pharmaceuticals,Active,https://clinicaltrials.gov/study/NCT00081549?cond=Pancreatic%20Cancer&viewType=Card&page=26&rank=255
Pancreatic Cancer,NCT04237441,The Results of Pancreatic Operations After the Implementation of Multidisciplinary Team Conference (MDT):,"Information provided by carsten palnaes hansen, Rigshospitalet, Denmark (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04237441?cond=Pancreatic%20Cancer&viewType=Card&page=26&rank=256
Pancreatic Cancer,NCT04085055,Fine Needle Biopsy of Solid Pancreatic Mass Lesions,Information provided by AdventHealth (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04085055?cond=Pancreatic%20Cancer&viewType=Card&page=26&rank=257
Pancreatic Cancer,NCT02301143,Phase 2 Nab®,Information provided by Celgene (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02301143?cond=Pancreatic%20Cancer&viewType=Card&page=26&rank=258&tab=results
Pancreatic Cancer,NCT06228599,Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High,"Information provided by Mandana Kamgar, MD, Medical College of Wisconsin (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06228599?cond=Pancreatic%20Cancer&viewType=Card&page=26&rank=259
Pancreatic Cancer,NCT06252545,Promoting CT Engagement for Pancreatic Cancer With App,Information provided by UNC Lineberger Comprehensive Cancer Center (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06252545?cond=Pancreatic%20Cancer&viewType=Card&page=26&rank=260
Pancreatic Cancer,NCT06255912,Clinical Trial for Advanced or Metastatic Pancreatic Cancer,"Information provided by NING LI, Cancer Institute and Hospital, Chinese Academy of Medical Sciences (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06255912?cond=Pancreatic%20Cancer&viewType=Card&page=27&rank=261
Pancreatic Cancer,NCT04165018,"Prospective Study FNB, Is It Time To Abandon Cytological Assessment","Information provided by Mohamed Othman, Baylor College of Medicine (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04165018?cond=Pancreatic%20Cancer&viewType=Card&page=27&rank=262
Pancreatic Cancer,NCT06206382,Surgical Results of Resection of Locally Advanced Pancreatic Cancer,"Information provided by Mina Melad Boshra Yosef, Assiut University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06206382?cond=Pancreatic%20Cancer&viewType=Card&page=27&rank=263
Pancreatic Cancer,NCT00178763,Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer,"Information provided by The University of Texas Health Science Center, Houston",Recruiting,https://clinicaltrials.gov/study/NCT00178763?cond=Pancreatic%20Cancer&viewType=Card&page=27&rank=264
Pancreatic Cancer,NCT06050317,Sintilimab Combined With Chemotherapy and Radiotherapy in Patients With Inoperable Pancreatic Cancer,"Information provided by Jinbo Yue, Shandong Cancer Hospital and Institute (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06050317?cond=Pancreatic%20Cancer&viewType=Card&page=27&rank=265
Pancreatic Cancer,NCT00300950,"Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post",Information provided by GlobeImmune (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00300950?cond=Pancreatic%20Cancer&viewType=Card&page=27&rank=266
Pancreatic Cancer,NCT03838029,Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery,Information provided by Assaf-Harofeh Medical Center (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03838029?cond=Pancreatic%20Cancer&viewType=Card&page=27&rank=267
Pancreatic Cancer,NCT01419483,Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer,"Information provided by Bryan Allen, University of Iowa (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT01419483?cond=Pancreatic%20Cancer&viewType=Card&page=27&rank=268
Pancreatic Cancer,NCT06172634,A Single-center Clinical Study to Evaluate the Safety and Efficacy of Autologous Bone Marrow-derived DCs(CellgramDC-WT1) and Immune Checkpoint Inhibitors in Patients With Metastatic Pancreatic Cancer Who Have Failed First,"Information provided by Jong-Ho Won, Soonchunhyang University Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06172634?cond=Pancreatic%20Cancer&viewType=Card&page=27&rank=269
Pancreatic Cancer,NCT04002778,Rapid On,"Information provided by Guilherme Rezende, Universidade Federal do Rio de Janeiro (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04002778?cond=Pancreatic%20Cancer&viewType=Card&page=27&rank=270
Pancreatic Cancer,NCT00842348,Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero,Information provided by Ipsen (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00842348?cond=Pancreatic%20Cancer&viewType=Card&page=28&rank=271&tab=results
Pancreatic Cancer,NCT05720338,Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?,Information provided by Case Comprehensive Cancer Center (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05720338?cond=Pancreatic%20Cancer&viewType=Card&page=28&rank=272
Pancreatic Cancer,NCT05959213,Preoperative CA 19.9 Level Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of the Head of the Pancreas.,"Information provided by Tommaso Farolfi, Fondazione Policlinico Universitario Campus Bio-Medico (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05959213?cond=Pancreatic%20Cancer&viewType=Card&page=28&rank=273
Pancreatic Cancer,NCT03803930,Comparing of a 22G EUS Procore Fine Needle Biopsy Device and a 20G EUS Procore Fine Needle Biopsy Device,"Information provided by Bin Cheng, Huazhong University of Science and Technology (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT03803930?cond=Pancreatic%20Cancer&viewType=Card&page=28&rank=274
Pancreatic Cancer,NCT05927298,Province of Ontario Strategy for Personalized Management of Pancreatic Cancer Trial,"Information provided by University Health Network, Toronto (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05927298?cond=Pancreatic%20Cancer&viewType=Card&page=28&rank=275
Pancreatic Cancer,NCT01673906,68-Ga-labeled Octreotide Analogues PET in Duodenal,Information provided by Azienda USL Reggio Emilia - IRCCS (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01673906?cond=Pancreatic%20Cancer&viewType=Card&page=28&rank=276
Pancreatic Cancer,NCT05880472,Percutaneous Holmium Injection in Pancreatic Cancer,Information provided by Radboud University Medical Center (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05880472?cond=Pancreatic%20Cancer&viewType=Card&page=28&rank=277
Pancreatic Cancer,NCT03665571,Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic Cancer,"Information provided by Song Cheol Kim, Asan Medical Center (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03665571?cond=Pancreatic%20Cancer&viewType=Card&page=28&rank=278
Pancreatic Cancer,NCT00839332,A Study for Participants With Pancreatic Cancer,Information provided by Eli Lilly and Company (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00839332?cond=Pancreatic%20Cancer&viewType=Card&page=28&rank=279&tab=results
Pancreatic Cancer,NCT03766659,EUS-FNB With MOSE vs EUS,"Information provided by Charing Chong, MD, Chinese University of Hong Kong (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03766659?cond=Pancreatic%20Cancer&viewType=Card&page=28&rank=280
Pancreatic Cancer,NCT05743049,Collection of Circulating Biomarkers in Pancreatic Cancer,Information provided by Abramson Cancer Center at Penn Medicine (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05743049?cond=Pancreatic%20Cancer&viewType=Card&page=29&rank=281
Pancreatic Cancer,NCT00417287,Phase II Study of PX,Information provided by Seagen Inc. (Cascadian Therapeutics Inc.) (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT00417287?cond=Pancreatic%20Cancer&viewType=Card&page=29&rank=282
Pancreatic Cancer,NCT06144762,Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer,Information provided by Institut du Cancer de Montpellier - Val d'Aurelle (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06144762?cond=Pancreatic%20Cancer&viewType=Card&page=29&rank=283
Pancreatic Cancer,NCT03469726,Contrast-enhanced Diffusion,Information provided by Radboud University Medical Center (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03469726?cond=Pancreatic%20Cancer&viewType=Card&page=29&rank=284
Pancreatic Cancer,NCT06602037,ImmunoPET Imaging of Pancreatic Cancer,Information provided by RenJi Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06602037?cond=Pancreatic%20Cancer&viewType=Card&page=29&rank=285
Pancreatic Cancer,NCT02896803,Fluorouracil and Oxaliplatin as First,Information provided by Instituto do Cancer do Estado de São Paulo (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT02896803?cond=Pancreatic%20Cancer&viewType=Card&page=29&rank=286
Pancreatic Cancer,NCT05493878,ITGA2b and SELP Expression in Cancer Pancreas and Biliary Tract Cancer,"Information provided by Amany Hamdy Radwan, Assiut University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05493878?cond=Pancreatic%20Cancer&viewType=Card&page=29&rank=287
Pancreatic Cancer,NCT05638698,Tg01 Vaccine / Qs,Information provided by University of Kansas Medical Center (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05638698?cond=Pancreatic%20Cancer&viewType=Card&page=29&rank=288
Pancreatic Cancer,NCT05497778,A Phase 1b Study of Gemcitabine and Nab,Information provided by M.D. Anderson Cancer Center (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05497778?cond=Pancreatic%20Cancer&viewType=Card&page=29&rank=289
Pancreatic Cancer,NCT00438906,Cancer of the Pancreas Screening Study (CAPS 3),Information provided by Johns Hopkins University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00438906?cond=Pancreatic%20Cancer&viewType=Card&page=29&rank=290
Pancreatic Cancer,NCT05435053,Irreversible Electroporation + Nivolumab for Patients With Metastatic Pancreatic Cancer,"Information provided by Ismail Gögenur, Zealand University Hospital (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT05435053?cond=Pancreatic%20Cancer&viewType=Card&page=30&rank=291
Pancreatic Cancer,NCT05702385,Clinical Utility Study for Exo,"Information provided by Qure Healthcare, LLC (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT05702385?cond=Pancreatic%20Cancer&viewType=Card&page=30&rank=292
Pancreatic Cancer,NCT05692323,A Supervised Prehabilitation Program for Patients With Pancreatic Cancer,"Information provided by Philip Chang, Cedars-Sinai Medical Center (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT05692323?cond=Pancreatic%20Cancer&viewType=Card&page=30&rank=293
Pancreatic Cancer,NCT03303352,Connect Your Needle to Your Phone to Increase EUS FNA Diagnostic Yield?,"Information provided by Mihai Ciocirlan, Carol Davila University of Medicine and Pharmacy (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03303352?cond=Pancreatic%20Cancer&viewType=Card&page=30&rank=294
Pancreatic Cancer,NCT05192044,Less Than 100 Hours Hospital Stay After Pancreatico,"Information provided by National Cancer Institute, Egypt (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05192044?cond=Pancreatic%20Cancer&viewType=Card&page=30&rank=295
Pancreatic Cancer,NCT02337465,KV,Information provided by Case Comprehensive Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02337465?cond=Pancreatic%20Cancer&viewType=Card&page=30&rank=296&tab=results
Pancreatic Cancer,NCT05248750,"Genetic, Microenvironmental, and Immunological Factors in Unresectable Pancreatic Ductal Adenocarcinoma","Information provided by Guido Costamagna, Catholic University of the Sacred Heart (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05248750?cond=Pancreatic%20Cancer&viewType=Card&page=30&rank=297
Pancreatic Cancer,NCT05253313,Magnetic Resonance Imaging for Better Selection of Pancreatic Cancer Patients for Surgery: A Randomized Clinical Trial,Information provided by University of Aarhus (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT05253313?cond=Pancreatic%20Cancer&viewType=Card&page=30&rank=298
Pancreatic Cancer,NCT05170802,Pancreatic Cancer & Surgical Resection,Information provided by Methodist Health System (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05170802?cond=Pancreatic%20Cancer&viewType=Card&page=30&rank=299
Pancreatic Cancer,NCT05191498,Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer,Information provided by Radboud University Medical Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05191498?cond=Pancreatic%20Cancer&viewType=Card&page=30&rank=300
Leukemia,NCT02333058,Treosulfan,Information provided by medac GmbH (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02333058?cond=Leukemia&viewType=Card&page=1&rank=1
Leukemia,NCT05756322,The Safety and Tolerability of LBS,"Information provided by Lin BioScience, Inc (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05756322?cond=Leukemia&viewType=Card&page=1&rank=2
Leukemia,NCT01826214,Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia,Information provided by Novartis (Novartis Pharmaceuticals) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01826214?cond=Leukemia&viewType=Card&page=1&rank=3&tab=results
Leukemia,NCT00796562,Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy,Information provided by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00796562?cond=Leukemia&viewType=Card&page=1&rank=4&tab=results
Leukemia,NCT00780104,Sirolimus in Combination With MEC in High Risk Myeloid Leukemias,Information provided by Abramson Cancer Center at Penn Medicine (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00780104?cond=Leukemia&viewType=Card&page=1&rank=5
Leukemia,NCT06226571,A Study of SNDX,Information provided by Syndax Pharmaceuticals (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06226571?cond=Leukemia&viewType=Card&page=1&rank=6
Leukemia,NCT07211958,Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation,Information provided by Syndax Pharmaceuticals (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT07211958?cond=Leukemia&viewType=Card&page=1&rank=7
Leukemia,NCT03594955,First in Human Testing of Dose,"First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome",Completed,https://clinicaltrials.gov/study/NCT03594955?cond=Leukemia&viewType=Card&page=1&rank=8&tab=results
Leukemia,NCT03466944,PUMA (Paediatric Osseous Marrow Assessment),"Information provided by Nandita deSouza, Institute of Cancer Research, United Kingdom (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03466944?cond=Leukemia&viewType=Card&page=1&rank=9
Leukemia,NCT01313689,Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine,Information provided by Novartis (Novartis Pharmaceuticals) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01313689?cond=Leukemia&viewType=Card&page=1&rank=10&tab=results
Leukemia,NCT01239108,Study of SGI,"Information provided by Astex Pharmaceuticals, Inc. (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT01239108?cond=Leukemia&viewType=Card&page=2&rank=11
Leukemia,NCT00380653,Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes,"Information provided by Cyclacel Pharmaceuticals, Inc. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00380653?cond=Leukemia&viewType=Card&page=2&rank=12
Leukemia,NCT01334060,WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation,Information provided by University Hospital Southampton NHS Foundation Trust (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01334060?cond=Leukemia&viewType=Card&page=2&rank=13
Leukemia,NCT05304754,"""Phase I / II Study on Infusion of Natural Killer Cells After Haploidentical Transplantation in Pediatric Patients""",Information provided by Instituto de Investigación Hospital Universitario La Paz (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05304754?cond=Leukemia&viewType=Card&page=2&rank=14
Leukemia,NCT01339988,Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT),Information provided by Tel-Aviv Sourasky Medical Center,Inconnu,https://clinicaltrials.gov/study/NCT01339988?cond=Leukemia&viewType=Card&page=2&rank=15
Leukemia,NCT07200882,What is the Impact of TKI on Thyroid Function in CML Patients?,"Information provided by Esraa salah sayed gaber, Assiut University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT07200882?cond=Leukemia&viewType=Card&page=2&rank=16
Leukemia,NCT01453062,Phase IV Observational Study in Chronic Lymphocytic Leukemia,Information provided by GlaxoSmithKline (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01453062?cond=Leukemia&viewType=Card&page=2&rank=17
Leukemia,NCT02177812,A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML),Information provided by GlaxoSmithKline (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02177812?cond=Leukemia&viewType=Card&page=2&rank=18&tab=results
Leukemia,NCT04175587,"Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high","Information provided by Xiaojun Huang,MD, Peking University People's Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT04175587?cond=Leukemia&viewType=Card&page=2&rank=19
Leukemia,NCT01621724,WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity Study,Information provided by Cell Medica Ltd (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01621724?cond=Leukemia&viewType=Card&page=2&rank=20
Leukemia,NCT00993538,Leukemia Cell Cultures for Research of New Anti,"Information provided by University Hospital, Strasbourg, France",Recruiting,https://clinicaltrials.gov/study/NCT00993538?cond=Leukemia&viewType=Card&page=3&rank=21
Leukemia,NCT01110031,Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine,Information provided by GlaxoSmithKline (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01110031?cond=Leukemia&viewType=Card&page=3&rank=22
Leukemia,NCT00748189,Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia,Information provided by Novartis (Novartis Pharmaceuticals) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00748189?cond=Leukemia&viewType=Card&page=3&rank=23&tab=results
Leukemia,NCT01051063,Evaluation of a New Anti,Information provided by GlaxoSmithKline (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01051063?cond=Leukemia&viewType=Card&page=3&rank=24&tab=results
Leukemia,NCT00725283,Evaluation of a New Anti,Information provided by GlaxoSmithKline (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00725283?cond=Leukemia&viewType=Card&page=3&rank=25&tab=results
Leukemia,NCT01890746,A Safety and Efficacy Study of Eltrombopag in Subjects With AML,Information provided by Novartis (Novartis Pharmaceuticals) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01890746?cond=Leukemia&viewType=Card&page=3&rank=26&tab=results
Leukemia,NCT00824265,Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine,Information provided by Novartis (Novartis Pharmaceuticals) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00824265?cond=Leukemia&viewType=Card&page=3&rank=27&tab=results
Leukemia,NCT01563055,"A Phase I/II, Open",Information provided by GlaxoSmithKline (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01563055?cond=Leukemia&viewType=Card&page=3&rank=28&tab=results
Leukemia,NCT01077622,"A Phase I/II, a Single Arm, Open",Information provided by GlaxoSmithKline (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01077622?cond=Leukemia&viewType=Card&page=3&rank=29&tab=results
Leukemia,NCT01808326,"A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia",Information provided by GlaxoSmithKline (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01808326?cond=Leukemia&viewType=Card&page=3&rank=30&tab=results
Leukemia,NCT00349349,HuMax-CD20 in B-Cell Chronic Lymphocytic Leukemia (B,Information provided by GlaxoSmithKline (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00349349?cond=Leukemia&viewType=Card&page=4&rank=31&tab=results
Leukemia,NCT00802737,Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B,Information provided by GlaxoSmithKline (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00802737?cond=Leukemia&viewType=Card&page=4&rank=32&tab=results
Leukemia,NCT02660762,Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL,"Information provided by dr. luyue, Sun Yat-sen University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02660762?cond=Leukemia&viewType=Card&page=4&rank=33
Leukemia,NCT06845592,Safely Delivered Targeted High-dose Irradiation Followed by Adoptive Immunotherapy with Regulatory and Conventional T Cells to Increase Potency of Hematopoietic Stem Cell Transplantation in High,"Information provided by Antonio Pierini, University Of Perugia (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06845592?cond=Leukemia&viewType=Card&page=4&rank=34
Leukemia,NCT01039376,Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy,Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy (PROLONG),Completed,https://clinicaltrials.gov/study/NCT01039376?cond=Leukemia&viewType=Card&page=4&rank=35&tab=results
Leukemia,NCT06928909,Leukemia Adapted Protocol,"Information provided by Casey McAtee, Baylor College of Medicine (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06928909?cond=Leukemia&viewType=Card&page=4&rank=36
Leukemia,NCT00410163,Ofatumumab With Fludarabine and Cyclophosphamide in B,Information provided by GlaxoSmithKline (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00410163?cond=Leukemia&viewType=Card&page=4&rank=37&tab=results
Leukemia,NCT02452099,Impact of DMSO Concentrations on Hematopoietic Recovery After Autologous HSC Transplantation.,"Information provided by Sebastian Giebel, Maria Sklodowska-Curie National Research Institute of Oncology (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02452099?cond=Leukemia&viewType=Card&page=4&rank=38
Leukemia,NCT04629443,Phase I/II Trial of S64315 Plus Azacitidine in Acute Myeloid Leukaemia,Information provided by Servier (Institut de Recherches Internationales Servier) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04629443?cond=Leukemia&viewType=Card&page=4&rank=39&tab=results
Leukemia,NCT01428427,Combination Study of GSK1120212 With Gemcitabine in Subjects With Solid Tumors,Information provided by GlaxoSmithKline (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01428427?cond=Leukemia&viewType=Card&page=4&rank=40
Leukemia,NCT05893836,Real,Information provided by Novartis (Novartis Pharmaceuticals) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05893836?cond=Leukemia&viewType=Card&page=5&rank=41
Leukemia,NCT01031641,Refinement of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO,Information provided by National Institutes of Health Clinical Center (CC) (National Cancer Institute (NCI)) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01031641?cond=Leukemia&viewType=Card&page=5&rank=42
Leukemia,NCT07062250,Feasibility and Safety of Home Blood Count Measurement and Transfusions in Patients With Acute Myeloid Leukemia,"Information provided by Iben Husted Nielsen, Rigshospitalet, Denmark (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT07062250?cond=Leukemia&viewType=Card&page=5&rank=43
Leukemia,NCT07036250,Clinical Study of U32 in Patients With Acute Myeloid Leukemia,"Information provided by Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT07036250?cond=Leukemia&viewType=Card&page=5&rank=44
Leukemia,NCT00502385,Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML,Information provided by AstraZeneca,Completed,https://clinicaltrials.gov/study/NCT00502385?cond=Leukemia&viewType=Card&page=5&rank=45
Leukemia,NCT06326697,Bioequivalence of Azacitidine 300 mg Film,Information provided by Hikma Pharmaceuticals LLC (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06326697?cond=Leukemia&viewType=Card&page=5&rank=46
Leukemia,NCT07249476,Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia,Information provided by Nantes University Hospital (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07249476?cond=Leukemia&viewType=Card&page=5&rank=47
Leukemia,NCT07238907,A Multi-center Retrospective Study of INO Treating B,"Information provided by Jin Wang, Ruijin Hospital (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT07238907?cond=Leukemia&viewType=Card&page=5&rank=48
Leukemia,NCT06345365,MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML),Information provided by Zhongnan Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06345365?cond=Leukemia&viewType=Card&page=5&rank=49
Leukemia,NCT02058888,Amplification and Selection of Antimicrobial Resistance in the Intestine,"Information provided by Dr. Matthias Willmann, University Hospital Tuebingen (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02058888?cond=Leukemia&viewType=Card&page=5&rank=50
Leukemia,NCT00464217,Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years,Information provided by PETHEMA Foundation,Completed,https://clinicaltrials.gov/study/NCT00464217?cond=Leukemia&viewType=Card&page=6&rank=51
Leukemia,NCT02844257,Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid Leukaemia,Information provided by Hospices Civils de Lyon (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02844257?cond=Leukemia&viewType=Card&page=6&rank=52
Leukemia,NCT06783478,NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial,Information provided by Hospital de Clinicas de Porto Alegre (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06783478?cond=Leukemia&viewType=Card&page=6&rank=53
Leukemia,NCT04106076,Phase I Study of UCART123 in Patient With Adverse Genetic Risk Acute Myeloid Leukemia,Information provided by Cellectis S.A. (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT04106076?cond=Leukemia&viewType=Card&page=6&rank=54
Leukemia,NCT01521611,Targeted Radiotherapy in HSCT for Poor Risk Haematological Malignancy,Information provided by University Hospital Southampton NHS Foundation Trust (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01521611?cond=Leukemia&viewType=Card&page=6&rank=55
Leukemia,NCT02724163,International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia,Information provided by University of Birmingham (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT02724163?cond=Leukemia&viewType=Card&page=6&rank=56
Leukemia,NCT05712278,A Study to Investigate Use of Off-the,Information provided by Sanofi (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT05712278?cond=Leukemia&viewType=Card&page=6&rank=57
Leukemia,NCT03217838,"Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants.",Information provided by AstraZeneca (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT03217838?cond=Leukemia&viewType=Card&page=6&rank=58
Leukemia,NCT01949129,Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia,"Information provided by Prof. Christina Peters, St. Anna Kinderspital, Austria (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT01949129?cond=Leukemia&viewType=Card&page=6&rank=59
Leukemia,NCT03672695,Phase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia.,Information provided by Servier (Institut de Recherches Internationales Servier) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03672695?cond=Leukemia&viewType=Card&page=6&rank=60
Leukemia,NCT00530699,"Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML)",Information provided by AstraZeneca,Completed,https://clinicaltrials.gov/study/NCT00530699?cond=Leukemia&viewType=Card&page=7&rank=61
Leukemia,NCT05682924,Condition Vasoregulation Function Endothelium in Patients With CML Getting TKI II Generation Bosutinib,Information provided by Samara State Medical University (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05682924?cond=Leukemia&viewType=Card&page=7&rank=62
Leukemia,NCT00840346,Panobinostat in Combination With Idarubicin and Cytarabine in Patients Aged 65 Years or Older With Newly Diagnosed Acute Myeloblastic Leukaemia (AML),Information provided by PETHEMA Foundation,Completed,https://clinicaltrials.gov/study/NCT00840346?cond=Leukemia&viewType=Card&page=7&rank=63
Leukemia,NCT01019161,"An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML)",Information provided by AstraZeneca,Completed,https://clinicaltrials.gov/study/NCT01019161?cond=Leukemia&viewType=Card&page=7&rank=64
Leukemia,NCT03294980,"Chronic Lymphoid Leukaemia Observatory in Finistere Area, France","Information provided by University Hospital, Brest (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03294980?cond=Leukemia&viewType=Card&page=7&rank=65
Leukemia,NCT03582098,Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland,Information provided by Gilead Sciences (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03582098?cond=Leukemia&viewType=Card&page=7&rank=66
Leukemia,NCT01616238,A Study for Older Adults With Acute Lymphoblastic Leukaemia,"Information provided by University College, London (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01616238?cond=Leukemia&viewType=Card&page=7&rank=67
Leukemia,NCT05286528,Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real,Information provided by Pfizer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05286528?cond=Leukemia&viewType=Card&page=7&rank=68&tab=results
Leukemia,NCT06788756,L,"Information provided by Moleculin Biotech, Inc. (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06788756?cond=Leukemia&viewType=Card&page=7&rank=69
Leukemia,NCT01343173,Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukaemia in Long Term After Stopping Imatinib,"Information provided by University Hospital, Bordeaux (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01343173?cond=Leukemia&viewType=Card&page=7&rank=70
Leukemia,NCT01063660,Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML),Information provided by medac GmbH,Completed,https://clinicaltrials.gov/study/NCT01063660?cond=Leukemia&viewType=Card&page=8&rank=71
Leukemia,NCT07154823,A Longitudinal Multi,Information provided by Tempus AI (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07154823?cond=Leukemia&viewType=Card&page=8&rank=72
Leukemia,NCT01804985,De,Information provided by University of Liverpool (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01804985?cond=Leukemia&viewType=Card&page=8&rank=73
Leukemia,NCT00390897,"Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic",Information provided by PETHEMA Foundation,Completed,https://clinicaltrials.gov/study/NCT00390897?cond=Leukemia&viewType=Card&page=8&rank=74
Leukemia,NCT07244367,Maintenance Venetoclax in AML Fit Patients,"Information provided by Eman Ibrahim Abdelshakour, Sohag University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT07244367?cond=Leukemia&viewType=Card&page=8&rank=75
Leukemia,NCT02631811,Early Palliative Care in Patient With Acute Leukaemia,Information provided by Hospices Civils de Lyon (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02631811?cond=Leukemia&viewType=Card&page=8&rank=76
Leukemia,NCT02001818,Pegylated Interferon Alfa,Information provided by Australasian Leukaemia and Lymphoma Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02001818?cond=Leukemia&viewType=Card&page=8&rank=77
Leukemia,NCT01475110,Observational Study in Adults With Imatinib,Information provided by Gruppo Italiano Malattie EMatologiche dell'Adulto (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01475110?cond=Leukemia&viewType=Card&page=8&rank=78
Leukemia,NCT01678430,A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment,Information provided by University of Liverpool,Recruiting,https://clinicaltrials.gov/study/NCT01678430?cond=Leukemia&viewType=Card&page=8&rank=79
Leukemia,NCT01251809,Trial of Oncaspar® and Three Doses of Pegylated Recombinant Asparaginase in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukaemia,Information provided by medac GmbH (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT01251809?cond=Leukemia&viewType=Card&page=8&rank=80
Leukemia,NCT00743028,Assess the Oral Bioavailability of New ABT,Information provided by Abbott,Completed,https://clinicaltrials.gov/study/NCT00743028?cond=Leukemia&viewType=Card&page=9&rank=81
Leukemia,NCT01440179,SAR3419 in Acute Lymphoblastic Leukemia,Information provided by Sanofi (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT01440179?cond=Leukemia&viewType=Card&page=9&rank=82
Leukemia,NCT00751296,"Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)","Information provided by University Health Network, Toronto (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00751296?cond=Leukemia&viewType=Card&page=9&rank=83&tab=results
Leukemia,NCT01272440,A Drug Monitoring Study on PEG,"Information provided by Louise Tram Henriksen, Aarhus University Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT01272440?cond=Leukemia&viewType=Card&page=9&rank=84
Leukemia,NCT05645172,Retention Rate of Acalabrutinib in a Non,Information provided by AstraZeneca (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05645172?cond=Leukemia&viewType=Card&page=9&rank=85
Leukemia,NCT01127542,RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL) Trial,Information provided by The Christie NHS Foundation Trust,Terminated,https://clinicaltrials.gov/study/NCT01127542?cond=Leukemia&viewType=Card&page=9&rank=86
Leukemia,NCT01279252,CLL Empirical Antibiotic Regimen,Information provided by King's College Hospital NHS Trust,Completed,https://clinicaltrials.gov/study/NCT01279252?cond=Leukemia&viewType=Card&page=9&rank=87
Leukemia,NCT02546375,A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands,Information provided by Pfizer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02546375?cond=Leukemia&viewType=Card&page=9&rank=88&tab=results
Leukemia,NCT00866671,Observational Study of Nelarabine in Children and Young Adults,Information provided by GlaxoSmithKline (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00866671?cond=Leukemia&viewType=Card&page=9&rank=89
Leukemia,NCT01414231,Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60a,Information provided by University of Leipzig,Recruiting,https://clinicaltrials.gov/study/NCT01414231?cond=Leukemia&viewType=Card&page=9&rank=90
Leukemia,NCT03205267,Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients,"Information provided by Prof. Dr. Dominik Wolf, University of Bonn (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03205267?cond=Leukemia&viewType=Card&page=10&rank=91
Leukemia,NCT02189824,Chemotherapy Followed by Infusion of Partially HLA Matched Unrelated Donor Cells for Patients With AML Who Are Ineligible for Stem Cell Transplantation,Information provided by University of Sydney (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT02189824?cond=Leukemia&viewType=Card&page=10&rank=92
Leukemia,NCT01832597,Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders,Information provided by Gruppo Italiano Studio Linfomi (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01832597?cond=Leukemia&viewType=Card&page=10&rank=93
Leukemia,NCT01497002,Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML>60a,Information provided by University of Leipzig (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01497002?cond=Leukemia&viewType=Card&page=10&rank=94
Leukemia,NCT02445742,CML Treated With Bosutinib After Relapse,Information provided by PETHEMA Foundation (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02445742?cond=Leukemia&viewType=Card&page=10&rank=95
Leukemia,NCT00292760,A Single-arm Phase II Study of Alemtuzumab in Combination With High,Information provided by Royal Marsden NHS Foundation Trust,Completed,https://clinicaltrials.gov/study/NCT00292760?cond=Leukemia&viewType=Card&page=10&rank=96
Leukemia,NCT02108951,Study to Assess Efficacy and Safety of Nilotinib 300mg Twice Daily in Patients With Philadelphia Positive Chronic Myeloid Leukaemia (CML) in Chronic Phase Who Are Intolerant to Prior Tyrosine Kinase Inhibitors.,Information provided by Novartis (Novartis Pharmaceuticals) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02108951?cond=Leukemia&viewType=Card&page=10&rank=97&tab=results
Leukemia,NCT04678869,CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia),"Information provided by University College, London (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04678869?cond=Leukemia&viewType=Card&page=10&rank=98
Leukemia,NCT02650414,CD22 Redirected Autologous T Cells for ALL,Information provided by University of Pennsylvania (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT02650414?cond=Leukemia&viewType=Card&page=10&rank=99
Leukemia,NCT06918054,Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia,Information provided by Ain Shams University (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06918054?cond=Leukemia&viewType=Card&page=10&rank=100
Leukemia,NCT01615809,Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia,Information provided by Fundació Sant Joan de Déu (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01615809?cond=Leukemia&viewType=Card&page=11&rank=101&tab=results
Leukemia,NCT03825146,The Effects of AMPC in the Treatments of Refractory or Relapsed AML,"Information provided by Supachai Ekwattanakit, Lai Corporation Pty. Ltd. (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03825146?cond=Leukemia&viewType=Card&page=11&rank=102
Leukemia,NCT01422603,Clofarabine Pre,Information provided by University Hospital Southampton NHS Foundation Trust (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01422603?cond=Leukemia&viewType=Card&page=11&rank=103
Leukemia,NCT07155226,"Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression",Information provided by AstraZeneca (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07155226?cond=Leukemia&viewType=Card&page=11&rank=104
Leukemia,NCT01941680,High Risk Adult T-cell Leukemia/Lymphoma (ATLL,Information provided by University Hospital Center of Martinique (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01941680?cond=Leukemia&viewType=Card&page=11&rank=105
Leukemia,NCT05942599,Base Edited CAR T Cells Against AML: Deep Conditioning Ahead of Allogeneic Stem Cell Transplantation,Information provided by Great Ormond Street Hospital for Children NHS Foundation Trust (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05942599?cond=Leukemia&viewType=Card&page=11&rank=106
Leukemia,NCT01756599,Multi-centre Prospective Cohort of Childhood Leukaemia: Determinants of Health and Quality of Life of the Patients After Treatment for an Acute Leukaemia During Childhood or Adolescence,Information provided by Assistance Publique Hopitaux De Marseille (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT01756599?cond=Leukemia&viewType=Card&page=11&rank=107
Leukemia,NCT03937544,Intravenous Autologous CD19 CAR-T Cells for R/R B,"Information provided by Prof. Dr S Fadilah Abdul Wahid, National University of Malaysia (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03937544?cond=Leukemia&viewType=Card&page=11&rank=108
Leukemia,NCT02123836,Natural Killer Cells in Acute Leukaemia and Myelodysplastic Syndrome,"Information provided by National University Hospital, Singapore (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02123836?cond=Leukemia&viewType=Card&page=11&rank=109
Leukemia,NCT06848270,Effectiveness of Early Intervention in Palliative Care for Acute Myeloid Leukemia Patients Comparing to Standard of Care,Information provided by Universidade do Porto (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06848270?cond=Leukemia&viewType=Card&page=11&rank=110
Leukemia,NCT01520922,Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL),Information provided by Novartis (Novartis Pharmaceuticals) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01520922?cond=Leukemia&viewType=Card&page=12&rank=111&tab=results
Leukemia,NCT06651970,Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure,Information provided by AstraZeneca (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06651970?cond=Leukemia&viewType=Card&page=12&rank=112
Leukemia,NCT03156790,"PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B",Information provided by medac GmbH (Responsible Party),Active,https://clinicaltrials.gov/study/NCT03156790?cond=Leukemia&viewType=Card&page=12&rank=113
Leukemia,NCT04811560,A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04811560?cond=Leukemia&viewType=Card&page=12&rank=114
Leukemia,NCT03895671,PONAZA : A COMBINATION OF PONATINIB AND 5,"Information provided by Philippe ROUSSELOT, Versailles Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03895671?cond=Leukemia&viewType=Card&page=12&rank=115
Leukemia,NCT02145039,Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases,"Information provided by Masonic Cancer Center, University of Minnesota (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02145039?cond=Leukemia&viewType=Card&page=12&rank=116&tab=results
Leukemia,NCT02310997,Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT),"Information provided by University College, London (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT02310997?cond=Leukemia&viewType=Card&page=12&rank=117
Leukemia,NCT06326021,Optimised CD33 (FL,"Information provided by Jing Pan, Beijing GoBroad Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06326021?cond=Leukemia&viewType=Card&page=12&rank=118
Leukemia,NCT02979366,Phase I Study of S64315 Administred Intravenously in Patients With Acute Myeloid Leukaemia or Myelodysplastic Syndrome,Information provided by Servier (Institut de Recherches Internationales Servier) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02979366?cond=Leukemia&viewType=Card&page=12&rank=119
Leukemia,NCT06429449,Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia,"Information provided by University of Colorado, Denver (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06429449?cond=Leukemia&viewType=Card&page=12&rank=120
Leukemia,NCT02920541,Dose,Information provided by Servier (Institut de Recherches Internationales Servier) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02920541?cond=Leukemia&viewType=Card&page=13&rank=121
Leukemia,NCT06790680,GITMO AML/MDS,Information provided by Gruppo Italiano Trapianto di Midollo Osseo (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06790680?cond=Leukemia&viewType=Card&page=13&rank=122
Leukemia,NCT06907797,Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing,"Information provided by Andrew Hantel, MD, Dana-Farber Cancer Institute (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06907797?cond=Leukemia&viewType=Card&page=13&rank=123
Leukemia,NCT01488565,"A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia","Information provided by Peter MacCallum Cancer Centre, Australia (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01488565?cond=Leukemia&viewType=Card&page=13&rank=124
Leukemia,NCT07060001,Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood,Information provided by The Methodist Hospital Research Institute (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07060001?cond=Leukemia&viewType=Card&page=13&rank=125
Leukemia,NCT02141828,A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ,"Information provided by Ipsen (Epizyme, Inc.) (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02141828?cond=Leukemia&viewType=Card&page=13&rank=126
Leukemia,NCT07203885,AI-Assisted Acute Myeloid Leukemia Evaluation With the Leukemia End-to-End Analysis Platform (LEAP) Versus Clinician,"Information provided by Kun-Hsing Yu, Harvard Medical School (HMS and HSDM) (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT07203885?cond=Leukemia&viewType=Card&page=13&rank=127
Leukemia,NCT00742144,Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia,Information provided by GlaxoSmithKline (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00742144?cond=Leukemia&viewType=Card&page=13&rank=128
Leukemia,NCT01955668,AZD6738 First Time in Patient Multiple Ascending Dose Study,Information provided by AstraZeneca (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01955668?cond=Leukemia&viewType=Card&page=13&rank=129
Leukemia,NCT02670525,Matched Targeted Therapy For High,"Information provided by Yana Pikman, MD, Dana-Farber Cancer Institute (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02670525?cond=Leukemia&viewType=Card&page=13&rank=130&tab=results
Leukemia,NCT05282459,Enasidenib in MDS &Non,Information provided by Stanford University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05282459?cond=Leukemia&viewType=Card&page=14&rank=131
Leukemia,NCT02272478,Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations,"Information provided by Prof Nigel Russell, Cardiff University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02272478?cond=Leukemia&viewType=Card&page=14&rank=132
Leukemia,NCT07117136,Blinatumomab Consolidation in Real World,"Information provided by Ehab L Atallah, Medical College of Wisconsin (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT07117136?cond=Leukemia&viewType=Card&page=14&rank=133
Leukemia,NCT02550535,A Phase I/II Study of Gene,Information provided by Cell Medica Ltd (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02550535?cond=Leukemia&viewType=Card&page=14&rank=134
Leukemia,NCT01549548,Compassionate Use Ponatinib,Information provided by OHSU Knight Cancer Institute (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT01549548?cond=Leukemia&viewType=Card&page=14&rank=135
Leukemia,NCT01396499,"Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias",Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01396499?cond=Leukemia&viewType=Card&page=14&rank=136
Leukemia,NCT04326764,Panobinostat Maintenance After HSCT fo High,"Information provided by Gesine Bug, Goethe University (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT04326764?cond=Leukemia&viewType=Card&page=14&rank=137
Leukemia,NCT05901974,Venetoclax Combined With Azactidine in the Treatment of ALAL,"Information provided by Sheng-Li Xue, MD, The First Affiliated Hospital of Soochow University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05901974?cond=Leukemia&viewType=Card&page=14&rank=138
Leukemia,NCT01659255,Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS,Information provided by Gilead Sciences (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01659255?cond=Leukemia&viewType=Card&page=14&rank=139&tab=results
Leukemia,NCT02273856,Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL),Information provided by Astellas Pharma Inc (Astellas Pharma International B.V.) (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT02273856?cond=Leukemia&viewType=Card&page=14&rank=140
Leukemia,NCT01919866,Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells,"Information provided by Peter Lang, University Children's Hospital Tuebingen (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT01919866?cond=Leukemia&viewType=Card&page=15&rank=141
Leukemia,NCT02074657,"""LANK","Information provided by Antonio Pérez Martínez, Hospital Universitario La Paz (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02074657?cond=Leukemia&viewType=Card&page=15&rank=142
Leukemia,NCT00339196,5,Information provided by Assistance Publique - Hôpitaux de Paris,Completed,https://clinicaltrials.gov/study/NCT00339196?cond=Leukemia&viewType=Card&page=15&rank=143
Leukemia,NCT06357585,Providing Web,Information provided by Saglik Bilimleri Universitesi (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06357585?cond=Leukemia&viewType=Card&page=15&rank=144
Leukemia,NCT00777036,A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib,Information provided by Bristol-Myers Squibb (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00777036?cond=Leukemia&viewType=Card&page=15&rank=145&tab=results
Leukemia,NCT05886491,A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia,Information provided by Takeda (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05886491?cond=Leukemia&viewType=Card&page=15&rank=146
Leukemia,NCT01446900,R,Information provided by European Institute of Oncology (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT01446900?cond=Leukemia&viewType=Card&page=15&rank=147
Leukemia,NCT01150656,Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01150656?cond=Leukemia&viewType=Card&page=15&rank=148
Leukemia,NCT01029509,Study to Assess OPB,Information provided by M.D. Anderson Cancer Center (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT01029509?cond=Leukemia&viewType=Card&page=15&rank=149
Leukemia,NCT00882076,"Clofarabine, Etoposide, and Mitoxantrone for Relapsed and Refractory Acute Leukemias","Information provided by David F. Claxton, MD, Milton S. Hershey Medical Center (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT00882076?cond=Leukemia&viewType=Card&page=15&rank=150
Leukemia,NCT05793801,Study of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute Leukemia,Information provided by Centre Hospitalier Universitaire de Nīmes (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05793801?cond=Leukemia&viewType=Card&page=16&rank=151
Leukemia,NCT03233763,Laboratory Studies Into the Pathology of Leukaemia,Information provided by Royal Marsden NHS Foundation Trust (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03233763?cond=Leukemia&viewType=Card&page=16&rank=152
Leukemia,NCT06795139,Pilot of a Trial Enrollment Diversity Dashboard,"Information provided by Andrew Hantel, MD, Dana-Farber Cancer Institute (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT06795139?cond=Leukemia&viewType=Card&page=16&rank=153
Leukemia,NCT05464836,Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05464836?cond=Leukemia&viewType=Card&page=16&rank=154&tab=results
Leukemia,NCT07120607,Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia,"Information provided by Xiaoyu Zhu, Anhui Provincial Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT07120607?cond=Leukemia&viewType=Card&page=16&rank=155
Leukemia,NCT03876834,Respiratory Training in Patients With Leukemia,"Information provided by Heba Ahmed Ali Abdeen, Cairo University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03876834?cond=Leukemia&viewType=Card&page=16&rank=156
Leukemia,NCT06762431,Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T,"Information provided by Mikalai Katsin, Vitebsk Regional Clinical Cancer Centre (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06762431?cond=Leukemia&viewType=Card&page=16&rank=157
Leukemia,NCT02310243,Study of Palbociclib in MLL,"Information provided by Peter Paschka, University of Ulm (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02310243?cond=Leukemia&viewType=Card&page=16&rank=158
Leukemia,NCT01395628,Cell Samples From Patients With Leukemia,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01395628?cond=Leukemia&viewType=Card&page=16&rank=159
Leukemia,NCT02643888,Pre-existing Kinase Domain Mutations in Ph,"Information provided by Prof DDr Thomas Lion, St. Anna Kinderkrebsforschung (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02643888?cond=Leukemia&viewType=Card&page=16&rank=160
Leukemia,NCT01597219,Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers,"Information provided by University College, London (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01597219?cond=Leukemia&viewType=Card&page=17&rank=161
Leukemia,NCT04856215,90Y-labelled Anti,Information provided by Great Ormond Street Hospital for Children NHS Foundation Trust (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04856215?cond=Leukemia&viewType=Card&page=17&rank=162
Leukemia,NCT01214603,A Study in Participants With Acute Leukemia,Information provided by Eli Lilly and Company (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01214603?cond=Leukemia&viewType=Card&page=17&rank=163&tab=results
Leukemia,NCT02089230,"MEK Inhibitor 162 Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Poor Prognosis, Not Suitable for or Unwilling to Receive Standard Therapy",Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02089230?cond=Leukemia&viewType=Card&page=17&rank=164&tab=results
Leukemia,NCT03593304,Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia Patients,"Information provided by Ferdaush Ahmed Sojib, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03593304?cond=Leukemia&viewType=Card&page=17&rank=165
Leukemia,NCT03826992,Venetoclax Combined With Vyxeos (CPX,"Information provided by Children's Hospital Medical Center, Cincinnati (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03826992?cond=Leukemia&viewType=Card&page=17&rank=166
Leukemia,NCT06095726,Peppermint Inhalation Versus Swedish Massage on Chemotherapy Induced,Information provided by Alexandria University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06095726?cond=Leukemia&viewType=Card&page=17&rank=167
Leukemia,NCT04272125,Safety and Efficacy of CD123-Targeted CAR,"Information provided by Chongqing Precision Biotech Co., Ltd (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04272125?cond=Leukemia&viewType=Card&page=17&rank=168
Leukemia,NCT06890494,Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B,"Information provided by Jing Pan, Beijing GoBroad Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06890494?cond=Leukemia&viewType=Card&page=17&rank=169
Leukemia,NCT06643962,Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy,Information provided by Affiliated Hospital of Nantong University (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06643962?cond=Leukemia&viewType=Card&page=17&rank=170
Leukemia,NCT04100187,Immunotherapy With CD19 CAR T-cells for B,Information provided by Kecellitics Biotech Company Ltd (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT04100187?cond=Leukemia&viewType=Card&page=18&rank=171
Leukemia,NCT06522373,Phase I Trial of MT,Information provided by M.D. Anderson Cancer Center (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT06522373?cond=Leukemia&viewType=Card&page=18&rank=172
Leukemia,NCT02860793,Role of PTK,Information provided by Institut Paoli-Calmettes (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02860793?cond=Leukemia&viewType=Card&page=18&rank=173
Leukemia,NCT01500499,Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01500499?cond=Leukemia&viewType=Card&page=18&rank=174
Leukemia,NCT00003437,Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia,Information provided by National Cancer Institute (NCI),Active,https://clinicaltrials.gov/study/NCT00003437?cond=Leukemia&viewType=Card&page=18&rank=175
Leukemia,NCT06360718,"Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.","Information provided by Erin Shields, Children's Hospital Los Angeles (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06360718?cond=Leukemia&viewType=Card&page=18&rank=176
Leukemia,NCT00460421,A Phase 1 Dose,Information provided by Swedish Orphan Biovitrum (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00460421?cond=Leukemia&viewType=Card&page=18&rank=177&tab=results
Leukemia,NCT00258271,"Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia",Information provided by University of Rochester (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00258271?cond=Leukemia&viewType=Card&page=18&rank=178
Leukemia,NCT07264010,"Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a Prospective, Single","Information provided by Nanfang Hospital, Southern Medical University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT07264010?cond=Leukemia&viewType=Card&page=18&rank=179
Leukemia,NCT06578247,Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3,Information provided by Daiichi Sankyo (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06578247?cond=Leukemia&viewType=Card&page=18&rank=180
Leukemia,NCT00083070,Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00083070?cond=Leukemia&viewType=Card&page=19&rank=181
Leukemia,NCT00898092,Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia,Information provided by Alliance for Clinical Trials in Oncology (Responsible Party),Active,https://clinicaltrials.gov/study/NCT00898092?cond=Leukemia&viewType=Card&page=19&rank=182
Leukemia,NCT01794702,"Decitabine Followed by Clofarabine, Idarubicin, and Cytarabine in Acute Leukemia",Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01794702?cond=Leukemia&viewType=Card&page=19&rank=183&tab=results
Leukemia,NCT05086315,"First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR",Information provided by Sanofi (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT05086315?cond=Leukemia&viewType=Card&page=19&rank=184
Leukemia,NCT00898456,Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia,Information provided by Alliance for Clinical Trials in Oncology (Responsible Party),Active,https://clinicaltrials.gov/study/NCT00898456?cond=Leukemia&viewType=Card&page=19&rank=185
Leukemia,NCT01656031,A Phase II Open-Label Study of High,Information provided by Wake Forest University Health Sciences (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01656031?cond=Leukemia&viewType=Card&page=19&rank=186&tab=results
Leukemia,NCT00004009,R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia,"Information provided by University of Maryland, Baltimore (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00004009?cond=Leukemia&viewType=Card&page=19&rank=187
Leukemia,NCT00509600,Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00509600?cond=Leukemia&viewType=Card&page=19&rank=188&tab=results
Leukemia,NCT01235117,Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia,Information provided by National Cancer Institute (NCI),Completed,https://clinicaltrials.gov/study/NCT01235117?cond=Leukemia&viewType=Card&page=19&rank=189
Leukemia,NCT01786343,Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML),Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01786343?cond=Leukemia&viewType=Card&page=19&rank=190&tab=results
Leukemia,NCT02652871,"LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia",Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02652871?cond=Leukemia&viewType=Card&page=20&rank=191
Leukemia,NCT01431664,AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia,Information provided by Cancer Research UK (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01431664?cond=Leukemia&viewType=Card&page=20&rank=192
Leukemia,NCT00503256,Genetic Study of Chronic Lymphocytic Leukemia Families,Information provided by M.D. Anderson Cancer Center (Responsible Party),Active,https://clinicaltrials.gov/study/NCT00503256?cond=Leukemia&viewType=Card&page=20&rank=193
Leukemia,NCT02141477,Omacetaxine and Decitabine in Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS),Information provided by M.D. Anderson Cancer Center (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT02141477?cond=Leukemia&viewType=Card&page=20&rank=194
Leukemia,NCT02225574,"An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY",Information provided by M.D. Anderson Cancer Center (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT02225574?cond=Leukemia&viewType=Card&page=20&rank=195
Leukemia,NCT00967057,Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia,Information provided by National Cancer Institute (NCI),Completed,https://clinicaltrials.gov/study/NCT00967057?cond=Leukemia&viewType=Card&page=20&rank=196
Leukemia,NCT01057199,Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01057199?cond=Leukemia&viewType=Card&page=20&rank=197
Leukemia,NCT02028039,IPI,Information provided by M.D. Anderson Cancer Center (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT02028039?cond=Leukemia&viewType=Card&page=20&rank=198
Leukemia,NCT00003230,Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia,Information provided by Swiss Cancer Institute (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00003230?cond=Leukemia&viewType=Card&page=20&rank=199
Leukemia,NCT00002534,Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission,Information provided by Memorial Sloan Kettering Cancer Center,Completed,https://clinicaltrials.gov/study/NCT00002534?cond=Leukemia&viewType=Card&page=20&rank=200
Leukemia,NCT00003305,Aminopterin in Treating Patients With Refractory Leukemia,Information provided by National Cancer Institute (NCI),Completed,https://clinicaltrials.gov/study/NCT00003305?cond=Leukemia&viewType=Card&page=21&rank=201
Leukemia,NCT00429910,Natural History Study of Patients With Chronic Myelogenous Leukemia,"Information provided by Jerome Ritz, MD, Dana-Farber Cancer Institute (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00429910?cond=Leukemia&viewType=Card&page=21&rank=202
Leukemia,NCT06824168,Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3,Information provided by Daiichi Sankyo (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06824168?cond=Leukemia&viewType=Card&page=21&rank=203
Leukemia,NCT00004905,Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia,Information provided by National Cancer Institute (NCI),Completed,https://clinicaltrials.gov/study/NCT00004905?cond=Leukemia&viewType=Card&page=21&rank=204
Leukemia,NCT01137747,Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic Leukemia,Information provided by Washington University School of Medicine (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01137747?cond=Leukemia&viewType=Card&page=21&rank=205
Leukemia,NCT01092741,Late Chronic Phase Chronic Myelogenous Leukemia,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01092741?cond=Leukemia&viewType=Card&page=21&rank=206
Leukemia,NCT01251965,Phase l/II Study of Ruxolitinib for Acute Leukemia,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01251965?cond=Leukemia&viewType=Card&page=21&rank=207&tab=results
Leukemia,NCT00003735,"Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia",Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00003735?cond=Leukemia&viewType=Card&page=21&rank=208
Leukemia,NCT00295841,Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia,Information provided by Wake Forest University Health Sciences (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00295841?cond=Leukemia&viewType=Card&page=21&rank=209
Leukemia,NCT01005368,Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia,Information provided by Alliance for Clinical Trials in Oncology (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01005368?cond=Leukemia&viewType=Card&page=21&rank=210
Leukemia,NCT02302846,Study of MLN9708 as Maintenance Therapy for Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS) in Remission,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02302846?cond=Leukemia&viewType=Card&page=22&rank=211&tab=results
Leukemia,NCT00006462,Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00006462?cond=Leukemia&viewType=Card&page=22&rank=212
Leukemia,NCT03564470,Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph,"Information provided by Hongsheng Zhou. M.D., Ph.D, Nanfang Hospital, Southern Medical University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03564470?cond=Leukemia&viewType=Card&page=22&rank=213
Leukemia,NCT00276601,Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia,Information provided by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Completed,https://clinicaltrials.gov/study/NCT00276601?cond=Leukemia&viewType=Card&page=22&rank=214
Leukemia,NCT00899652,DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00899652?cond=Leukemia&viewType=Card&page=22&rank=215
Leukemia,NCT00021242,Docetaxel in Treating Children With Relapsed or Refractory Acute Lymphoblastic or Acute Myeloid Leukemia,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00021242?cond=Leukemia&viewType=Card&page=22&rank=216
Leukemia,NCT00004862,Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia,Information provided by National Cancer Institute (NCI) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00004862?cond=Leukemia&viewType=Card&page=22&rank=217
Leukemia,NCT01229124,RNA Biomarkers in Tissue Samples From Infants With Acute Myeloid Leukemia,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01229124?cond=Leukemia&viewType=Card&page=22&rank=218
Leukemia,NCT00015860,STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia,Information provided by National Cancer Institute (NCI),Completed,https://clinicaltrials.gov/study/NCT00015860?cond=Leukemia&viewType=Card&page=22&rank=219
Leukemia,NCT03244306,A Phase 1 Study of CD22,"Information provided by Colleen Annesley, Seattle Children's Hospital (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT03244306?cond=Leukemia&viewType=Card&page=22&rank=220
Leukemia,NCT00502983,Molecular Epidemiology of Acute Myelogenous Leukemia,Information provided by M.D. Anderson Cancer Center (Responsible Party),Active,https://clinicaltrials.gov/study/NCT00502983?cond=Leukemia&viewType=Card&page=23&rank=221
Leukemia,NCT02481297,"Lirilumab With Rituximab for Relapsed, Refractory or High",Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02481297?cond=Leukemia&viewType=Card&page=23&rank=222&tab=results
Leukemia,NCT02194374,Autologous ROR1R-CAR,Information provided by M.D. Anderson Cancer Center (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT02194374?cond=Leukemia&viewType=Card&page=23&rank=223
Leukemia,NCT01059734,S9031-S9126-S9333-S9500,Information provided by SWOG Cancer Research Network (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01059734?cond=Leukemia&viewType=Card&page=23&rank=224
Leukemia,NCT00816283,Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia,Information provided by City of Hope Medical Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00816283?cond=Leukemia&viewType=Card&page=23&rank=225
Leukemia,NCT05480501,Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B,"Information provided by Beijing Immunochina Medical Science & Technology Co., Ltd. (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05480501?cond=Leukemia&viewType=Card&page=23&rank=226
Leukemia,NCT01385150,Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia,Information provided by Eastern Cooperative Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01385150?cond=Leukemia&viewType=Card&page=23&rank=227
Leukemia,NCT00940342,Rituximab Plus Sargramostim (GM,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00940342?cond=Leukemia&viewType=Card&page=23&rank=228&tab=results
Leukemia,NCT01156883,Combination Chemotherapy in Treating Young Adult Patients With Acute Lymphoblastic Leukemia,Information provided by Gruppo Italiano Malattie EMatologiche dell'Adulto (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01156883?cond=Leukemia&viewType=Card&page=23&rank=229
Leukemia,NCT00003931,Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia,Information provided by Alliance for Clinical Trials in Oncology (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00003931?cond=Leukemia&viewType=Card&page=23&rank=230
Leukemia,NCT00458523,Alemtuzumab in Treating Patients With B,Information provided by National Cancer Institute (NCI),Completed,https://clinicaltrials.gov/study/NCT00458523?cond=Leukemia&viewType=Card&page=24&rank=231
Leukemia,NCT05743465,"A Study to Evaluate Available Treatment Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and Nilotinib in Adults With Chronic Myeloid Leukemia",Information provided by Takeda (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05743465?cond=Leukemia&viewType=Card&page=24&rank=232
Leukemia,NCT00506597,Erwinase Study in Patients With Acute Lymphoblastic Leukemia,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00506597?cond=Leukemia&viewType=Card&page=24&rank=233&tab=results
Leukemia,NCT01284010,Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia,Information provided by Alliance for Clinical Trials in Oncology (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01284010?cond=Leukemia&viewType=Card&page=24&rank=234
Leukemia,NCT02799147,GVHD Prophylaxis With Post,"Information provided by Ivan S Moiseev, St. Petersburg State Pavlov Medical University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02799147?cond=Leukemia&viewType=Card&page=24&rank=235
Leukemia,NCT01407757,Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01407757?cond=Leukemia&viewType=Card&page=24&rank=236
Leukemia,NCT00723203,Panobinostat in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia,Information provided by City of Hope Medical Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00723203?cond=Leukemia&viewType=Card&page=24&rank=237&tab=results
Leukemia,NCT00053131,Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia,Information provided by Roswell Park Cancer Institute,Completed,https://clinicaltrials.gov/study/NCT00053131?cond=Leukemia&viewType=Card&page=24&rank=238
Leukemia,NCT04265963,CD123-Targeted CAR,"Information provided by Chongqing Precision Biotech Co., Ltd (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04265963?cond=Leukemia&viewType=Card&page=24&rank=239
Leukemia,NCT04136665,Physical Activity Adapted at Home Supervised by Videoconferencing in Post,"Information provided by University Hospital, Montpellier (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT04136665?cond=Leukemia&viewType=Card&page=24&rank=240
Leukemia,NCT00514189,Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines,Information provided by M.D. Anderson Cancer Center (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT00514189?cond=Leukemia&viewType=Card&page=25&rank=241
Leukemia,NCT00482833,Phase III Trial in Acute Promyelocytic Leukemia Patients,Information provided by Gruppo Italiano Malattie EMatologiche dell'Adulto (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00482833?cond=Leukemia&viewType=Card&page=25&rank=242
Leukemia,NCT00005795,Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia,Information provided by Northwestern University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00005795?cond=Leukemia&viewType=Card&page=25&rank=243
Leukemia,NCT00004932,STI571 in Treating Patients With Recurrent Leukemia,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00004932?cond=Leukemia&viewType=Card&page=25&rank=244
Leukemia,NCT00550992,Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia,Information provided by Dutch Childhood Oncology Group (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT00550992?cond=Leukemia&viewType=Card&page=25&rank=245
Leukemia,NCT01150058,Drug Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01150058?cond=Leukemia&viewType=Card&page=25&rank=246
Leukemia,NCT00372619,Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00372619?cond=Leukemia&viewType=Card&page=25&rank=247&tab=results
Leukemia,NCT05309213,Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B,"Information provided by Beijing Immunochina Medical Science & Technology Co., Ltd. (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05309213?cond=Leukemia&viewType=Card&page=25&rank=248
Leukemia,NCT00006097,Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia,Information provided by Boston Medical Center,Completed,https://clinicaltrials.gov/study/NCT00006097?cond=Leukemia&viewType=Card&page=25&rank=249
Leukemia,NCT01016379,Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01016379?cond=Leukemia&viewType=Card&page=25&rank=250
Leukemia,NCT02420938,"Urelumab (CD137 mAb) With Rituximab for Relapsed, Refractory or High",Information provided by M.D. Anderson Cancer Center (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT02420938?cond=Leukemia&viewType=Card&page=26&rank=251
Leukemia,NCT00896701,Relationship Between Natural Killer Cells' Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin,Information provided by Alliance for Clinical Trials in Oncology (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00896701?cond=Leukemia&viewType=Card&page=26&rank=252
Leukemia,NCT00963521,Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete Remission,Information provided by National Cancer Institute (NCI),Completed,https://clinicaltrials.gov/study/NCT00963521?cond=Leukemia&viewType=Card&page=26&rank=253
Leukemia,NCT01891981,Study of Moxetumomab Pasudotox in Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia (ALL),Information provided by M.D. Anderson Cancer Center (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT01891981?cond=Leukemia&viewType=Card&page=26&rank=254
Leukemia,NCT01295476,Biomarker Study in Bone Marrow Samples From Patients With T,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01295476?cond=Leukemia&viewType=Card&page=26&rank=255
Leukemia,NCT01581528,Studying Samples From Patients With T,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01581528?cond=Leukemia&viewType=Card&page=26&rank=256
Leukemia,NCT00277056,Dysregulated Tyrosine Kinase Signaling in Leukemia,Information provided by University of New Mexico (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT00277056?cond=Leukemia&viewType=Card&page=26&rank=257
Leukemia,NCT02933320,BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B,Information provided by Cancer Research UK (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02933320?cond=Leukemia&viewType=Card&page=26&rank=258&tab=results
Leukemia,NCT00053144,Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia,Information provided by Roswell Park Cancer Institute,Completed,https://clinicaltrials.gov/study/NCT00053144?cond=Leukemia&viewType=Card&page=26&rank=259
Leukemia,NCT00002609,Monoclonal Antibody Therapy and Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia in Remission,Information provided by Memorial Sloan Kettering Cancer Center,Completed,https://clinicaltrials.gov/study/NCT00002609?cond=Leukemia&viewType=Card&page=26&rank=260
Leukemia,NCT05536349,"Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment",Information provided by M.D. Anderson Cancer Center (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05536349?cond=Leukemia&viewType=Card&page=27&rank=261
Leukemia,NCT01653613,Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia,Information provided by National Cancer Institute (NCI) (Eastern Cooperative Oncology Group),Inconnu,https://clinicaltrials.gov/study/NCT01653613?cond=Leukemia&viewType=Card&page=27&rank=262
Leukemia,NCT01570868,Ponatinib,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01570868?cond=Leukemia&viewType=Card&page=27&rank=263&tab=results
Leukemia,NCT00005829,Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia,Information provided by Alliance for Clinical Trials in Oncology (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00005829?cond=Leukemia&viewType=Card&page=27&rank=264
Leukemia,NCT00551460,"S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia",Information provided by SWOG Cancer Research Network (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00551460?cond=Leukemia&viewType=Card&page=27&rank=265&tab=results
Leukemia,NCT00003746,Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia,Information provided by Swiss Cancer Institute (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00003746?cond=Leukemia&viewType=Card&page=27&rank=266
Leukemia,NCT01893320,Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01893320?cond=Leukemia&viewType=Card&page=27&rank=267&tab=results
Leukemia,NCT02441803,Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML),Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02441803?cond=Leukemia&viewType=Card&page=27&rank=268&tab=results
Leukemia,NCT00528450,Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia,Information provided by Memorial Sloan Kettering Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00528450?cond=Leukemia&viewType=Card&page=27&rank=269&tab=results
Leukemia,NCT01046305,Symptom Burden in Chronic Myeloid Leukemia (CML),Information provided by M.D. Anderson Cancer Center (Responsible Party),Active,https://clinicaltrials.gov/study/NCT01046305?cond=Leukemia&viewType=Card&page=27&rank=270
Leukemia,NCT00643240,Yttrium Y 90 Anti-CD19 Antibody BU,"Information provided by Masonic Cancer Center, University of Minnesota (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT00643240?cond=Leukemia&viewType=Card&page=28&rank=271
Leukemia,NCT02096042,Phase I/II - Brentuximab/5,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02096042?cond=Leukemia&viewType=Card&page=28&rank=272&tab=results
Leukemia,NCT00343369,Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia,Information provided by National Cancer Institute (NCI),Recruiting,https://clinicaltrials.gov/study/NCT00343369?cond=Leukemia&viewType=Card&page=28&rank=273
Leukemia,NCT00002844,Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00002844?cond=Leukemia&viewType=Card&page=28&rank=274
Leukemia,NCT02272777,A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase,Information provided by Novartis (Novartis Pharmaceuticals) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02272777?cond=Leukemia&viewType=Card&page=28&rank=275&tab=results
Leukemia,NCT02981784,Comparative Evaluation of Results of Allogeneic Hematopoietic Stem Cells Versus Ponatinib in CML Patients Carrying a Mutation T315I,Information provided by Hospices Civils de Lyon (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02981784?cond=Leukemia&viewType=Card&page=28&rank=276
Leukemia,NCT00006223,flt3L in Treating Patients With Acute Myeloid Leukemia,Information provided by National Cancer Institute (NCI),Completed,https://clinicaltrials.gov/study/NCT00006223?cond=Leukemia&viewType=Card&page=28&rank=277
Leukemia,NCT00008697,Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia,Information provided by Washington University School of Medicine (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00008697?cond=Leukemia&viewType=Card&page=28&rank=278
Leukemia,NCT00016159,Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia,Information provided by Memorial Sloan Kettering Cancer Center,Completed,https://clinicaltrials.gov/study/NCT00016159?cond=Leukemia&viewType=Card&page=28&rank=279
Leukemia,NCT00609739,Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation,"Information provided by Masonic Cancer Center, University of Minnesota (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00609739?cond=Leukemia&viewType=Card&page=28&rank=280&tab=results
Leukemia,NCT00002705,Topotecan in Treating Children With Refractory Leukemia,Information provided by National Cancer Institute (NCI) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00002705?cond=Leukemia&viewType=Card&page=29&rank=281
Leukemia,NCT00899899,Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00899899?cond=Leukemia&viewType=Card&page=29&rank=282
Leukemia,NCT00003255,Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia,Information provided by Alliance for Clinical Trials in Oncology (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00003255?cond=Leukemia&viewType=Card&page=29&rank=283
Leukemia,NCT00462787,Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia,Information provided by Memorial Sloan Kettering Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00462787?cond=Leukemia&viewType=Card&page=29&rank=284
Leukemia,NCT01319981,Hyper,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01319981?cond=Leukemia&viewType=Card&page=29&rank=285&tab=results
Leukemia,NCT00004052,Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia,Information provided by Memorial Sloan Kettering Cancer Center,Completed,https://clinicaltrials.gov/study/NCT00004052?cond=Leukemia&viewType=Card&page=29&rank=286
Leukemia,NCT01247584,Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia,Information provided by Children's Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01247584?cond=Leukemia&viewType=Card&page=29&rank=287
Leukemia,NCT00900380,Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia,Information provided by Eastern Cooperative Oncology Group (ECOG-ACRIN Cancer Research Group) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00900380?cond=Leukemia&viewType=Card&page=29&rank=288
Leukemia,NCT00003910,Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia,Information provided by Eastern Cooperative Oncology Group (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00003910?cond=Leukemia&viewType=Card&page=29&rank=289&tab=results
Leukemia,NCT04597086,"Bright White Light Therapy for the Improvement of Sleep, Fatigue, Distress, Depression, and Anxiety in Hospitalized Leukemia Patients","Information provided by Shelly Brown, Ohio State University Comprehensive Cancer Center (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04597086?cond=Leukemia&viewType=Card&page=29&rank=290
Leukemia,NCT00505700,VELCADE in Combination With Idarubicin and Cytosine Arabinoside in Patients With Acute Myelogenous Leukemia,Information provided by Massachusetts General Hospital,Completed,https://clinicaltrials.gov/study/NCT00505700?cond=Leukemia&viewType=Card&page=30&rank=291
Leukemia,NCT00049075,Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia,Information provided by Canadian Cancer Trials Group (NCIC Clinical Trials Group) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00049075?cond=Leukemia&viewType=Card&page=30&rank=292
Leukemia,NCT02484261,Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children,"Information provided by Reuven Schore, Children's National Research Institute (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT02484261?cond=Leukemia&viewType=Card&page=30&rank=293
Leukemia,NCT01752426,Pilot Study to Determine Effects of the Btk Inhibitor PCI,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01752426?cond=Leukemia&viewType=Card&page=30&rank=294&tab=results
Leukemia,NCT00265915,Rituximab and GM,Information provided by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Terminated,https://clinicaltrials.gov/study/NCT00265915?cond=Leukemia&viewType=Card&page=30&rank=295
Leukemia,NCT00021983,Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia,Information provided by National Cancer Institute (NCI),Completed,https://clinicaltrials.gov/study/NCT00021983?cond=Leukemia&viewType=Card&page=30&rank=296
Leukemia,NCT00003808,"Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia",Information provided by Eastern Cooperative Oncology Group,Completed,https://clinicaltrials.gov/study/NCT00003808?cond=Leukemia&viewType=Card&page=30&rank=297
Leukemia,NCT02196857,Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3,Information provided by M.D. Anderson Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02196857?cond=Leukemia&viewType=Card&page=30&rank=298&tab=results
Leukemia,NCT00004218,Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia,Information provided by National Cancer Institute (NCI),Completed,https://clinicaltrials.gov/study/NCT00004218?cond=Leukemia&viewType=Card&page=30&rank=299
Leukemia,NCT00038805,"Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)",Information provided by M.D. Anderson Cancer Center (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT00038805?cond=Leukemia&viewType=Card&page=30&rank=300
Prostate Cancer,NCT05428319,Expression of STEAP,"Information provided by Aliaa Bakr Ahmed, Sohag University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT05428319?cond=Prostate%20Cancer&viewType=Card&page=1&rank=1
Prostate Cancer,NCT03088202,PALLiON,"Information provided by Marianne Jensen Hjermstad, Oslo University Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03088202?cond=Prostate%20Cancer&viewType=Card&page=1&rank=2
Prostate Cancer,NCT01743638,MR,"Information provided by David A. Woodrum, Mayo Clinic (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT01743638?cond=Prostate%20Cancer&viewType=Card&page=1&rank=3
Prostate Cancer,NCT01727284,MR,"Information provided by David A. Woodrum, Mayo Clinic (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT01727284?cond=Prostate%20Cancer&viewType=Card&page=1&rank=4
Prostate Cancer,NCT02177526,Imaging of High Grade Prostate Cancer,Information provided by Ottawa Hospital Research Institute (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT02177526?cond=Prostate%20Cancer&viewType=Card&page=1&rank=5
Prostate Cancer,NCT05830838,Daily Adaptive Post,"Information provided by Bradley (Brad) Stish, Mayo Clinic (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT05830838?cond=Prostate%20Cancer&viewType=Card&page=1&rank=6
Prostate Cancer,NCT06093971,Remimazolam Versus Propofol for General Anesthesia Induction in Patients on Renin-angiotensin System Blockers Undergoing Robot,Information provided by Yonsei University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06093971?cond=Prostate%20Cancer&viewType=Card&page=1&rank=7
Prostate Cancer,NCT01890096,A Phase II Trial of High Dose,"Information provided by Dr. Gerard Morton, Sunnybrook Health Sciences Centre (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT01890096?cond=Prostate%20Cancer&viewType=Card&page=1&rank=8
Prostate Cancer,NCT05265988,Multiparametric Assessment of Bone Response in mCRPC Patients Treated With Cabozantinib,"Information provided by Alfredo Berruti, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05265988?cond=Prostate%20Cancer&viewType=Card&page=1&rank=9
Prostate Cancer,NCT03535831,PSMA PET Registry (18F,"Information provided by University Health Network, Toronto (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT03535831?cond=Prostate%20Cancer&viewType=Card&page=1&rank=10
Prostate Cancer,NCT03323879,Combined LDR Boost and HDR Whole Gland,Information provided by Sunnybrook Health Sciences Centre (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT03323879?cond=Prostate%20Cancer&viewType=Card&page=2&rank=11
Prostate Cancer,NCT03103724,A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease.,"Information provided by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03103724?cond=Prostate%20Cancer&viewType=Card&page=2&rank=12
Prostate Cancer,NCT01939743,Efficacy of Diclofenac Suppository for Pain Control in Ultrasound Guided Biopsy of Prostate,"Information provided by Naveed Haroon, Aga Khan University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01939743?cond=Prostate%20Cancer&viewType=Card&page=2&rank=13
Prostate Cancer,NCT06641219,Clinical Evaluation of [177Lu]Lu-BQ7876 for Targeting of Prostate,Information provided by Tomsk National Research Medical Center of the Russian Academy of Sciences (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06641219?cond=Prostate%20Cancer&viewType=Card&page=2&rank=14
Prostate Cancer,NCT06929884,"Effectiveness, Safety, and Economic Evaluation of Goserelin Microspheres for Injection and Goserelin Sustained-Release Implants in Prostate Cancer Patients: A Real","Information provided by Rui Yang, Qianfoshan Hospital (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT06929884?cond=Prostate%20Cancer&viewType=Card&page=2&rank=15
Prostate Cancer,NCT06607783,PRostate Cancer Enhanced Diagnosis by Calibration Technology,Information provided by Gold Standard Phantoms (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06607783?cond=Prostate%20Cancer&viewType=Card&page=2&rank=16
Prostate Cancer,NCT02810886,Prospective Evaluation of 68Ga-PSMA PET,Information provided by Jules Bordet Institute (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT02810886?cond=Prostate%20Cancer&viewType=Card&page=2&rank=17
Prostate Cancer,NCT05204927,177Lu-PSMA-I&T for Metastatic Castration,Information provided by Curium US LLC (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05204927?cond=Prostate%20Cancer&viewType=Card&page=2&rank=18
Prostate Cancer,NCT00917865,FACBC Positron Emission Tomography/Computed Tomography(PET/CT) Used in the Diagnosis of Primary Prostate Cancer,"Information provided by David M. Schuster, MD, Emory University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00917865?cond=Prostate%20Cancer&viewType=Card&page=2&rank=19&tab=results
Prostate Cancer,NCT06437496,68Ga-AAZTA-093 PET/CT: First-in,Information provided by First Affiliated Hospital of Fujian Medical University (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06437496?cond=Prostate%20Cancer&viewType=Card&page=2&rank=20
Prostate Cancer,NCT02235142,Prostatic Cancer Versus Androgen Deficiency,Information provided by Hopital Foch (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02235142?cond=Prostate%20Cancer&viewType=Card&page=3&rank=21
Prostate Cancer,NCT04765423,Fluciclovine (Axumin) PET/CT vs. NaF PET/CT in Prostate Cancer Osseous Metastatic Disease,Information provided by Case Comprehensive Cancer Center (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT04765423?cond=Prostate%20Cancer&viewType=Card&page=3&rank=22
Prostate Cancer,NCT04696263,Single-Port Versus Multi,Information provided by Case Comprehensive Cancer Center (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT04696263?cond=Prostate%20Cancer&viewType=Card&page=3&rank=23
Prostate Cancer,NCT04556045,Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer,Information provided by Case Comprehensive Cancer Center (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04556045?cond=Prostate%20Cancer&viewType=Card&page=3&rank=24
Prostate Cancer,NCT03987568,Characterize Tumor Hypoxia by Magnetic Resonance Imaging,Information provided by Wake Forest University Health Sciences (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT03987568?cond=Prostate%20Cancer&viewType=Card&page=3&rank=25
Prostate Cancer,NCT06318559,Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical,Information provided by Fondazione del Piemonte per l'Oncologia (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06318559?cond=Prostate%20Cancer&viewType=Card&page=3&rank=26
Prostate Cancer,NCT05361798,T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate,Information provided by National Institutes of Health Clinical Center (CC) (National Cancer Institute (NCI)) (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05361798?cond=Prostate%20Cancer&viewType=Card&page=3&rank=27
Prostate Cancer,NCT06150417,MDRT in Prostate Cancer Treated With Long,Information provided by Case Comprehensive Cancer Center (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06150417?cond=Prostate%20Cancer&viewType=Card&page=3&rank=28
Prostate Cancer,NCT06406803,The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer Patients,Information provided by Maastricht University Medical Center (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06406803?cond=Prostate%20Cancer&viewType=Card&page=3&rank=29
Prostate Cancer,NCT04703543,Evaluating the Role of Both PSMA and 64Cu,"Information provided by Giuseppe Sanguineti, Regina Elena Cancer Institute (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04703543?cond=Prostate%20Cancer&viewType=Card&page=3&rank=30
Prostate Cancer,NCT06554587,Investigation of Three Biomarkers for the Detection of Prostate Cancer,Information provided by Medtechtomarket Consulting Ltd (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06554587?cond=Prostate%20Cancer&viewType=Card&page=4&rank=31
Prostate Cancer,NCT05653856,Cu-64-PSMA,Information provided by Curium US LLC (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05653856?cond=Prostate%20Cancer&viewType=Card&page=4&rank=32&tab=results
Prostate Cancer,NCT03442075,Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy,"Information provided by EDGAR BELTRAN-SUAREZ, Instituto Mexicano del Seguro Social (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03442075?cond=Prostate%20Cancer&viewType=Card&page=4&rank=33
Prostate Cancer,NCT05577689,Novel Therapy Target in Metastatic Prostate Cancer,"Information provided by Ding-Wei Ye, Fudan University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05577689?cond=Prostate%20Cancer&viewType=Card&page=4&rank=34
Prostate Cancer,NCT03579680,De,"Information provided by Ted Skolarus, University of Michigan (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03579680?cond=Prostate%20Cancer&viewType=Card&page=4&rank=35&tab=results
Prostate Cancer,NCT06315595,Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non,Information provided by Mayo Clinic (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06315595?cond=Prostate%20Cancer&viewType=Card&page=4&rank=36
Prostate Cancer,NCT03899077,Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP,Information provided by Cancer Research Antwerp (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03899077?cond=Prostate%20Cancer&viewType=Card&page=4&rank=37
Prostate Cancer,NCT03632980,Dynamic Focusing Evaluation for Prostate Cancer Treatment,Information provided by EDAP TMS S.A. (Responsible Party),Active,https://clinicaltrials.gov/study/NCT03632980?cond=Prostate%20Cancer&viewType=Card&page=4&rank=38
Prostate Cancer,NCT03450109,A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer,Information provided by Luye Pharma Group Ltd. (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03450109?cond=Prostate%20Cancer&viewType=Card&page=4&rank=39
Prostate Cancer,NCT01695135,A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01695135?cond=Prostate%20Cancer&viewType=Card&page=4&rank=40&tab=results
Prostate Cancer,NCT01715285,"A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone","Information provided by Janssen Research & Development, LLC (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01715285?cond=Prostate%20Cancer&viewType=Card&page=5&rank=41&tab=results
Prostate Cancer,NCT01834209,A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT01834209?cond=Prostate%20Cancer&viewType=Card&page=5&rank=42
Prostate Cancer,NCT01692483,Post,Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer,Withdrawn,https://clinicaltrials.gov/study/NCT01692483?cond=Prostate%20Cancer&viewType=Card&page=5&rank=43
Prostate Cancer,NCT03031418,Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI),"Information provided by Exosome Diagnostics, Inc. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03031418?cond=Prostate%20Cancer&viewType=Card&page=5&rank=44
Prostate Cancer,NCT01664728,An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01664728?cond=Prostate%20Cancer&viewType=Card&page=5&rank=45
Prostate Cancer,NCT02614859,Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients,Information provided by Fox Chase Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02614859?cond=Prostate%20Cancer&viewType=Card&page=5&rank=46&tab=results
Prostate Cancer,NCT00910754,A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00910754?cond=Prostate%20Cancer&viewType=Card&page=5&rank=47
Prostate Cancer,NCT00600535,A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer,"Information provided by Cougar Biotechnology, Inc. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00600535?cond=Prostate%20Cancer&viewType=Card&page=5&rank=48
Prostate Cancer,NCT01017939,A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01017939?cond=Prostate%20Cancer&viewType=Card&page=5&rank=49
Prostate Cancer,NCT04797039,MRI,"Information provided by David A. Woodrum, Mayo Clinic (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04797039?cond=Prostate%20Cancer&viewType=Card&page=5&rank=50
Prostate Cancer,NCT00474383,An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel,"Information provided by Cougar Biotechnology, Inc. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00474383?cond=Prostate%20Cancer&viewType=Card&page=6&rank=51&tab=results
Prostate Cancer,NCT03438552,Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence,Information provided by UNICANCER (Responsible Party),Active,https://clinicaltrials.gov/study/NCT03438552?cond=Prostate%20Cancer&viewType=Card&page=6&rank=52
Prostate Cancer,NCT00473746,Abiraterone Acetate Dose,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00473746?cond=Prostate%20Cancer&viewType=Card&page=6&rank=53&tab=results
Prostate Cancer,NCT06836271,Cleaning the Biopsy Needle in TRUS Bx,"Information provided by Mustafa Serdar CAGLAYAN, Hitit University (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06836271?cond=Prostate%20Cancer&viewType=Card&page=6&rank=54
Prostate Cancer,NCT00544440,An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00544440?cond=Prostate%20Cancer&viewType=Card&page=6&rank=55&tab=results
Prostate Cancer,NCT04376008,A Prospective Study Of Free,"Information provided by Hongqian Guo, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04376008?cond=Prostate%20Cancer&viewType=Card&page=6&rank=56
Prostate Cancer,NCT04124107,Unfavorable MRI But Favorable 68Ga,"Information provided by Hongqian Guo, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT04124107?cond=Prostate%20Cancer&viewType=Card&page=6&rank=57
Prostate Cancer,NCT01639859,Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci,Information provided by Hospices Civils de Lyon (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01639859?cond=Prostate%20Cancer&viewType=Card&page=6&rank=58
Prostate Cancer,NCT01581749,Evaluation of Truebeam for Low,"Information provided by Albert DeNittis, Main Line Health (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT01581749?cond=Prostate%20Cancer&viewType=Card&page=6&rank=59
Prostate Cancer,NCT03828838,,Information provided by Radboud University Medical Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03828838?cond=Prostate%20Cancer&viewType=Card&page=6&rank=60
Prostate Cancer,NCT03702439,Prostate Cancer Screening Trial Using Imaging,Information provided by Imperial College London (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03702439?cond=Prostate%20Cancer&viewType=Card&page=7&rank=61&tab=results
Prostate Cancer,NCT03572946,Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection,"Information provided by Hongqian Guo, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03572946?cond=Prostate%20Cancer&viewType=Card&page=7&rank=62
Prostate Cancer,NCT01228760,A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration,Information provided by Astellas Pharma Inc (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01228760?cond=Prostate%20Cancer&viewType=Card&page=7&rank=63
Prostate Cancer,NCT03241537,COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer,Information provided by Samsung Medical Center (Responsible Party),Active,https://clinicaltrials.gov/study/NCT03241537?cond=Prostate%20Cancer&viewType=Card&page=7&rank=64
Prostate Cancer,NCT00805883,MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer Followed by Radical Prostatectomy,"Information provided by University Health Network, Toronto",Completed,https://clinicaltrials.gov/study/NCT00805883?cond=Prostate%20Cancer&viewType=Card&page=7&rank=65
Prostate Cancer,NCT02787434,Addressing Prostate Cancer Information Disparities With eHealth Technology,"Information provided by Jennifer Allen, Tufts University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02787434?cond=Prostate%20Cancer&viewType=Card&page=7&rank=66
Prostate Cancer,NCT00001266,A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma,Information provided by National Institutes of Health Clinical Center (CC),Completed,https://clinicaltrials.gov/study/NCT00001266?cond=Prostate%20Cancer&viewType=Card&page=7&rank=67
Prostate Cancer,NCT03490838,177Lu-PSMA,Information provided by Advanced Accelerator Applications (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT03490838?cond=Prostate%20Cancer&viewType=Card&page=7&rank=68
Prostate Cancer,NCT02809690,18F,Information provided by University of Southern California (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT02809690?cond=Prostate%20Cancer&viewType=Card&page=7&rank=69
Prostate Cancer,NCT00425503,PS,"Information provided by Teresa Hayes, Baylor College of Medicine (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00425503?cond=Prostate%20Cancer&viewType=Card&page=7&rank=70&tab=results
Prostate Cancer,NCT00220194,"A Six-Month, Open",Information provided by San Bernardino Urological Associates Medical Group Inc,Completed,https://clinicaltrials.gov/study/NCT00220194?cond=Prostate%20Cancer&viewType=Card&page=8&rank=71
Prostate Cancer,NCT06236789,Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration,Information provided by Yonsei University (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06236789?cond=Prostate%20Cancer&viewType=Card&page=8&rank=72
Prostate Cancer,NCT06439784,Contribution of the VERITON,Information provided by Centre Henri Becquerel (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06439784?cond=Prostate%20Cancer&viewType=Card&page=8&rank=73
Prostate Cancer,NCT04017325,European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow,Information provided by Steba Biotech S.A. (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04017325?cond=Prostate%20Cancer&viewType=Card&page=8&rank=74
Prostate Cancer,NCT02380027,PRostate Evaluation for Clinically Important Disease: Sampling Using Image,"Information provided by Veeru Kasivisvanathan, University College, London (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02380027?cond=Prostate%20Cancer&viewType=Card&page=8&rank=75
Prostate Cancer,NCT04057859,PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training,Information provided by CMX Research (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04057859?cond=Prostate%20Cancer&viewType=Card&page=8&rank=76
Prostate Cancer,NCT00255125,Role of Soy Supplementation in Prostate Cancer Development,Information provided by VA Office of Research and Development (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00255125?cond=Prostate%20Cancer&viewType=Card&page=8&rank=77&tab=results
Prostate Cancer,NCT06059859,Impact of Augmented Reality During Robot,Information provided by European Institute of Oncology (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06059859?cond=Prostate%20Cancer&viewType=Card&page=8&rank=78
Prostate Cancer,NCT05969704,Fusion Versus Cognitive MRI Targeted Prostatic Biopsy,"Information provided by Ahmed Mohamed Shebl Mehanna, Menoufia University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05969704?cond=Prostate%20Cancer&viewType=Card&page=8&rank=79
Prostate Cancer,NCT05849298,A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC,Information provided by Novartis (Novartis Pharmaceuticals) (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05849298?cond=Prostate%20Cancer&viewType=Card&page=8&rank=80
Prostate Cancer,NCT03564275,Proton Boost in Prostate Cancer,"Information provided by William Barrett, University of Cincinnati (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT03564275?cond=Prostate%20Cancer&viewType=Card&page=9&rank=81
Prostate Cancer,NCT05612841,A Study on Drug,Information provided by Centre Hospitalier Universitaire de Besancon (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05612841?cond=Prostate%20Cancer&viewType=Card&page=9&rank=82
Prostate Cancer,NCT05667636,Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP,"Information provided by Giuseppe Sanguineti, Regina Elena Cancer Institute (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05667636?cond=Prostate%20Cancer&viewType=Card&page=9&rank=83
Prostate Cancer,NCT05754580,High,Information provided by University of Nebraska (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05754580?cond=Prostate%20Cancer&viewType=Card&page=9&rank=84
Prostate Cancer,NCT03348722,"Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer START","Information provided by Rete Oncologica Piemonte, Valle d'Aosta (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03348722?cond=Prostate%20Cancer&viewType=Card&page=9&rank=85
Prostate Cancer,NCT00417274,Quinacrine Treatment in Patients With Androgen,Information provided by Cleveland BioLabs (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00417274?cond=Prostate%20Cancer&viewType=Card&page=9&rank=86&tab=results
Prostate Cancer,NCT05566405,The Effects of Method of Anaesthesia on the Safety and Effectiveness of Radical Retropubic Prostatectomy,"Information provided by Konstantinos Pikramenos, Sismanoglio General Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05566405?cond=Prostate%20Cancer&viewType=Card&page=9&rank=87
Prostate Cancer,NCT03238170,MR,Information provided by Guy's and St Thomas' NHS Foundation Trust (Responsible Party),Active,https://clinicaltrials.gov/study/NCT03238170?cond=Prostate%20Cancer&viewType=Card&page=9&rank=88
Prostate Cancer,NCT01630967,Efficacy Study of Switching to a Lutenizing Hormone,"Information provided by Kim Chi, British Columbia Cancer Agency (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT01630967?cond=Prostate%20Cancer&viewType=Card&page=9&rank=89
Prostate Cancer,NCT03124433,Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancer,Information provided by Singapore General Hospital (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03124433?cond=Prostate%20Cancer&viewType=Card&page=9&rank=90
Prostate Cancer,NCT03235687,Decision Impact Trial of the ExoDx Prostate (IntelliScore),"Information provided by Exosome Diagnostics, Inc. (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT03235687?cond=Prostate%20Cancer&viewType=Card&page=10&rank=91
Prostate Cancer,NCT05162573,EBRT + Lu,Information provided by The Netherlands Cancer Institute (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05162573?cond=Prostate%20Cancer&viewType=Card&page=10&rank=92
Prostate Cancer,NCT05623878,68Ga,"Information provided by Chunjing Yu, Affiliated Hospital of Jiangnan University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05623878?cond=Prostate%20Cancer&viewType=Card&page=10&rank=93
Prostate Cancer,NCT02958787,Vessel Sparing Prostate Radiation Therapy,Information provided by University of Michigan Rogel Cancer Center (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02958787?cond=Prostate%20Cancer&viewType=Card&page=10&rank=94&tab=results
Prostate Cancer,NCT01240551,F,"Information provided by Karen Kurdziel, M.D., National Institutes of Health Clinical Center (CC) (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01240551?cond=Prostate%20Cancer&viewType=Card&page=10&rank=95&tab=results
Prostate Cancer,NCT02939456,Comparison Of DIR-MRI And DCE,Information provided by University Hospitals of North Midlands NHS Trust (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02939456?cond=Prostate%20Cancer&viewType=Card&page=10&rank=96
Prostate Cancer,NCT02879851,Evaluation of the Accuracy of the Elastic Fusion MRI,Information provided by Hospices Civils de Lyon (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT02879851?cond=Prostate%20Cancer&viewType=Card&page=10&rank=97
Prostate Cancer,NCT04774133,The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients.,"Information provided by Giuseppe Sanguineti, Regina Elena Cancer Institute (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04774133?cond=Prostate%20Cancer&viewType=Card&page=10&rank=98
Prostate Cancer,NCT02578940,Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer,Information provided by Blue Earth Diagnostics (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02578940?cond=Prostate%20Cancer&viewType=Card&page=10&rank=99&tab=results
Prostate Cancer,NCT04523896,HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High,"Information provided by David Büchser, Biocruces Bizkaia Health Research Institute (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04523896?cond=Prostate%20Cancer&viewType=Card&page=10&rank=100
Prostate Cancer,NCT02274350,The Herlev Hospital Post Radiation Therapy for Localized Prostate Cancer Database for Sexual Side Effects,"Information provided by Anders Frey, Herlev Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02274350?cond=Prostate%20Cancer&viewType=Card&page=11&rank=101
Prostate Cancer,NCT04398173,Detection Rate of Prostate Cancer in Men Undergoing MRI,Information provided by Fondazione del Piemonte per l'Oncologia (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04398173?cond=Prostate%20Cancer&viewType=Card&page=11&rank=102
Prostate Cancer,NCT02349386,Maintaining Suppression of Testosterone With Transdermal Estradiol Gel,"Information provided by BHR Pharma, LLC (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02349386?cond=Prostate%20Cancer&viewType=Card&page=11&rank=103&tab=results
Prostate Cancer,NCT02355054,Detecting Recurrent Prostate Cancer With C,"Information provided by Farrokh Dehdashti, Washington University School of Medicine (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT02355054?cond=Prostate%20Cancer&viewType=Card&page=11&rank=104
Prostate Cancer,NCT04266431,EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression,Information provided by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04266431?cond=Prostate%20Cancer&viewType=Card&page=11&rank=105
Prostate Cancer,NCT02212548,Prostate,"Information provided by Professor Thomas Eade, Royal North Shore Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02212548?cond=Prostate%20Cancer&viewType=Card&page=11&rank=106
Prostate Cancer,NCT04421781,Salvage HIFU for Local Recurrence in the Prostatic Bed After Prostatectomy and External Beam Radiation Therapy : Preliminary Results,Information provided by Hospices Civils de Lyon (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04421781?cond=Prostate%20Cancer&viewType=Card&page=11&rank=107
Prostate Cancer,NCT01897207,Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone,"Information provided by Prof. Dr. Silke Gillessen, Cantonal Hospital of St. Gallen (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01897207?cond=Prostate%20Cancer&viewType=Card&page=11&rank=108
Prostate Cancer,NCT03947515,Urinary and Prostate Microbiotes and Prostate Cancer,Information provided by Centre Hospitalier Universitaire de Nice (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03947515?cond=Prostate%20Cancer&viewType=Card&page=11&rank=109
Prostate Cancer,NCT04495959,Dynamic Whole Body PET/ MRI,Information provided by British Columbia Cancer Agency (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT04495959?cond=Prostate%20Cancer&viewType=Card&page=11&rank=110
Prostate Cancer,NCT03952793,Organoids From Metastases of Prostate Cancer,Information provided by Centre Antoine Lacassagne (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT03952793?cond=Prostate%20Cancer&viewType=Card&page=12&rank=111
Prostate Cancer,NCT04234399,"Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post","Information provided by Dmitriy Akselrod, MD, University of Vermont (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT04234399?cond=Prostate%20Cancer&viewType=Card&page=12&rank=112
Prostate Cancer,NCT03693703,Comparison of Multi-parametric and Bi,Information provided by Fondazione del Piemonte per l'Oncologia (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03693703?cond=Prostate%20Cancer&viewType=Card&page=12&rank=113
Prostate Cancer,NCT03893123,Prostate Cancer Risk in Firefighters,"Information provided by Jarle Jakobsen, Norwegian Institute of Public Health (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT03893123?cond=Prostate%20Cancer&viewType=Card&page=12&rank=114
Prostate Cancer,NCT01787630,To Evaluate the Technique and Effects of Separating the Prostate and Rectum With Hyaluronic Acid During Radiotherapy,"Information provided by Anders Widmark, Umeå University (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT01787630?cond=Prostate%20Cancer&viewType=Card&page=12&rank=115
Prostate Cancer,NCT03289130,Dietary Factors and Racial Disparities in Prostate Cancer Aggressiveness,"Information provided by Susan Steck, University of South Carolina (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03289130?cond=Prostate%20Cancer&viewType=Card&page=12&rank=116
Prostate Cancer,NCT00992251,Eligard Observational Registry for Patients With Prostate Cancer,Information provided by CMX Research (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00992251?cond=Prostate%20Cancer&viewType=Card&page=12&rank=117
Prostate Cancer,NCT03397030,Impact of Exercise on Prognostic Biomarkers Related to Prostate Cancer,Information provided by The University of Texas Health Science Center at San Antonio (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03397030?cond=Prostate%20Cancer&viewType=Card&page=12&rank=118
Prostate Cancer,NCT03183544,Dosimetry and Safety Phase 1 Study With 68Ga-PSMA,Information provided by Cliniques universitaires Saint-Luc- Université Catholique de Louvain (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03183544?cond=Prostate%20Cancer&viewType=Card&page=12&rank=119
Prostate Cancer,NCT02967458,"Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study","Information provided by Flemming Forsberg, Thomas Jefferson University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02967458?cond=Prostate%20Cancer&viewType=Card&page=12&rank=120&tab=results
Prostate Cancer,NCT03361969,Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.,Information provided by Pantarhei Oncology B.V. (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03361969?cond=Prostate%20Cancer&viewType=Card&page=13&rank=121
Prostate Cancer,NCT03343093,Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors,Information provided by University of Minnesota (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03343093?cond=Prostate%20Cancer&viewType=Card&page=13&rank=122&tab=results
Prostate Cancer,NCT01171729,Autologous Dendritic Cell Therapy for Hormone,Information provided by Samsung Medical Center,Completed,https://clinicaltrials.gov/study/NCT01171729?cond=Prostate%20Cancer&viewType=Card&page=13&rank=123
Prostate Cancer,NCT03061643,An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously,"Information provided by Park, Se-Hoon, Samsung Medical Center (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT03061643?cond=Prostate%20Cancer&viewType=Card&page=13&rank=124
Prostate Cancer,NCT02729103,Treatment Patterns in Metastatic Prostate Cancer,Information provided by Bayer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02729103?cond=Prostate%20Cancer&viewType=Card&page=13&rank=125
Prostate Cancer,NCT01086956,Effect of Adding Sufentanil to Epidural Ropivacaine on Perioperative Metabolic and Stress Responses in Combined General/Epidural Anaesthesia for Geriatric Radical Retropubic Prostatectomy,Information provided by Yonsei University,Completed,https://clinicaltrials.gov/study/NCT01086956?cond=Prostate%20Cancer&viewType=Card&page=13&rank=126
Prostate Cancer,NCT01443026,The Effects of Lycopene on High Risk Prostatic Tissue,"Information provided by Peter Gann, University of Illinois at Chicago (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01443026?cond=Prostate%20Cancer&viewType=Card&page=13&rank=127&tab=results
Prostate Cancer,NCT00502723,Multicentric Study Comparing Carcinological and Functional Results of Surgery,Information provided by Assistance Publique - Hôpitaux de Paris (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT00502723?cond=Prostate%20Cancer&viewType=Card&page=13&rank=128
Prostate Cancer,NCT02909049,Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy,"Information provided by José Luis Ponce Díaz-Reixa, Complexo Hospitalario Universitario de A Coruña (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02909049?cond=Prostate%20Cancer&viewType=Card&page=13&rank=129
Prostate Cancer,NCT02311764,Carboplatin in Castration,"Information provided by Aurelius Omlin, Cantonal Hospital of St. Gallen (Responsible Party)",Terminated,https://clinicaltrials.gov/study/NCT02311764?cond=Prostate%20Cancer&viewType=Card&page=13&rank=130
Prostate Cancer,NCT01284608,Metabolic Changes in Prostate Cancer Patients With Androgen,Information provided by AstraZeneca (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01284608?cond=Prostate%20Cancer&viewType=Card&page=14&rank=131
Prostate Cancer,NCT01696539,Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer Patients,"Information provided by Ove Andrén, Örebro University, Sweden (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01696539?cond=Prostate%20Cancer&viewType=Card&page=14&rank=132
Prostate Cancer,NCT01996696,Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate,Information provided by AHS Cancer Control Alberta (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT01996696?cond=Prostate%20Cancer&viewType=Card&page=14&rank=133
Prostate Cancer,NCT01081873,Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer,Information provided by Abbott (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01081873?cond=Prostate%20Cancer&viewType=Card&page=14&rank=134&tab=results
Prostate Cancer,NCT06201078,Stereotactic Re,Information provided by Maria Sklodowska-Curie National Research Institute of Oncology (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06201078?cond=Prostate%20Cancer&viewType=Card&page=14&rank=135
Prostate Cancer,NCT00956228,Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer,Information provided by Mayo Clinic,Completed,https://clinicaltrials.gov/study/NCT00956228?cond=Prostate%20Cancer&viewType=Card&page=14&rank=136
Prostate Cancer,NCT01540994,Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer,"Information provided by Geoffrey Weinstein, M.D., Sharp HealthCare (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01540994?cond=Prostate%20Cancer&viewType=Card&page=14&rank=137&tab=results
Prostate Cancer,NCT00751790,Efficacy and Safety of a Triptorelin 6,Information provided by Debiopharm International SA (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00751790?cond=Prostate%20Cancer&viewType=Card&page=14&rank=138&tab=results
Prostate Cancer,NCT01337518,"A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration","Information provided by Enzon Pharmaceuticals, Inc. (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT01337518?cond=Prostate%20Cancer&viewType=Card&page=14&rank=139
Prostate Cancer,NCT00252460,CT/MRI Co,"Information provided by University Health Network, Toronto (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00252460?cond=Prostate%20Cancer&viewType=Card&page=14&rank=140
Prostate Cancer,NCT00247312,Pd-103 Dose De,"Information provided by Gregory Merrick, M.D., Schiffler Cancer Center (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00247312?cond=Prostate%20Cancer&viewType=Card&page=15&rank=141
Prostate Cancer,NCT00174863,Evaluation of SR 31747A Versus Placebo in Androgen,Information provided by Sanofi,Completed,https://clinicaltrials.gov/study/NCT00174863?cond=Prostate%20Cancer&viewType=Card&page=15&rank=142
Prostate Cancer,NCT00252447,Preop Conformal Radiotherapy,"Information provided by University Health Network, Toronto",Completed,https://clinicaltrials.gov/study/NCT00252447?cond=Prostate%20Cancer&viewType=Card&page=15&rank=143
Prostate Cancer,NCT00126854,High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy Implantation,Information provided by AHS Cancer Control Alberta (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00126854?cond=Prostate%20Cancer&viewType=Card&page=15&rank=144
Prostate Cancer,NCT00001446,A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone,Information provided by National Institutes of Health Clinical Center (CC),Completed,https://clinicaltrials.gov/study/NCT00001446?cond=Prostate%20Cancer&viewType=Card&page=15&rank=145
Prostate Cancer,NCT00178113,A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia,Information provided by University of Pittsburgh,Completed,https://clinicaltrials.gov/study/NCT00178113?cond=Prostate%20Cancer&viewType=Card&page=15&rank=146
Prostate Cancer,NCT06859203,"A Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA",Information provided by Technical University of Munich (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06859203?cond=Prostate%20Cancer&viewType=Card&page=15&rank=147
Prostate Cancer,NCT04304196,"Tailored, wEb-based, Psychosocial and Physical Activity Self","Information provided by Sylvie Lambert, St. Mary's Research Center, Canada (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04304196?cond=Prostate%20Cancer&viewType=Card&page=15&rank=148
Prostate Cancer,NCT06020287,The Robot,"Information provided by Fan Feng, Nanjing University School of Medicine (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT06020287?cond=Prostate%20Cancer&viewType=Card&page=15&rank=149
Prostate Cancer,NCT03444532,Feasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With Insomnia,"Information provided by Christoffer Johansen, Danish Cancer Society (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03444532?cond=Prostate%20Cancer&viewType=Card&page=15&rank=150
Prostate Cancer,NCT05048537,18F,Information provided by National Taiwan University Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05048537?cond=Prostate%20Cancer&viewType=Card&page=16&rank=151
Prostate Cancer,NCT06363266,A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers,"Information provided by Sylvie Lambert, St. Mary's Research Center, Canada (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06363266?cond=Prostate%20Cancer&viewType=Card&page=16&rank=152
Prostate Cancer,NCT00535977,"Broccoli, Peas and PIN",Information provided by Quadram Institute Bioscience,Completed,https://clinicaltrials.gov/study/NCT00535977?cond=Prostate%20Cancer&viewType=Card&page=16&rank=153
Prostate Cancer,NCT04633252,M9241 in Combination With Docetaxel in Adults With Metastatic Castration Sensitive and Castration Resistant Prostate Cancer,Information provided by National Institutes of Health Clinical Center (CC) (National Cancer Institute (NCI)) (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04633252?cond=Prostate%20Cancer&viewType=Card&page=16&rank=154
Prostate Cancer,NCT04801186,Retrospective Study to Describe the Real-world Treatment Patterns and Associated Clinical Outcomes in Patients With Metastatic Castration,Information provided by AstraZeneca (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04801186?cond=Prostate%20Cancer&viewType=Card&page=16&rank=155
Prostate Cancer,NCT05712174,A Study of [18]F-PSMA,Information provided by AHS Cancer Control Alberta (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT05712174?cond=Prostate%20Cancer&viewType=Card&page=16&rank=156
Prostate Cancer,NCT05407311,64Cu-SAR,Information provided by Clarity Pharmaceuticals Ltd (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05407311?cond=Prostate%20Cancer&viewType=Card&page=16&rank=157&tab=results
Prostate Cancer,NCT05249127,64Cu-SAR,Information provided by Clarity Pharmaceuticals Ltd (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05249127?cond=Prostate%20Cancer&viewType=Card&page=16&rank=158&tab=results
Prostate Cancer,NCT00298155,Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer,"Information provided by Bruce Montgomery, University of Washington (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00298155?cond=Prostate%20Cancer&viewType=Card&page=16&rank=159&tab=results
Prostate Cancer,NCT02436122,Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer,"Information provided by Sung Kyu Hong, Seoul National University Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02436122?cond=Prostate%20Cancer&viewType=Card&page=16&rank=160
Prostate Cancer,NCT00167648,Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancer,Information provided by University of Washington,Completed,https://clinicaltrials.gov/study/NCT00167648?cond=Prostate%20Cancer&viewType=Card&page=17&rank=161
Prostate Cancer,NCT00028353,A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN),Information provided by GTx,Completed,https://clinicaltrials.gov/study/NCT00028353?cond=Prostate%20Cancer&viewType=Card&page=17&rank=162
Prostate Cancer,NCT04457232,Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation,Information provided by Jonsson Comprehensive Cancer Center (Responsible Party),Active,https://clinicaltrials.gov/study/NCT04457232?cond=Prostate%20Cancer&viewType=Card&page=17&rank=163
Prostate Cancer,NCT06776172,Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0.,"Information provided by University Hospital, Basel, Switzerland (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06776172?cond=Prostate%20Cancer&viewType=Card&page=17&rank=164
Prostate Cancer,NCT03285048,Cognitive Remediation Therapy (CRT) for Adults Treated for Cancer,Information provided by Yale University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03285048?cond=Prostate%20Cancer&viewType=Card&page=17&rank=165
Prostate Cancer,NCT01764646,Hypofractionated Radiation Therapy in Prostate Cancer,"Information provided by Thomas Zilli, University Hospital, Geneva (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT01764646?cond=Prostate%20Cancer&viewType=Card&page=17&rank=166
Prostate Cancer,NCT03475433,An Observational Prospective Cohort Study Using an Actigraphy Device.,Information provided by Taipei Medical University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03475433?cond=Prostate%20Cancer&viewType=Card&page=17&rank=167
Prostate Cancer,NCT03242265,Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy,Information provided by ATGen Canada Inc (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT03242265?cond=Prostate%20Cancer&viewType=Card&page=17&rank=168
Prostate Cancer,NCT02526589,Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical Prostatectomy,Information provided by Tampere University Hospital (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02526589?cond=Prostate%20Cancer&viewType=Card&page=17&rank=169
Prostate Cancer,NCT04101305,Measurement of Circulating Tumor Cells in Prostate Cancer,"Information provided by Christer Ericsson, Sormland County Council, Sweden (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT04101305?cond=Prostate%20Cancer&viewType=Card&page=17&rank=170
Prostate Cancer,NCT04104607,The Bispecific PSMAxCD3 Antibody CC,Information provided by University Hospital Tuebingen (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04104607?cond=Prostate%20Cancer&viewType=Card&page=18&rank=171
Prostate Cancer,NCT01998685,Prothrombotic Factors and Anaesthesia in Prostate Cancer,"Information provided by Ester Forastiere, Regina Elena Cancer Institute (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01998685?cond=Prostate%20Cancer&viewType=Card&page=18&rank=172
Prostate Cancer,NCT06223295,Effectiveness of Focal Therapy in Men With Prostate Cancer,Information provided by Radboud University Medical Center (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06223295?cond=Prostate%20Cancer&viewType=Card&page=18&rank=173
Prostate Cancer,NCT04484701,[68Ga]Ga-PSMA,Information provided by British Columbia Cancer Agency (Responsible Party),Active,https://clinicaltrials.gov/study/NCT04484701?cond=Prostate%20Cancer&viewType=Card&page=18&rank=174
Prostate Cancer,NCT07006779,Effects of Music and Conversation in Prostate Biopsy,"Information provided by Volkan Selmi, Bozok University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT07006779?cond=Prostate%20Cancer&viewType=Card&page=18&rank=175
Prostate Cancer,NCT02687308,Open Anterograde Radical Prostatectomy Compared to Open Retrograde Technique,"Information provided by Fabricio Borges Carrerette, Rio de Janeiro State University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02687308?cond=Prostate%20Cancer&viewType=Card&page=18&rank=176
Prostate Cancer,NCT02430649,Irreversible Electroporation(IRE) For Unresectable Prostatic Neoplasms,"Information provided by Fuda Cancer Hospital, Guangzhou (Responsible Party)",Withdrawn,https://clinicaltrials.gov/study/NCT02430649?cond=Prostate%20Cancer&viewType=Card&page=18&rank=177
Prostate Cancer,NCT04887935,Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer,Information provided by Washington University School of Medicine (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04887935?cond=Prostate%20Cancer&viewType=Card&page=18&rank=178
Prostate Cancer,NCT02632669,Hemi,"Information provided by Stephen Langley, Royal Surrey County Hospital NHS Foundation Trust (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02632669?cond=Prostate%20Cancer&viewType=Card&page=18&rank=179
Prostate Cancer,NCT00152789,Normal Prostate: Oxygenation of the Prostate Gland in Men Undergoing Prostate Biopsy,"Information provided by University Health Network, Toronto",Completed,https://clinicaltrials.gov/study/NCT00152789?cond=Prostate%20Cancer&viewType=Card&page=18&rank=180
Prostate Cancer,NCT00660686,Exercise for Physical Health in Men With Prostate Cancer,Information provided by OHSU Knight Cancer Institute (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00660686?cond=Prostate%20Cancer&viewType=Card&page=19&rank=181
Prostate Cancer,NCT05714774,Evaluation of Different Methods of Ultrasound Image Analysis for Real,Information provided by Hospices Civils de Lyon (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05714774?cond=Prostate%20Cancer&viewType=Card&page=19&rank=182
Prostate Cancer,NCT05441501,A Study of JNJ,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05441501?cond=Prostate%20Cancer&viewType=Card&page=19&rank=183
Prostate Cancer,NCT06836154,Prostate Hyperfixation on PET-choline in Patients With Prostate Cancer: Correlation With MRI and Pathological Data (LOC,"Information provided by University Hospital, Brest (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT06836154?cond=Prostate%20Cancer&viewType=Card&page=19&rank=184
Prostate Cancer,NCT06601205,Finasteride and Flutamide in Pre,"Information provided by Andrea DeCensi, Ente Ospedaliero Ospedali Galliera (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT06601205?cond=Prostate%20Cancer&viewType=Card&page=19&rank=185
Prostate Cancer,NCT05228197,Imperial Prostate 6,Information provided by Imperial College London (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05228197?cond=Prostate%20Cancer&viewType=Card&page=19&rank=186
Prostate Cancer,NCT06072196,A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration,Information provided by Pfizer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06072196?cond=Prostate%20Cancer&viewType=Card&page=19&rank=187
Prostate Cancer,NCT03232164,PSMA-based 18F,"Information provided by University of Wisconsin, Madison (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03232164?cond=Prostate%20Cancer&viewType=Card&page=19&rank=188
Prostate Cancer,NCT05214937,A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors,"Information provided by Linda Trinh, University of Toronto (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05214937?cond=Prostate%20Cancer&viewType=Card&page=19&rank=189
Prostate Cancer,NCT07221825,Low-Count Quantitative SPECT for Men Treated With Radium,Information provided by Washington University School of Medicine (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT07221825?cond=Prostate%20Cancer&viewType=Card&page=19&rank=190
Prostate Cancer,NCT04428788,Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration,Information provided by Celgene (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04428788?cond=Prostate%20Cancer&viewType=Card&page=20&rank=191
Prostate Cancer,NCT02230059,Study to Assess the Treatment Patterns in Metastatic Castration,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02230059?cond=Prostate%20Cancer&viewType=Card&page=20&rank=192
Prostate Cancer,NCT07082920,A Study of JNJ-78278343 in Combination With JNJ,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT07082920?cond=Prostate%20Cancer&viewType=Card&page=20&rank=193
Prostate Cancer,NCT03819751,MRI,Information provided by Universitaire Ziekenhuizen KU Leuven (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03819751?cond=Prostate%20Cancer&viewType=Card&page=20&rank=194
Prostate Cancer,NCT06209853,Correlation Between PSA Levels and F,"Information provided by Aalaa Wael Hussein, Assiut University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT06209853?cond=Prostate%20Cancer&viewType=Card&page=20&rank=195
Prostate Cancer,NCT07109427,Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10,Information provided by Washington University School of Medicine (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT07109427?cond=Prostate%20Cancer&viewType=Card&page=20&rank=196
Prostate Cancer,NCT04854369,68Ga-PSMA,Information provided by Tulane University (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT04854369?cond=Prostate%20Cancer&viewType=Card&page=20&rank=197
Prostate Cancer,NCT02702908,Second Primary Cancers in Patients With Castration Resistant Prostate Cancer,Information provided by Bayer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02702908?cond=Prostate%20Cancer&viewType=Card&page=20&rank=198
Prostate Cancer,NCT03481816,Treatment of Castration Resistant Prostate Cancer Using Multi,"Information provided by Marijo Bilusic, M.D., National Cancer Institute (NCI) (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03481816?cond=Prostate%20Cancer&viewType=Card&page=20&rank=199&tab=results
Prostate Cancer,NCT05958004,The Application Value of Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA Grey Area Prostate Cancer,Information provided by First Affiliated Hospital Xi'an Jiaotong University (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT05958004?cond=Prostate%20Cancer&viewType=Card&page=20&rank=200
Prostate Cancer,NCT03648359,Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance,"Information provided by Lars Boesen, Herlev Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT03648359?cond=Prostate%20Cancer&viewType=Card&page=21&rank=201
Prostate Cancer,NCT02364531,A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting,Information provided by Janssen Inc. (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02364531?cond=Prostate%20Cancer&viewType=Card&page=21&rank=202
Prostate Cancer,NCT05422105,Diagnostic Performance of 18F-PSMA,"Information provided by Primo Biotechnology Co., Ltd (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05422105?cond=Prostate%20Cancer&viewType=Card&page=21&rank=203
Prostate Cancer,NCT04521894,The Application Value of 18F-prostate,Information provided by First Affiliated Hospital Xi'an Jiaotong University (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04521894?cond=Prostate%20Cancer&viewType=Card&page=21&rank=204
Prostate Cancer,NCT06151418,A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration,Information provided by Pfizer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT06151418?cond=Prostate%20Cancer&viewType=Card&page=21&rank=205&tab=results
Prostate Cancer,NCT04964271,Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants,Information provided by Tethis S.p.A. (Responsible Party),Active,https://clinicaltrials.gov/study/NCT04964271?cond=Prostate%20Cancer&viewType=Card&page=21&rank=206
Prostate Cancer,NCT05373316,Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR,Information provided by Radboud University Medical Center (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT05373316?cond=Prostate%20Cancer&viewType=Card&page=21&rank=207
Prostate Cancer,NCT06457854,Real-life Experience in Brazil in Patients With Castration,Information provided by AstraZeneca (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT06457854?cond=Prostate%20Cancer&viewType=Card&page=21&rank=208
Prostate Cancer,NCT04248621,Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients,Information provided by Wonju Severance Christian Hospital (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04248621?cond=Prostate%20Cancer&viewType=Card&page=21&rank=209
Prostate Cancer,NCT07104110,Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer,"Information provided by Qilu Pharmaceutical Co., Ltd. (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT07104110?cond=Prostate%20Cancer&viewType=Card&page=21&rank=210
Prostate Cancer,NCT04298112,PSMA,Information provided by Norwegian University of Science and Technology (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04298112?cond=Prostate%20Cancer&viewType=Card&page=22&rank=211
Prostate Cancer,NCT02759744,Fusion Guided Focal Laser Ablation of Prostate Cancer,Information provided by National Institutes of Health Clinical Center (CC) (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT02759744?cond=Prostate%20Cancer&viewType=Card&page=22&rank=212
Prostate Cancer,NCT04024475,Prostate Cancer Biobank,Information provided by Swiss Cancer Institute (Responsible Party),Active,https://clinicaltrials.gov/study/NCT04024475?cond=Prostate%20Cancer&viewType=Card&page=22&rank=213
Prostate Cancer,NCT05137561,Robotic,"Information provided by Rajender Kumar, Post Graduate Institute of Medical Education and Research, Chandigarh (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT05137561?cond=Prostate%20Cancer&viewType=Card&page=22&rank=214
Prostate Cancer,NCT05999968,Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment,Information provided by Eli Lilly and Company (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05999968?cond=Prostate%20Cancer&viewType=Card&page=22&rank=215
Prostate Cancer,NCT06547398,Prostate Adaptive Radiation Therapy,Information provided by Royal North Shore Hospital (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06547398?cond=Prostate%20Cancer&viewType=Card&page=22&rank=216
Prostate Cancer,NCT04898634,"A Study of JNJ-78278343, a T-Cell","Information provided by Janssen Research & Development, LLC (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04898634?cond=Prostate%20Cancer&viewType=Card&page=22&rank=217
Prostate Cancer,NCT04693910,Multimedia,"Information provided by Ching-Hui Chien, National Taipei University of Nursing and Health Sciences (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04693910?cond=Prostate%20Cancer&viewType=Card&page=22&rank=218
Prostate Cancer,NCT04852224,"Strength, Aging, and Memory in Prostate Cancer",Information provided by University of Nebraska (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04852224?cond=Prostate%20Cancer&viewType=Card&page=22&rank=219
Prostate Cancer,NCT00573820,Far Infrared Radiation Treatment for Prostate Cancer,Information provided by GAAD Medical Research Institute Inc.,Active,https://clinicaltrials.gov/study/NCT00573820?cond=Prostate%20Cancer&viewType=Card&page=22&rank=220
Prostate Cancer,NCT03961321,Stereotactic MR,"Information provided by Anna Bruynzeel, Amsterdam UMC, location VUmc (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03961321?cond=Prostate%20Cancer&viewType=Card&page=23&rank=221
Prostate Cancer,NCT05628363,Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate,Information provided by Washington University School of Medicine (Responsible Party),Active,https://clinicaltrials.gov/study/NCT05628363?cond=Prostate%20Cancer&viewType=Card&page=23&rank=222
Prostate Cancer,NCT04792138,Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.,"Information provided by University College, London (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04792138?cond=Prostate%20Cancer&viewType=Card&page=23&rank=223
Prostate Cancer,NCT04736199,Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone,Information provided by Bayer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04736199?cond=Prostate%20Cancer&viewType=Card&page=23&rank=224&tab=results
Prostate Cancer,NCT05241236,MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer,"Information provided by Urological Research Network, LLC (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05241236?cond=Prostate%20Cancer&viewType=Card&page=23&rank=225
Prostate Cancer,NCT02526797,Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance,"Information provided by Lars Boesen, Herlev Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT02526797?cond=Prostate%20Cancer&viewType=Card&page=23&rank=226
Prostate Cancer,NCT04295447,Adjuvant Apalutamide in Subjects With High,Information provided by Universität Münster (Responsible Party),Active,https://clinicaltrials.gov/study/NCT04295447?cond=Prostate%20Cancer&viewType=Card&page=23&rank=227
Prostate Cancer,NCT02546908,A Registry of Participants With Prostate Cancer in Asia,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02546908?cond=Prostate%20Cancer&viewType=Card&page=23&rank=228
Prostate Cancer,NCT04836949,Verification of Shear Wave Elastography for DEtection of Prostate Cancer,Information provided by Yonsei University (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT04836949?cond=Prostate%20Cancer&viewType=Card&page=23&rank=229
Prostate Cancer,NCT00160979,Transrectal Tumour Oxygen,"Information provided by University Health Network, Toronto (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00160979?cond=Prostate%20Cancer&viewType=Card&page=23&rank=230
Prostate Cancer,NCT03261999,"Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer","Information provided by Foresee Pharmaceuticals Co., Ltd. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT03261999?cond=Prostate%20Cancer&viewType=Card&page=24&rank=231&tab=results
Prostate Cancer,NCT02391025,Gallium,"Information provided by Rahul Aggarwal, University of California, San Francisco (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02391025?cond=Prostate%20Cancer&viewType=Card&page=24&rank=232
Prostate Cancer,NCT03565835,Abiraterone With Discontinuation of Gonadotropin,Information provided by Montefiore Medical Center (Responsible Party),Active,https://clinicaltrials.gov/study/NCT03565835?cond=Prostate%20Cancer&viewType=Card&page=24&rank=233
Prostate Cancer,NCT06707974,Prognostic Study of Via Dynamic Change of dT,"Information provided by Liu Cheng, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06707974?cond=Prostate%20Cancer&viewType=Card&page=24&rank=234
Prostate Cancer,NCT01347476,Aggressive Prostate Cancers in Elderly Patients,Information provided by Seoul National University Hospital,Completed,https://clinicaltrials.gov/study/NCT01347476?cond=Prostate%20Cancer&viewType=Card&page=24&rank=235
Prostate Cancer,NCT02788409,Incidence of Second Primary Malignancies in Castration,Information provided by Bayer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02788409?cond=Prostate%20Cancer&viewType=Card&page=24&rank=236
Prostate Cancer,NCT02963675,Incidence of Second Primary Malignancies in Prostate Cancer Patients With Bone Metastases,Information provided by Bayer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02963675?cond=Prostate%20Cancer&viewType=Card&page=24&rank=237
Prostate Cancer,NCT05364229,MR,"Information provided by University Health Network, Toronto (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT05364229?cond=Prostate%20Cancer&viewType=Card&page=24&rank=238
Prostate Cancer,NCT04628988,A Study of CC,Information provided by Celgene (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT04628988?cond=Prostate%20Cancer&viewType=Card&page=24&rank=239
Prostate Cancer,NCT00188708,Effect of Casodex on Tumour Hypoxia,"Information provided by University Health Network, Toronto (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT00188708?cond=Prostate%20Cancer&viewType=Card&page=24&rank=240
Prostate Cancer,NCT04689828,177Lu-PSMA-617 vs. Androgen Receptor,Information provided by Novartis (Novartis Pharmaceuticals) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04689828?cond=Prostate%20Cancer&viewType=Card&page=25&rank=241&tab=results
Prostate Cancer,NCT02940977,Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique,"Information provided by Jun Qi, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02940977?cond=Prostate%20Cancer&viewType=Card&page=25&rank=242
Prostate Cancer,NCT02363855,Phase 1 Dose Escalation Study of BAY 1841788 in Japanese Metastatic Castration,Information provided by Bayer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02363855?cond=Prostate%20Cancer&viewType=Card&page=25&rank=243
Prostate Cancer,NCT01400555,A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration,"Information provided by Cougar Biotechnology, Inc. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01400555?cond=Prostate%20Cancer&viewType=Card&page=25&rank=244
Prostate Cancer,NCT05022849,A Study of JNJ-75229414 for Metastatic Castration,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT05022849?cond=Prostate%20Cancer&viewType=Card&page=25&rank=245
Prostate Cancer,NCT01424930,A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration,"Information provided by Janssen-Ortho Inc., Canada (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01424930?cond=Prostate%20Cancer&viewType=Card&page=25&rank=246&tab=results
Prostate Cancer,NCT04126915,Precise Therapy for mCRPC Patients Through Whole Exome Sequencing(PTtWES),"Information provided by Yinghao Sun, Changhai Hospital (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT04126915?cond=Prostate%20Cancer&viewType=Card&page=25&rank=247
Prostate Cancer,NCT06276465,Treatment With Darolutamide +/,Information provided by UNICANCER (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT06276465?cond=Prostate%20Cancer&viewType=Card&page=25&rank=248
Prostate Cancer,NCT02102477,Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer,"Information provided by Olof Akre, Karolinska University Hospital (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT02102477?cond=Prostate%20Cancer&viewType=Card&page=25&rank=249
Prostate Cancer,NCT01976962,Functional MR,Information provided by CancerCare Manitoba (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT01976962?cond=Prostate%20Cancer&viewType=Card&page=25&rank=250
Prostate Cancer,NCT00568516,Phase II Study of ASP3550 in Patients With Prostate Cancer,Information provided by Astellas Pharma Inc (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00568516?cond=Prostate%20Cancer&viewType=Card&page=26&rank=251
Prostate Cancer,NCT02744534,Targeted Fusion Biopsy of the Prostate,"Information provided by Baowei Fei, PhD, EngD, Emory University (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02744534?cond=Prostate%20Cancer&viewType=Card&page=26&rank=252&tab=results
Prostate Cancer,NCT02446405,Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer,Information provided by University of Sydney (Responsible Party),Active,https://clinicaltrials.gov/study/NCT02446405?cond=Prostate%20Cancer&viewType=Card&page=26&rank=253
Prostate Cancer,NCT02854436,An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02854436?cond=Prostate%20Cancer&viewType=Card&page=26&rank=254&tab=results
Prostate Cancer,NCT03587285,A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer,"Information provided by Songtao Xiang, Guangzhou University of Traditional Chinese Medicine (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT03587285?cond=Prostate%20Cancer&viewType=Card&page=26&rank=255
Prostate Cancer,NCT06033001,Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration,Information provided by Lantheus Medical Imaging (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT06033001?cond=Prostate%20Cancer&viewType=Card&page=26&rank=256
Prostate Cancer,NCT03321864,Capture of Prostatic Trans,"Information provided by David Thurtle, Cambridge University Hospitals NHS Foundation Trust (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT03321864?cond=Prostate%20Cancer&viewType=Card&page=26&rank=257
Prostate Cancer,NCT04093375,,Non spécifié,Inconnu,https://clinicaltrials.gov/study/NCT04093375?cond=Prostate%20Cancer&viewType=Card&page=26&rank=258
Prostate Cancer,NCT02640534,Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone,Information provided by Swiss Cancer Institute (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT02640534?cond=Prostate%20Cancer&viewType=Card&page=26&rank=259
Prostate Cancer,NCT03424850,,Non spécifié,Inconnu,https://clinicaltrials.gov/study/NCT03424850?cond=Prostate%20Cancer&viewType=Card&page=26&rank=260
Prostate Cancer,NCT02869594,,Non spécifié,Inconnu,https://clinicaltrials.gov/study/NCT02869594?cond=Prostate%20Cancer&viewType=Card&page=27&rank=261
Prostate Cancer,NCT02531516,,Non spécifié,Inconnu,https://clinicaltrials.gov/study/NCT02531516?cond=Prostate%20Cancer&viewType=Card&page=27&rank=262
Prostate Cancer,NCT07202247,"Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT",Information provided by City of Hope Medical Center (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT07202247?cond=Prostate%20Cancer&viewType=Card&page=27&rank=263
Prostate Cancer,NCT04839367,Positron Emission Tomography (PET) Imaging of Participants With Confirmed Prostate Cancer Using 64Cu-SAR,Information provided by Clarity Pharmaceuticals Ltd (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04839367?cond=Prostate%20Cancer&viewType=Card&page=27&rank=264
Prostate Cancer,NCT03677414,Analysis of Androgene Receptors Axis and DNA Damage Repair Genes in Patients With Prostate Cancer,Information provided by Medical University of Graz (Responsible Party),Active,https://clinicaltrials.gov/study/NCT03677414?cond=Prostate%20Cancer&viewType=Card&page=27&rank=265
Prostate Cancer,NCT02260349,Interest of Indocyanine Green in Neoplastic Prostatic Tissue,Information provided by Centre Hospitalier Universitaire de Saint Etienne (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT02260349?cond=Prostate%20Cancer&viewType=Card&page=27&rank=266
Prostate Cancer,NCT03421015,Genetic Analysis of Prostate Cancer to Identify Predictive Markers of Disease Relapse or Metastatic Evolution,"Information provided by University Hospital, Lille (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT03421015?cond=Prostate%20Cancer&viewType=Card&page=27&rank=267
Prostate Cancer,NCT01640262,Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish Setup,Information provided by Copenhagen University Hospital at Herlev (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01640262?cond=Prostate%20Cancer&viewType=Card&page=27&rank=268
Prostate Cancer,NCT01946204,A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration,"Information provided by Aragon Pharmaceuticals, Inc. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01946204?cond=Prostate%20Cancer&viewType=Card&page=27&rank=269&tab=results
Prostate Cancer,NCT03501173,A Study of Participants With Advanced Prostate Cancer in Canada,Information provided by Janssen Inc. (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT03501173?cond=Prostate%20Cancer&viewType=Card&page=27&rank=270
Prostate Cancer,NCT05851547,Dose Escalation For INtraprostatic LEsions,Information provided by Ottawa Hospital Research Institute (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT05851547?cond=Prostate%20Cancer&viewType=Card&page=28&rank=271
Prostate Cancer,NCT06675357,Using FAPI PET/MRI to Evaluate Prostate Cancer,"Information provided by University of Wisconsin, Madison (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT06675357?cond=Prostate%20Cancer&viewType=Card&page=28&rank=272
Prostate Cancer,NCT03824275,18F,"Information provided by Matthew Dallos, Columbia University (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT03824275?cond=Prostate%20Cancer&viewType=Card&page=28&rank=273
Prostate Cancer,NCT03805919,Men at High Genetic Risk for Prostate Cancer,Information provided by National Institutes of Health Clinical Center (CC) (National Cancer Institute (NCI)) (Responsible Party),Recruiting,https://clinicaltrials.gov/study/NCT03805919?cond=Prostate%20Cancer&viewType=Card&page=28&rank=274
Prostate Cancer,NCT03066154,Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High,Information provided by The Netherlands Cancer Institute (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT03066154?cond=Prostate%20Cancer&viewType=Card&page=28&rank=275
Prostate Cancer,NCT00035113,EPO906 Therapy in Patients With Prostate Cancer,Information provided by Novartis (Novartis Pharmaceuticals) (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT00035113?cond=Prostate%20Cancer&viewType=Card&page=28&rank=276
Prostate Cancer,NCT04577833,A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT04577833?cond=Prostate%20Cancer&viewType=Card&page=28&rank=277
Prostate Cancer,NCT02560051,Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer,"Information provided by Robert J Amato, The University of Texas Health Science Center, Houston (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02560051?cond=Prostate%20Cancer&viewType=Card&page=28&rank=278&tab=results
Prostate Cancer,NCT03533998,Biomarkers in Prostate Cancer Treated With SRP Following Failure of FAT,Information provided by Institut Mutualiste Montsouris (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT03533998?cond=Prostate%20Cancer&viewType=Card&page=28&rank=279
Prostate Cancer,NCT02631616,Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga,"Information provided by Ofer Gofrit, Hadassah Medical Organization (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT02631616?cond=Prostate%20Cancer&viewType=Card&page=28&rank=280
Prostate Cancer,NCT04425200,Prevalence of HRR,Information provided by AstraZeneca (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04425200?cond=Prostate%20Cancer&viewType=Card&page=29&rank=281
Prostate Cancer,NCT01821404,Atorvastatin Before Prostatectomy and Prostate Cancer,"Information provided by Teemu Murtola, Tampere University Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01821404?cond=Prostate%20Cancer&viewType=Card&page=29&rank=282
Prostate Cancer,NCT02506114,Neoadjuvant PROSTVAC,"Information provided by Lawrence Fong, University of California, San Francisco (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02506114?cond=Prostate%20Cancer&viewType=Card&page=29&rank=283&tab=results
Prostate Cancer,NCT02563691,Stereotactic Radiotherapy for Oligometastatic Prostate Cancer,"Information provided by Dr. Patrick Cheung, Sunnybrook Health Sciences Centre (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT02563691?cond=Prostate%20Cancer&viewType=Card&page=29&rank=284
Prostate Cancer,NCT04034095,A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone,Information provided by Janssen Pharmaceutical K.K. (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT04034095?cond=Prostate%20Cancer&viewType=Card&page=29&rank=285
Prostate Cancer,NCT04108208,A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM,"Information provided by Janssen Research & Development, LLC (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT04108208?cond=Prostate%20Cancer&viewType=Card&page=29&rank=286&tab=results
Prostate Cancer,NCT02446444,"Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer",Information provided by University of Sydney (Responsible Party),Active,https://clinicaltrials.gov/study/NCT02446444?cond=Prostate%20Cancer&viewType=Card&page=29&rank=287
Prostate Cancer,NCT01446731,Dendritic Cell Vaccination and Docetaxel for Patients With Prostate Cancer,"Information provided by Inge Marie Svane, Herlev Hospital (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT01446731?cond=Prostate%20Cancer&viewType=Card&page=29&rank=288&tab=results
Prostate Cancer,NCT02217566,"Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo","Information provided by Janssen Research & Development, LLC (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02217566?cond=Prostate%20Cancer&viewType=Card&page=29&rank=289&tab=results
Prostate Cancer,NCT01796028,Metformin-Docetaxel Association in Metastatic Hormone,Information provided by Centre Antoine Lacassagne (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01796028?cond=Prostate%20Cancer&viewType=Card&page=29&rank=290
Prostate Cancer,NCT04918810,Biomarker-driven Intermittent Docetaxel in Metastatic Castration,Information provided by Australian and New Zealand Urogenital and Prostate Cancer Trials Group (Responsible Party),Terminated,https://clinicaltrials.gov/study/NCT04918810?cond=Prostate%20Cancer&viewType=Card&page=30&rank=291
Prostate Cancer,NCT04699344,"A Prospective, Single-centre，Single","Information provided by Yueqing Tang, Qilu Hospital of Shandong University (Responsible Party)",Recruiting,https://clinicaltrials.gov/study/NCT04699344?cond=Prostate%20Cancer&viewType=Card&page=30&rank=292
Prostate Cancer,NCT02234115,"Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma","Information provided by Foresee Pharmaceuticals Co., Ltd. (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02234115?cond=Prostate%20Cancer&viewType=Card&page=30&rank=293&tab=results
Prostate Cancer,NCT04557059,A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone,"Information provided by Janssen Pharmaceutica N.V., Belgium (Responsible Party)",Active,https://clinicaltrials.gov/study/NCT04557059?cond=Prostate%20Cancer&viewType=Card&page=30&rank=294
Prostate Cancer,NCT01618370,Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone,Information provided by Bayer (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01618370?cond=Prostate%20Cancer&viewType=Card&page=30&rank=295
Prostate Cancer,NCT01516762,Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone,Information provided by Bayer (Responsible Party),Inconnu,https://clinicaltrials.gov/study/NCT01516762?cond=Prostate%20Cancer&viewType=Card&page=30&rank=296
Prostate Cancer,NCT03523338,An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration,"Information provided by Aragon Pharmaceuticals, Inc. (Responsible Party)",Inconnu,https://clinicaltrials.gov/study/NCT03523338?cond=Prostate%20Cancer&viewType=Card&page=30&rank=297
Prostate Cancer,NCT02668276,Engaging Newly Diagnosed Men About Cancer Treatment Options,"Information provided by Peter Gann, University of Illinois at Chicago (Responsible Party)",Completed,https://clinicaltrials.gov/study/NCT02668276?cond=Prostate%20Cancer&viewType=Card&page=30&rank=298
Prostate Cancer,NCT01685489,A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration,Information provided by Bastyr University (Responsible Party),Withdrawn,https://clinicaltrials.gov/study/NCT01685489?cond=Prostate%20Cancer&viewType=Card&page=30&rank=299
Prostate Cancer,NCT01288911,A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer,Information provided by Astellas Pharma Inc (Responsible Party),Completed,https://clinicaltrials.gov/study/NCT01288911?cond=Prostate%20Cancer&viewType=Card&page=30&rank=300&tab=results
